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A range of non-sterile pharmaceutical preparations and raw materials were 
examined to determine level and type of microbial contamination. Various culture 
media were evaluated and where necessary methods developed to improve 
analysis. 
Emphasis was placed on development of membrane filtration procedures and 
evaluation of such procedures using natural contaminants of raw materials 
or final preparations rather than laboratory cultured organisms. 
Microbiological aspects of the manufacturing processes for creams and 
tablet preparations were also examined. 
Escherichia coli and Ps aeruginosa were isolated from a limited number of 
raw materials and final products, Salmonella and S aureus were not 
detected. 
Deficiencies were noted in certain media recommended for examination 
of raw materials, notably 0.03% cetrimide broth BP (1973). 
A membrane filtration procedure was developed for examination of gelatin 
which involved enzymic solubilisation, it was found to have advantages over 
BP and USP recommended methods. 
Published membrane filtration procedures for the microbiological analysis 
or sterility testing of ointment preparations were found to be unsatisfactory 
in terms of the quantity of material which could be tested. Alternative 
I. '" 
I 
filtration procedures were developed and validated for testing 20g samples 
of ointment. 
Tablet compression was demonstrated as having a marked antimicrobial 
effect, particularly against enterobacteria. 
The source of Ps aeruginosa contamination in a cream was identified, and 
the susceptibility of the preparation to contamination was demonstrated to 
be due, at least in part, to the final pH of the preparation. A problem in 
effective quality control sampling for determination of Ps aeruginosa 
contamination was demonstrated. A sensitive procedure for detection of Ps 
aeruginosa contamination is proposed. 
A BPC (197.3) procedure for sterilization of propylene glycol, a constituent 
of certain topical preparations, was found to be ineffective against various 
groups of micro-organisms from the soil. 
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The existence of spurious or inferior drugs in the market is not at all 
surprising, when we consider the perishable nature of vegetable substances 
and chemical compounds, the delicacy of many pharmaceutical processes, 
and the numerous casualties to which medicines are exposed in passing 
through a variety of hands. 
Jacob Bell 1841 
Pharmaceutical Journal&: Transactions Vol. 1 
2 
The problems involved in producing pharmaceutical preparations of 
consistent high quality have been recognised for many years, as witnessed 
by the quoted statement. Now it is essential to ensure that all pharmaceutical 
preparations and dosage forms attain the best achievable standards of 
quality and safety. These standards are regarded as 'Good Manufacturing 
Practice' and stated in official documents and guides such as the United 
States and British Pharmacopoeias, Code of Federal Regulations, and 
'Orange Guide' (1977). 
However, when the manufacture of sterile and non-sterile pharmaceutical 
preparations is considered certain important differences are apparent. 
Parenteral and other sterile preparations are manufactured to the highest 
standards to ensure freedom from viable micro-organisms and pyrogenic 
material. Non-sterile preparations are manufactured to less demanding 
standards which do not necessarily take such strict account of either 
the resultant level or type of microbial contamination. 
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1.1 Sterile pharmaceutical preparations 
The National Formulary (1926) was the first official controlling 
body to require all injectable drugs to be sterile, subsequently 
other authorities such as the British Pharmacopoeia made 
similar stipulations. 
Reports of deaths due to injection of anti toxin contaminated 
with Staphylococcus aureus were given by Kellway et al (1928) 
and Olin and Lithander (1948). Rabinowitz and Schiffrin 
(19 52) gave details of a glucose saline parenteral infusion 
contaminated with Serratia marcesens which caused meningitis 
but the report of Michaels and Ruebner (1953) which instanced 
2 cases of septicaemia contracted from a glucose saline infusion 
contaminated with coliform bacilli, created the greatest 
awareness of the dangers presented by contaminated parenterals 
(Maki 1976). Over the last 10 years, there have been further 
reported instances of infection caused by contaminated parenterals 
which have brought the problem under more serious review 
(Lapage et al 1973, Meers et al 1973). An epidemic of nosocomial 
septicaemia (USA Morbidity and Mortality Report 1971) occurred 
in the USA due to intrinsic contamination of one manufacturers 
infusion product with Enterobacter cloacae and E agglomerans. 
In Britain a similar but less widespread incident was reported 
by Meers et a! (1973) in which 4 people died, the causftive CL--
organisms were members of the Enterbacteriaceae which 
proliferated after surviving a faulty autoclave cycle. 
Table 1 A summarises some of the reported infections caused 
by contaminated parenteral drugs over the last 50 years. 
The majority are intravenous infusions and the implicated 
organisms are Gram negative bacilli which include species 
of Klebsiella, Enterobacter, Serratia and Pseudomonas; The 
clinical consequences of infection are usually bacteraemic 
shock and generalised septic infection. 
In reviewing the clinical significance of micro-organisms 
in parenteral products Parker (1971) suggests that low numbers 
of most organisms can be implanted in tissue with little effect, 
but that subcutaneous or intramuscular inoculation of S aureus, 
Clostridia and especially haemolytic streptococci could be 
more serious. He points out the most serious effects are 
associated with intravenous injection of fluids in which micro- . 
organisms have already multiplied, this is substantiated by 
the data available at present on reported infections (eg Meers 
et all973, Lapage et a! 1973 and Sack 1970). However, it 
must be appreciated that the converse is harder to demonstrate, 
a low level of microbial contamination in a drug may be difficult 
to identify and may only be associated with a limit~d number 
of units in a manufactured batch. 
To place the problem in perspective as far as the drug manufacturer 
is concerned, Maki (1974 and 1976) reports, that in spite of 
i 
the focus of attention placed on infusion therapy due to recent 
outbreaks caused by intrinsically contaminated infusions, 
the majority of infusion related infections are caused by 
extrinsic contamination. The organisms are introduced during 
use to the sterile cannula and infusion fluid. Basset (1971) 
similarly reports cases of septicaemia and wound infection 
due to catheters contaminated with Klebsiella and Pseudomonas. 
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TABLE lA 
PHARMACEUTICAL PREPARATIONS DOCUMENTED AS SOURCES 
OF HUMAN INFECTION 
Route of Administration:- Injection and Infusion 
SOURCE ORGANISM ILLNESS AUTHOR 
Blood Enterobacter sp. Endotoxic shock McEntegart 1956 
Human albumen Pseudomonas sp. Endotoxic shock Dykes 1962 
Heparin saline Ps. cepacia Bacteraemia Phillips et al 1972 
solution 
Glucose solution S. marcescens Meningitis and Rabinowitz and 
wound infection Schiffrin 1952 
Various drugs !.V. Fl. mengosepticum Transient Olsen 1967 
anaesthesia bacteraemia 
Various I. V. fluids Ps. thomasii Bacteraemia Phillip~ et a! 1972 
Dextrose Ringer C. freundii Not specified USA Morbidity and 
solution Mortality Report 
22' 1973 
Lymph for Staphylococcus Endotoxic shock Elek 1959 
vaccination sp. 
Unspecified S. viridans Mild shock Sack 1970 
intravenous solution 
Dextrose solution Klebsiella sp. Endotoxic shock Sack 1970 
Glucose Ringer E. cloacae Endotoxic shock Sack 1970 
solution K. pneumoniae 
Dextrose solution K. aerogenes Bacteraemia La page et a! 197 3 
Dextrose saline K. aerogenes Bacteraemia Lapage et al1973 
solution 
Dextrose solution K. aerogenes and Acute endotoxic Meers et a! 197 3 
unspecified shock 
enterobacteria 
Diphtheria antitoxin S. pyogenes Death by toxaemia Kellway et al 1928 
Measles convalescent S. pyogenes Death by toxaemia Olin and Lithander 
serum 1948 
Infusion product E. cloacae Septicaemia USA Morbidity and 
E. agglomerans Mortality Report 1971 
Dextrose saline Coliforms Septicaemia Michaels and Ruebner 
1953 
-- ---------
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1.2 Non-sterile pharmaceutical preparations 
It is only within the last 14 years that non-sterile pharmaceutical 
preparations have been seriously considered as a source of 
infection, but instances of infection were published much 
earlier. 
Garretson and Cosgrove (1927) and Bignell (1951) both reported 
Ps aeruginosa eye infections due respectively to administration 
of contaminated boric acid solution and penicillin eye drops. 
Kunz and Ouchterlomy (1955) reported cases of salmonellosis 
attributed to dried yeast used for tube feeding which was 
contaminated with Salmonella oranienberg and S montevideo 
and S softenberg. 
Tremewan (1946) demonstrated cases of tetanus in babies 
were caused by contaminated dusting powder used on umbilical 
cords. 
Reports published in the 1960's by five groups of workers 
were largely responsible for our present awareness of the 
health risks which may be associated with 'non-sterile' pharmaceutical 
preparations. 
Kallings et a! (1965 and 1966) gave details of an eye infection 
caused by a cortisone ointment contaminated with Ps aeruginosa 
and also reported of 200 cases of salmonellosis caused by 
thyroid tablets contaminated with S muenchen and S bareilly. 
Further investigations traced the source of the Salmonella 
to defatted thyroid powder. 
7 
Ayliffe et al (1966) reported 15 cases of post operative eye 
infection with subsequent loss of an eye in 6 cases. These 
infections were caused by saline solution used for moistening 
the cornea, the solution was found to be contaminated with 
strains of Ps aeruginosa of the same phage, pyocine and serological 
type as isolated from the infected eyes. 
Noble and Savin (1966) reported skin infections due to administration 
of a hospital diluted steroid cream found to be contaminated 
with Ps aeruginosa 
Lang et al (1967) and Eikhoff (1967) both reported many cases 
of salmonellosis caused by S cubana. The source was found 
to be carmine tablets contaminated with S cubana, the organism 
was traced back to the carmine dye which is derived from 
insects. 
A summary of infections attributed to non-sterile pharmaceutical 
preparations is given in Tables lB and lC. The number of 
infections attributed to non-sterile pharmaceutical products 
is relatively small in relation to their extensive use. However, 
it is doubtful if these fully mirror the extent of the problem. 
In most of the examples quoted it required a large number 
of infections or a hospital environment to reveal the source 
of the infection. A lower infection rate would be much more 
difficult to trace especially if a patient is not subject to 
regular hospital or medical supervision. A high patient infection 
rate could also be missed if the offending batch were not 
in common use, if only one patient in a hospital or locality 
is receiving product from the batch, possibly in association 
with other medicaments, the link between any resultant infection 
and the product could easily go undetected. 
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TABLE lB 
PHARMACEUTICAL REPARATIONS DOCUMENTED AS SOURCES 
OF HUMAN INFECTION 
Route of Administration:- Oral 
SOURCE ORGANISM ILLNESS AUTHOR 
Thyroid tablets S. muenchen Salmonellosis Kallings et al 1966 
S. bareilly 
Carmine capsules S. cubana Salmonellosis Lang et al 1967 
Carmine capsules S.cubana Salmonellosis Eikhoff 196 7 
Or ied yeast dietary S. oranienb~rg Salmonellosis Kunz and Ouchterlomy 
supplement S. montevideo 
S. softenb~rg 
1955 
f-
,r 1 
9 
TABLE lC 
PHARMACEUTICAL PREPARATIONS DOCUMENTED AS SOURCES 
OF HUMAN INFECTION 
Route of Administration:~ Topical (including inhalers) 
SOURCE ORGANISM ILLNESS AUTHOR 
Steroid cream Ps. aeruginosa Local skin Nobel and Savin 1966 
infection 
Dusting powder for Cl. tetani Tetanus Tremewan J91j.6 
umbilical cords 
Bronchodilator K. pneumoniae Septicaemia Morse et a! 1967 
vapourisary aerosol 
Hand cream K. pneumoniae Septicaemia Morse et a! 1967 
Eye irrigation fluid Ps.aeruginosa Panophthalmitis Aycliffe et a! 1966 
I hypopyon 
Lignocaine jelly Ps. aeruginosa 
(for endotracheal 
Respiratory Phillips !966 
tubes) 
Saline S. marcescens Umbilical sepsis McCormack and Kunin 1966 
Saline for eye FJ. Meningitis in Plotkin and McKitrick 
cleaning meningosepticum babies 1966 
Boric acid eye Ps. aeruginosa Ulceration of Garretson and Cosgrove 
irrigation soln. cornea 1927 
Corticosteroid Ps. aeruginosa Eye infection Kallings et a! 1966 
eye ointment 
Penicillin eye drops Ps. aeruginosa Eye infection Bignelll951 
Sodium bicarbonate Paecilomyces Eye infection USA Morbidity and 
contact lens rinse Jilacinus Mortality Weekly 
Report 1975 
Baby lotion Klebsiella sp. Eye infection Evans et a! 1972 
Aerosol solution S. marcescens Respiratory Sanders et a! 1970 
infection 
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In addition to the limited direct evidence of infections caused 
by non-sterile pharmaceutical preparations there are other 
arguments demonstrating that the microbiological state of 
non-sterile pharmaceutical preparations is significant, these 
are outlined in paragraphs 1.2.1 to 1.2.7. 
1.2.1 A pre-existing disease or condition increases susceptibility 
to infection 
The body has a range of defence mechanisms, if one of these 
is functioning incorrectly or is damaged, the chance of infection 
increases. 
Diseases such as diabetes mellitus, granulocytic leukaemia 
(Roberts 1971) interfere with immunological defence mechanisms. 
Patients with renal insufficiency, progressive uraemia and 
increasing acidosis have impairment of the normal granulocytic 
inflammatory reaction (Bruch 1972). 
Age can also affect the natural immunological defences, 
these can be impaired in the aged patient or lacking in the 
new born child, Antibody (!gM) fails to cross the placenta 
and this deficiency at birth is thought to increase chances 
of infection with Gram negative bacteria (Neter et al !955). 
Damage to the skin through dermatitis (Selwyn &: Chalmers 
1965), accident or burns, can greatly increase susceptibility 
to infection. Pseudomonas aeruginosa and other gram negative 
bacilli are particularly effective opportunistic pathogens and 
can rapidly colonise a layer of moist slough. 
11 
1.2.2 Modern medical treatments and techniques may decrease 
resistance to infection 
Topical steroids can locally depress both phagocytosis (Rebuck 
and Mellinger 1953) and the inflammatory response. The 
adrenol steroids predispose to infection by, destroying Jymphocytes, 
reducing inflammation, decreasing antibody production and reducing 
blood eosinophils (Laurence 1974). Polyethylene 
occlusion dressings are frequently used with topical steroid 
preparations, these cause a local increase in humidity with 
a resultant increase in the population of Gram negative bacteria. 
Savin (1967) suggests, that some ointments may also maintain 
the hydration of the skin with a similar effect on the population 
of Gram negative bacteria. 
Immunosuppressive drugs given to patients who have undergone 
transplant surgery, depress natural immunological defences. 
Ionising radiation and cytotoxic drugs both reduce normal 
leucocyte function. Antibiotics can interfere with the normal 
autochthonous microbial residents of the body which confer 
some resistance to the host against opportunistic invaders. 
Forkner (1958) demonstrated that systemic antibiotics can 
predispose to Pseudomonas septicaemia and Shehadeh and 
Kligman (I 963) showed antibiotic deodorants effective against 
Gram-positive bacteria, caused increased colonisation of 
the skin with Gram negative bacteria. 
Surgical techniques expose tissue to invading organisms, and 
certain parts of the body such as the meninges, chambers 
of the eye, endocardium and the urinary tract seem particularly 
susceptible to infection. 
---~~ ~--~~- ------------------ --~~ 
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The extensive use of catheters and artificial surgical implants 
provide further routes for invasion of opportunistic pathogens. 
1.2.3 Drugs may contain raw materials from animal and vegetable 
sources 
Many non-sterile pharmaceuticals contain active ingredients 
or excipients derived ..from a range of animal and vegetable 
sources. Infections currently attributed to such raw materials 
suggest they are not necessarily subject to controls which 
will ensure absence of pathogenic organisms. 
Carmine, a dyestuff derived from a dried and ground South 
African insect has caused two epidemics of salmone11osis, 
(Lang et al 1967 and Eikhoff 1967). Defatted thyroid powder 
used in thyroid tablets caused 200 cases of salmonellosis 
(Kallings 1966). Kallings (1966) suggests that routine bacteriological 
safety measures are not always applied by drug manufacturers 
when handling such materials. 
Sykes (1971) in his review of the microbial contamination 
raw materials cites a range of raw materials found to have 
high total viable counts including, senna, pancreatin, ginger, 
digitalis and thyroid powder which could have counts up to 
106 g-1• Other common excipients such as starch, agar, gelatin 
and gum acacia may be contaminated with enterobacteria 
and have total viable counts of up to 7 x 104 g - 1• (Pedersen 
and Ulrich 1968 and Kallings 1966). 
---------------------------------------------~-
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1.2.4 Modern pharmaceutical formulations may increase chances 
of microbial growth or survival in the product 
This situation applies mainly to creams which over the last 
20 years have been increasingly formulated with non-ionic 
rather than anionic emulsifiers (Bean 1967). Non-ionic surfactants 
give a more stable, smooth and visually appealing product. 
Unfortunately such preparations more readily support the 
growth of micro-organisms, notably species of Pseudomonas. 
The concentration of anionic surfactants used previously 
could be bactericidal, in contrast non-ionic emulsifiers possess 
little or no activity and may even be metabolized by certain 
micro-organisms (James 1965). 
1.2.5 The continual increase in the number of microbial species 
considered pathogenic 
Enterobacteria such as Serratia, species of Pseudomonas, 
Flavobacteria and other related bacteria which are entirely 
free living, have now been demonstrated as the cause of infections 
in man. 
A typical example is Serratia marcescens which like most 
other opportunistic pathogens infects patients with existing 
disorders or who have received broad spectrum antibiotics 
(Dodson 1968). Outbreaks of infection due to S marcescens 
have been associated mainly with intensive care (Dodson 
1968), renal dialysis (Taylor and Keane 1962) and nursery 
units (MacCormack and Kunin 1966). Patients at special 
risk are those with indwelling urinary catheters, endotracheal 
tubes and tracheostomy tubes (Lancaster 1962). In addition 
11; 
to urinary tract and respiratory infections S marcescens has 
been the cause of, septicaemia, endocarditis, meningitis and 
osteomyelitis (Anon Lancet 1977). The organism is usually 
transmitted by hand and can be isolated from sources such 
as, liquid soap, respirators, humidifier reservoirs and nebulisers 
(Farmer 1976). Ma<;Cormack and Kunin (1966) report umbilical 
sepsis caused by S marcescens contaminating a saline solution 
used on new born babies. 
Flavobacterium meningosepticum, an organism often found 
in tap water can cause meningitis in new born infants. Pseudomonas 
cepatia a plant pathogen and soil organism may cause urinary c 
tract infection, wound infection and bacteraemia; the source 
of the organism is invariably contaminated disinfectants 
(Phillips et all972) (Spiller et all971). Acinetobacter anitratus, 
a soil organism that can be isolated from the skin of 30% 
of healthy persons has been shown as the source of infections 
in man (Talpin et al 1963). Figure 1 illustrates the groups 
of Gram negative bacilli causing infection in man. 
Certain species of fungi must also be considered as free living 
organisms capable of causing infection. Fungi causing disease 
in humans are not obligate parasites requiring infection to 
diseminate the species. Aspergillus, a regularly isolated 
saprophyte, can cause localised infection of the foot, external 
ear, eye and lungs and under· certain circumstances may cause 
systemic infections. Patients receiving prolonged drug therapy 
or who suffer from a debilitating disease are most susceptible. 
Utz (1962) reported that A fumigatus and A flavus may invade 
the central nervous system of patients with diabetes melli tus 
or who are undergoing corticosteroid therapy. 
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FIGURE 1 
GROUPS OF GRAM-NEGATIVE BACILLI THAT CAUSE 
SEPTIC INFECTIONS IN MAN AS DESCRIBED BY 
PARKER 1971 
NORMAL FLORA OF MAN FREE LIVING 
Enterobacteria 
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E. coli 
Proteus group(--------
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Other fluorescen~ 
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? other 
?- - - - - - - - - - - - - -F1. meningosepticum 
---------Acinetobacter·---------+ 
{A. anitratus) {A. calcoaceticus) 
{A. lwoffi) 
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16 
1.2.6 Microbial spoilage of pharmaceutical preparations may occur 
A product must be considered as spoiled if contaminated 
with pathogenic micro-organisms. However, spoilage is more 
commonly understood as damage caused by the metabolic 
activity of contaminating organisms which renders the product 
unfit for use. 
A spoiled pharmaceutical product may be detected by the 
normal body senses but if missed could present a serious risk 
to the patient. Microbial activity may result in the accumulation 
of toxins or even inactivation of therapeutic properties. 
Given the correct growth conditions, a variety (microbial c\ 
"-
species produce toxic molecules. Endotoxins produced by 
Gram negative bacteria such as E coli or Pseudomonas are 
tightly bound to the cell lipopolysaccharide, these toxins 
are heat stable and extremely dangerous if present in products 
administered by injection. 
Endotoxins are of less significance in 'non-sterile' products 
as they are poorly absorbed by the oral route. In contrast 
exotoxins are lethal if allowed to enter the body by this route 
(Smart & Spoon er 1971 ), they are less tightly bound to the 
cell than endotoxins and readily liberated into the surrounding 
growth media. 
Bacterial exotoxins are strongly antigenic proteins and usually 
produced by Gram positive bacteria, but in recent years certain 
Gram negative species such as Shigella dysenteriae have 
also been found to produce such toxins. 
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Several species from the genus Clostridium produce exotoxins 
most notable being Cl botulinum, fortunately this anaerobic 
organism has strict conditions for growth unlikely to be attained 
in pharmaceutical preparations. 
Staphylococcus aureus produces toxin if allowed to multiply 
to the correct levels, this exotoxin has it's effects upon the 
tissues of the enteric tract causing food poisoning. 
Mycotoxins can be highly toxic and carcinogenic, the notable 
example is aflatoxin produced by A flavus (Barnes 1970) growing 
on stored ground nuts and grain. This suggests raw materials 
possessing a high fungal count must be viewed with extreme 
suspicion and storage conditions controlled to prevent fungal 
growth in raw materials or final products. 
Smart and Spooner (1971) also suggest, that the presence 
of micro-organisms or metabolic products in topical preparations 
may have an irritant effect, but as yet there is little direct 
evidence to support this. 
The ability of organisms such as Pseudomonas to use a wide 
variety of energy sources suggests that if growth occurs in 
a pharmaceutical preparation, pharmacologically active material 
could be metabolised. There appears to be little evidence 
for this as yet but Kedzia et al (1961) showed Pseudomonas 
and Corynebacterium species could cause a 20% reduction 
in the atropine content of eye drops. 
~---~~~ ---------------
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Final products or intermediates which contain large amounts 
of free water are particularly susceptible to microbial spoilage, 
hence simple aqueous solutions, aqueous suspensions, oil water 
emulsions, creams and lotions can be considered as higher 
spoilage risks than powders, tablets, capsules, oils and ointments. 
However, this latter anhydrous group cannot be ignored as 
traces of water may still contaminate the preparation permitting 
microbial growth. 
Certain pharmaceutical preparations are naturally preserved 
by ingredients such as sugar, alcohol or glycerol. Products 
in this category include syrups, linctuses, elixirs and tinctures. 
Other aqueous products require the addition of a preservative, 
to kill or inhibit the growth of contaminating micro-organisms. 
Selection of a suitable preservative for a pharmaceutical 
preparation can be a complex exercise and dependant on the 
product formulation and intended use. The agent chosen 
must not sensitise the user and must attain biologically active 
concentrations in the aqueous phase of the preparation. The 
biological activity of a preservative may be reduced in a 
number of ways which include, chemical reaction producing 
an inactive derivative; preferential partitioning of the preservative 
into the non-aqueous phase of a two phase or multi-phase 
product, adsorption onto the product container or closure, 
The choice of preservative is further complicated by the 
fact that certain micro-organisms notably pseudomonads 
can metabolise many anti-microbial agents (Hugo 1965). 
Reviews by Bean (1965, 1967 and 1971) and Russell (1974 & 1978) 
and Hugo & Russell (1980) discuss in detail problems associated with 
preservation of pharmaceutical preparations. 
---------------------------------- ----
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1.2.7 Consumer requirement 
The consumer is now more aware of the need for safety in 
materials to be ingested or used on the body, Bruch (1972) 
summarises the situation as "a change in the expectation 
of the consuming public". 
1.3 Regulatory controls imposed on non-sterile pharmaceutical 
preparations 
Reports of infections acquired from non-sterile pharmaceutical 
preparations, combined with the general concern over the 
possible health hazards presented by presence of pathogens 
in such preparations have resulted in regulatory authorities 
placing microbial limits on certain pharmaceutical products 
and raw materials. Examples of such controls are given in 
Table 2. 
1.4 Micro-organisms considered objectionable in non-sterile pharmaceutical 
products 
1.4.1 Oral Preparations 
Salmonellae are the only intestinal pathogens known to have 
caused infection due to ingestion of a contaminated oral 
medicament. The organisms implicated were S cubana in 
carmine capsules (Lang et al 1967 and Eikhoff 1967), S muenchen 
and S bareilly in thyroid powder (Kallings et al 1966) and 
three species of Salmonella present in a dietry supplement 
(Kunz and Ouchterlomy 1955). 
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TABLE 2 
EXAMPLES OF MICROBIAL LIMITS PLACED ON CERTAIN 
NON•STERILE PHARMACEUTICAL PREPARATIONS AND 
RAW MATERIALS 
Regulatory Micro-organisms Are total viable 
Authority recommended or count specifications 
required to be absent · recommended or 
required? 
British Pharmacopoeia Salmonella, E coli, No 
1973 Pseudomonas 
United States Salmonella, E coli, Yes 
Pharmacopoeia XIX Ps aeruginosa, 
S aureus 
Nordic Pharmacopoeia 'Coli-aerogenes' Yes 
1973 group 
Czechoslovak 'Pathogenic micro- Yes 
Pharmacopoeia organisms', indicators 
3rd Edition of faecal contamination 
European Not specified No 
Pharmacopoeia 
National Formulary Salmonella Yes 
1975 
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It is impossible to predict the minimum infective dose of 
a particular species or strain of Salmonella. This is dependant 
on many factors which include, the general health and natural 
resistance of the indivii:lual and the degree of protection 
given by material ingested, to the antibacterial effects of 
the digestive system. Approximately 30,000 viable cells 
of S cubana caused the infection associated with carmine 
capsules and Armstrong et al (1970) report, 104 viable cells 
of 5 typhimurium in ice cream caused infection. McCullough 
and Eisele (1951) using adult volunteers found 105 - 107 viable 
cells of 5 meleagridis and S anatum cause infection. Craven 
(1975) reported that as few as 103 viable cells of S eastbourne 
in chocolate were sufficient to cause infection. 
Salmonella also causes infection in a wide range of animals 
such as turkeys, chickens, cattle, horses and pigs. The animals 
named are all sources of, pharmacologically active ingredients 
such as thyroid powder, pancreatin, liver powder, pepsin and 
also non-active excipients such as gelatin. Lennington (1967) 
reports that salmonellae have been isolated from all these 
materials and also quotes dried yeast as a further source. 
Salmonellae have also been isolated from materials of vegetable 
origin, due to secondary contamination from an animal or 
insect source. Craven et al (1975) reports of salmonellosis 
contracted from chocolate made from cocoa beans contaminated 
with S eastbourne. Cocoa and other raw materials of vegetable 
origin such as starch are regularly incorporated in tablet 
preparations. 
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Salmonellae can infect apparently healthy people so are fairly 
obvious objectionable contaminants of oral medicaments, 
as Table 2 shows this has been recognised by regulatory authorities. 
It is harder to decide which other micro-organisms to consider 
as objectionable contaminants of oral preparations. Other 
organisms appearing in regulatory monographs are, Pseudomonas, 
S aureus and E coli and other members of the Enterobacteriaceae. 
Escherichia coli is a member of the normal bowel flora of 
man and many animals but certain serotypes cause diarrhoea! 
disease in infants. The presence of E coli in water is indicative 
of recent faecal pollution as the organism has limited ability 
to survive and multiply outside the body. It must be concluded 
that the presence of E coli in a non~sterile preparation is 
similarly indicative of faecal pollution and poor hygienic 
standards, at some stage in the preparation of the raw material 
or final product. 
Other members of the Enterobacteriaceae must also be considered 
_such as Proteus, Citrobacter, Enterobacter and Serratia. 
Certain species or strains may be normal members of the 
bowel flora while others are entirely free living (Fig 1). Under 
normal circumstances these organisms are not likely to cause 
infection via the oral route, they are opportunistic pathogens and 
attack areas of the body such as the urinary tract eg Proteus 
and K pneumoniae (Pelczar and Reid 1965 and Stewart 1968). The 
presence of enterobacteria in either a raw materials or final 
products must be viewed with suspicion as such organisms 
must have arrived by one of the following routes: 
----------------· -
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(a) A raw material or final product may have been in 
direct contact with faecal material. This is further 
substantiated if E coli or Streptococcus faecalis is 
isolated. 
(b) If the enterobacteria isolated are 'free living' species, 
the presence of large numbers in the final product 
would suggest proliferation had occurred during the 
manufacture or storage of either, the final product 
or one of it's constituent raw materials. 
(c) A raw material or the final product has been in contact 
with decayed material containing free living enterobacteria. 
(d) The pres~nce of low numbers of enterobacteria in 
the final product or a raw material may be due to 
cross contamination from a heavily contaminated 
container, piece of equipment or raw material. 
Staphylococcus aureus produces exotoxins under certain growth 
conditions so if detected in large numbers in a raw material 
or final product toxin may be present. If low numbers of 
S aureus are detected these could be survivors from a large 
population but it is more likely they are incidental contaminants 
from process operators or the atmosphere. Repeated isolation 
of S aureus in these circumstances is certainly indicative 
of poor hygiene during manufacture, even though the organism 
presents no health risk when ingested by the patient. 
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Species of Pseudomonas are most significant as contaminants 
of topical preparations but cannot be completely ignored 
as contaminants of oral medicaments, even though there 
is only limited evidence they cause clinical infection when 
entering the body orally. Pseudomonas aeruginosa, if ingested 
at levels of over I o6 (Buck and Cooke I 969) may colonise 
the gut of the normal person, but this condition is usually 
transitory unless antibiotic therapy is being given concurrently. 
Shooter et a! (1969) suggest the patient undergoing such therapy 
is then at risk of septic infection due to self infection with 
Ps aeruginosa. 
Just as E coli is used as an indicator of faecal contamination, 
isolation of Pseudomonas from a pharmaceutical preparation 
or constitutive raw material suggests contact with various 
contamination sources. Such sources include stored or stagnant 
water, damp cleaning equipment and disinfectant solutions 
(Baird et a! 1976). In each of these situations certain species 
of Pseudomonas may multiply rapidly, all can occur during 
pharmaceutical manufacture. Manufacturing machines may 
be left wet after cleaning, cleaning equipment stored damp, 
. disinfectant solutions may be incorrectly prepared, controlled 
or even stored in a dilute state. 
Pseudomonas species may cause spoilage if allowed to proliferate 
in either, a poorly preserved product or during an aqueous 
intermediate stage of manufacture (eg tablet granulation). 
It would be dangerous to ignore presence of Pseudomonas 
species in oral preparations, they serve as a warning of, questionable 
e 
raw materials, a poor manufacturing process or an inatquately 
preserved product. 
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There are other micro-organisms such as Shigella and Brucella 
which also present a risk of infection if present in an oral 
preparation. Bruch (1971) includes Candida albicans in this 
category as this species causes infections of the mouth, Louira 
(1971) also reports Candida may infect the lungs and kidneys 
via the gut. In addition to S aureus there are other organisms 
which under certain conditions produce enterotoxins, these 
include readily isolated species such as S faecalis and Bacillus 
cereus. 
1.4.2 Preparations for topical administration 
Included in this group are preparations administered to both 
the external body surfaces and to mucous membranes. 
Pseudomonas aeruginosa shows little pathogenicity to healthy 
people or to tissues which have a good blood supply. In contrast 
it is very infective, to patients with poor resistance to infection 
and to tissues of the body with a low antibody content such 
as the exterior eye and meninges. Bruch (1971) states that, 
Ps aeruginosa is the most lethal organism to the human eye 
and Crompton (1962) reported that as few as 50 cells of Ps 
aeruginosa in the anterior chamber of the eye could cause 
infection. Garretson and Cosgrove (1927), Bignell (1951), 
Ridley (1958) and other workers such as Vaughan (1955) report 
on the danger and consequences of eye infection caused by 
Ps aeruginosa, which can result in corneal ulcers and possible 
evisceration of the eye. They further suggest that use of 
contaminated medicaments may be the cause of a significant 
proportion of these infections. Theodore and Feinstein (1952) 
state that nearly all Pseudomonas infections of the eye could 
be attributed to contaminated eye solutions. 
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As a result of these observations the FDA (1953) required ophthalmic 
solutions to be sterile and multidose preparations to contain 
a preservative. In 1964 the FDA also required contact lens 
solutions and cosmetic preparations for eye cleansing to be 
sterile. Prompted by incidents involving a contaminated 
saline solution (Ayliffe et al 1966) and a contaminated antibiotic 
ointment (Kallings et al 1966) in Britain and Sweden respectively, 
the British and Nordic Pharmacopoeias further require eye 
ointments to be sterile. In both incidents severe eye disorders 
and even blindness resulted from infection with Ps aeruginosa. 
The list of infections attributed to contaminated topical 
pharmaceutical preparations (Table 1 C) shows Ps aeruginosa 
to be the most common cause of eye infection. 
Ps aeruginosa is also infectious to other parts of the body. 
Bruch (1971) states that this organism may be associated 
with, septicaemia, endocarditis, skin infections, meningitis, 
gastroenteritis, osteomyelitis, arthritis, genito-urinary tract 
infections, respiratory tract infections, a complication in cystic 
fibrosis and general infection possibly leading to death in leukaemic 
patients. Polk et al (1969) state that, Ps aeruginosa is the major 
cause of sepsis and death in patients suffering burns. 
There have been two major reports of infection attributed 
to topical pharmaceutical preparations contaminated with 
Ps aeruginosa other than to the eye. Noble and Savin (1966) 
showed skin infections were caused by a contaminated diluted 
steroid cream. Phillips (1966) demonstrated that contaminated 
lignocaine jelly used on endotracheal tubes caused a respiratory 
infection. 
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Infections attributed to medical equipment and disinfectants 
contaminated with Ps aeruginosa are more numerous as shown 
in Table 3. The list clearly demonstrates the special risk 
Ps aeruginosa presents to the patient. 
Ps aeruginosa shows a high degree of resistance to many 
antibiotics and so has an advantage as an opportunistic pathogeri 
taking over the biological vacuum created by such therapy. 
Increased use of antibiotics has certainly caused a rise in 
the number of Ps aeruginosa infections (Savin 1967). 
Pseudomonas aeruginosa also demonstrates resistance to 
many other non-antibiotic antibacterial agents (Russell 1974), 
some agents may even serve as a carbon source for the organism. 
Adair et al (1969} report a strain of Ps aeruginosa was able 
to grow in a solution containing only benzalkonium chloride 
and sodium chioride. 
Pseudomonas aeruginosa is found in moist environments such 
as sinks, drains, damp cleaning cloths and mops, this is significant 
as these environments may occur in hospitals or pharmaceutical 
manufacturing areas (Ayliffe 1974), (Whitby and Rampling 
1972). Like many other free living Gram negative bacilli Ps 
aeruginosa will proliferate in water apparently devoid of 
organic matter, by metabolising traces of nutrient material. 
Baird et al (1976) reported on a contamination problem encountered 
in a number of hospital pharmacies; distilled water supplies 
and certain items of equipment in the manufacture areas 
were found contaminated with Ps aeruginosa. Creams, lotions 
and disinfectants prepared in these pharmacies were regularly 
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TABLE 3 
NOSOCOMIAL INFECTIONS ATTRIBUTED TO HOSPITAL EQUIPMENT 
AND DISINFECT ANTS 
SOURCE ORGANISM ILLNESS AUTHOR 
Cytoscope disinfected Pseudomonas sp. Urinary tract Mitchell & Hayward 
in chlorohexidine infection 1966 
Catheter disinfected Ps. cepacia Urinary tract Hardy et a! 1970 
in quaternary infection 
ammonium 
Diluted Savlon Ps. cepacia Wound sepsis Bassett et a1 1970 
disinfectant 
Oxygenator Pseudomonas sp. Wound sepsis Keown et a! 1957 
disinfected with 
benzalkonium chloride 
Cardiac ea theters Ps. aeruginosa Bacteraemia Schick man 19 59 
disinfected with 
benzalkonium chloride 
Faucet aerator Pseudomonas sp Wound infection Cross et a! 1966 
Respiratory Ps. aeruginosa Respiratory Phillips & Spencer 
ventilator infection 1965 
Surgical instrument Ps. aeruginosa Urinary infection Moore & Forman 1966 
Pre-operative shaving Ps. aeruginosa Meningitis Ayliffe et a! 1965 
equipment for neuro-
surgery 
Plaster of Paris Ps. aeruginosa Wound infection Sussman & Stevens 
bandages 1960 
Ventilator S. marcescens Respiratory, wound Cabrera 1969 
infections 
Suction apparatus Ps. aeruginosa Meningitis and Bassett et a! 1965 
pneumonia 
Ultra-sonic nebulizer, S. marcescens Respiratory Ringrose et a! 1968 
disinfected in 
gluteraldehyde 
Benzalkonium E. c1oacae Septicaemia Malizia et a! 1960 
chloride soln 
Printol and Pseudomonas sp. Wound infection Cragg & Andrews 1969 
ch1orohexidine 
Tracheal catheters Ps. aeruginosa Pneumonia Sutter et a1 1966 
Blood pressure Ps. cepacia Septicaemia Philipps et a! 1971 
monitoring apparatus 
-------------~-------------------------
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Table 3 Cont'd 
SOURCE ORGANISM ILLNESS AUTHOR 
Water trap on Salmonella sp. Salmonellosis Rubenstein &. Fowler 19 55 
resuscitator 
Delivery room Ps. aeruginosa Septicaemia and Fierer et al 1967 
resuscitator pneumonia 
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contaminated with Ps aeruginosa, similar strains were subsequently 
isolated from patients. 
The dangers presented by the use of topical pharmaceutical 
preparations contaminated with Ps aeruginosa can be summarised 
as follows: 
(a) These preparations present an ideal vehicle for Ps 
aeruginosa enabling contact with a debilitated host 
or susceptible part of the body. 
(b) The hospital pharmacy or industrial manufacturing 
area can provide an ideal growth situation for Ps aeruginosa. 
(c) Topical preparations may serve as selective media 
for the growth of Ps aeruginosa. 
Other members of the genus Pseudomonas are opportunistic 
pathogens and may cause nosocomial infections, their presence 
in topical preparations certainly represent a possible hazard 
to the user. Mitchell and Hayward (1966) and Hardy et al 
(1970), report urinary tract infections due respectively to 
chlorohexidine contaminated with an unspeciated Pseudomonas 
and a quaternary ammonium compound contaminated with 
Ps cepacia. In both cases the antibacterial preparations were 
used to disinfect medical equipment. Basset et a! (1970) 
reports of wound sepsis caused by diluted Savlon contaminated 
with Ps cepada. There are a number of reports of contaminated 
medical equipment (Table 3) causing Pseudomonas infections 
eg Keown et a! (1957), Shickman (1959). 
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Bruch (1971) suggests that two other species should be considered 
as objectionable in topical preparations, Ps putida and Ps 
multivorans. These organisms can be associated with urinary 
tract infections and wound sepsis. He further indicates that 
Ps stutzeri (a soil and water organism) as a contaminant of 
eye preparations could play on indicator role for presence 
of Ps aeruginosa. In the USA (Bruch 1971), Ps stutzeri found 
as a contaminant of eye cosmetics has already resulted in 
a number of product recalls. 
Like Ps aeruginosa many other pseudomonads can multiply 
in distilled water, disinfectant solutions (Bur don and Whitby 
1967) and in damp conditions such as drains, mops and sinks 
(Baird et a! 1976). Pseudomonads can break down a wide 
range of industrial products, so as contaminants of topical 
preparations must be considered as potential spoilage oragnisms. 
Tenenbaum (1971) lists some of these products as, hydrocarbons 
including petrolatum, alkanes and aromatics such as benzene. 
They produce enzymes induced by benzoic and anthranilic 
acid; produce lipase, oxidise fatty acids, ferment maltose 
lactose, cellobiose and melibiose. They produce enzymes 
which can liquify gelatin, attack casein and perform amylolysis. 
They are micro-aerophilic and some species can even grow 
at 0°C. 
The presence of Salmonella, E coli and other members of 
--
the Enterobacteriaceae in topical preparations may not present 
a significant hazard to the patient but certain species may 
cause infection, such as E coli which can cause urinary tract 
infections. 
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However, the presence of enterobacteria in topical preparations 
is indicative of poor hygiene in manufacture of the raw material 
or final product and must place a product under suspicion. 
There are two members of the Enterobacteriaceae, Klebsiella 
and Serratia which are important exceptions and present 
a risk of infection 'to the patient. Certain species of each 
are known to be opportunistic pathogens and to be the cause 
of nosocomial infections. 
Klebsiella has been demonstrated as the cause of septicaemia, 
urinary tract infections, respiratory infections, eye infections 
and wound infection, usually attacking the newborn (Bruch 
1972). Species of Klebsiella are frequently resistant to antibiotics 
and Weil et <1!. (1966) report that on one ward, Klebsiella type 
25 caused six cases of septicaemia, in infants with enterocolitis, 
this strain was resistant to all the common antibiotics used 
at the hospital. Some strains of Klebsiella are free living, 
others are found as commencals in the bowel. 
There have been a number of Klebsiella infections attributed 
to non-sterile topical preparations (Table !C). Evans et al 
(1972) report, five cases of conjunctivitis in newborn children 
due to the use of baby lotions contaminated with a strain 
of Klebsiella. Morse et al (1967) gives details of septicaemia 
in an intensive care unit caused by hand cream contaminated 
with Klebsiella. Mertz et al (1967) reports of necrotising 
Gram negative bacillary pneumonia caused by K pneumoniae, 
the organism contaminating bronchodilator solutions (chlorobutanol 
0.5%) administered by intermittant positive pressure breathing 
--------
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apparatus (IPPB). The nebulisers used with IPPB machines 
are designed to produce aerosols that on inhalation will reach 
the alveoli, by-passing protective mechanisms in the upper 
respiratory tract. It is not surprising therefore, that pulmonary 
infection may result from inhalation of contaminated aerosol 
solutions. 
Most strains of Serratia isolated in clinical practice are~ 
marcescens and 9096 of these are the non-pigmented, (Phillips 
and King 1977) (Wilkowske et a! 1970), other strains such 
as S liquefaciens and S rubidaea may be isolated, usually 
from the respiratory tract (Johnson & Ellner 1974), (Ewing 
et a! 1972). Serratia marcescens has been discussed previously 
as an example of a recently recognised opportunistic pathogen, 
that causes a range of infections, usually in young or debilitated 
patients. It has also been reported as the cause of infections 
derived from topical pharmaceutical preparations and medical 
equipment. McCormack & Kunin (1966) reported cases of 
umbilical sepsis due to use of contaminated saline solution. 
Cabrera (1969) reports of respiratory and urinary infections 
contracted from an IPPB machine with a contaminated nebuliser. 
There are no reports of S aureus infections aquired either 
from topical pharmaceutical preparations, or from disinfectants 
and medical equipment (Table 3). This organism is normally 
isolated from the anterior nares and may spread from this 
site, temporarily surviving on the skin or in the atmosphere. 
It is the cause of severe skin infection such as impetigo boils 
and carbuncles, but is not thought to have any important 
reservoir outside man (Elek 19 59). It is not surprising therefore, 
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that S aureus is considered by Bruch (1972) as an 'objectionable' 
contaminant of topical pharmaceutical preparations and the 
USP XIX recommends examination for this organism. Marples 
(1976) discussing toiletries and cosmetics suggests that these 
products should also be free of S aureus. 
Elek and Conen (1957) demonstrated that in man an inoculum 
of about 106 viable cells of S aureus given by intradermal 
injection was required to form pus. This number could be 
reduced if a foreign body or thread were left in the wound. 
Singh et a! (1971) demonstrated that application of 106 or 
moreS aureus cells cm2 of skin then covered.by an occlusive 
dressing, produces a flora containing large numbers of S aureus, 
and if maintained for a few days lesions could be induced. 
Marples and Kligman (1972) demonstrated an inoculum of 
104 viable cells on skin damag~d by the repeated application 
and removal of clear adhesive tape, caused rapid infection 
which was 'too severe for experimental use'. 
Although evidence points to the necessity of high inocula 
of S aureus to cause infection, there is an increased risk to 
damaged skin or skin in which hydration is increased. Both 
these conditions may occur when topical pharmaceutical 
preparations are administered. Occulsive dressings are regularly 
used in conjunction with skin preparations such as corticosteroid 
creams and ointments. The preparations themselves also 
have an occlusive effect increasing hydration of the skin. 
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There appears to be only one report of a mycotic infection 
attributed to topical pharmaceutical preparations. An allegedly 
sterile solution of sodium bicarbonate used to pretreat intraocular 
lenses prior to implantation in the eye was contaminated 
with Paecilomyces li!acinus, this caused eleven cases of ocular 
infection (USA Morbidity and Mortality Weekly Report 1975). 
In assessing the health risk presented by fungi as contaminants 
of topical pharmaceutical preparations it must be appreciated 
that modern medicine has increased the chance of infection 
with these organisms. The use of, antibiotics (~uria et a! 
1962) and adrenal glucocorticoids, the advent of transplantation 
surgery (Remington 1971) and disruption of host defences 
to treat tumours, all predispose the patient to opportunistic 
infection which can be, and often is, mycotic. 
Louria (1971), lists fungi known to have caused superinfection 
and the fungi which can commonly cause infection in a host 
compromised in varying ways (Tables 4A and 4C). Both lists 
illustrate the range of disorders and treatments which facilitate 
infection and the wide range of fungi which can be pathogenic, 
many of which are common saprophytes. Bruch 0976) lists 
a range of fungi isolated from lesions of the eye (Table 4B) 
and suggests a trauma such as a corneal puncture by a mascara 
brush may be sufficient to facilitate infection. 
The two genera of fungi probably of most concern to the 
debilitated patient, are Aspergillus and Candida. 
36 
TABLE 4A 
FUNGI INVOLVED IN SUPERINFECTION (LOURIA 1971) 
Candida albicans 
Candida tropicalis 
Candida guilliermondi 
Candida parapsilosis 
Candida krusei 
Geotrichum sp. 
Histoplasma capsulatam 
Nocardia asteroides 
Coccidioides immitis 
Saccharomyces 
Rhodotorula 
Aspergillus sp. 
Mucor sp. 
Allescheria boydii 
Trichophyton sp. 
Cryptococcus neoformans 
Torulopsis glabrata 
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TABLE 4B 
FUNGI INVOLVED IN EYE INFECTIONS (BRUCH 1976) 
Candida albicans 
Candida parapsilosis 
Aspergillus sp. 
Cephalosporium sp. 
Cladosporium sp. 
Curvularia sp. 
Fusarium sp. 
Monosporium sp. 
Penicillum sp. 
Paecilomyces sp. 
Scopulariopsis sp. 
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TABLE 4C 
MYCOTIC SUPERINFECTION IN THE DEBILITATED HOST 
(LOURIA 1971) 
Disease or Circumstance 
Lymphoma 
Acute leukemia 
Alveolar proteinosis 
Tuberculosis 
Bronchiectasis 
Kidney transplantation 
Heart transplantation 
Diabetes 
During steroid therapy 
During intensive antibiotic therapy 
Following major cardiac vulvular 
surgery 
Burns 
Intravenous use of illicit drugs 
Subacute bacterial endocarditis during 
intravenous treatment 
Fungal Agents Likely to Superinfect 
Cryptococcus, Nocardia 
Candida, Aspergillus, Mucor 
Nocardia 
Aspergillus 
Aspergillus 
Candida, Aspergillus, Nocardia, 
Cryptococcus 
Aspergillus 
Mucor, Cryptococcus, Candida 
Candida, Aspergillus, Nocardia 
Candida, Aspergillus 
Candida 
Mucor 
Candida 
Candida, Rhodotorula 
I 
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Aspergillus can grow in blood vessels producing symptoms 
which mimic non-infected pulmonary infarction (Young et 
a! 1970), and can colonise cavities in the lung forming Aspergillomas. 
Fungus growing on the wall of a cavity may then peel off 
to form a fungus ball, which gives a characteristic X-ray 
picture. Aspergillomas nearly always arise in diseased lungs, 
tuberculous cavities being a common site but other conditions 
may predispose such as, lung abscess, sarcoidosis, pulmonary 
infarction, lung cyst, pneumoconiosis, histoplasmosis, or carcinoma 
of the lung (Anon Lancet 1977). 
Epstein et a! (1967) have shown that Aspergillus infections 
in mice mediated by aerosol are far worse in cortisone-treated 
animals, they observed that lung phagocytes were unable 
to destroy ingested spores. Merkow et a! (1968) suggest this 
inability is related to steroid stabilisation of 1ysosomes which 
prevent degranulation within macrophages. 
Species of Candida cause a wide range of local and systemic 
infections. Bodey (1966) reported that of 91 patients with 
leukaemia and a complicating severe fungal infection, 55 
were infected with Candida. Louria (1971) reports that C 
albicans and C tropica!is can infect damaged heart valves. 
Systemic candidiasis can occur also, the organism gaining 
access, through the gut, a vascular needle or a catheter. 
Candida species further cause common less severe local infections 
of mucous membranes, skin and nails, an example being the 
tongue infection, 'thrush'. 
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The data available ori fungal infections clearly suggests that, 
the manufacturer of topical pharmaceutical preparations 
should examine his products for these organisms. The degree 
of risk presented by any isolates, then needs to be assessed 
in the context of the product and its intended use. The FDA 
have already suggested recalls of certain medical products 
when significant levels of fungal contaminants have been 
demonstrated. (FDA Weekly Recall Reports 1973 and 1974). 
The fungi commonly implicated were Aspergillus species. 
In addition to the groups of organisms mentioned, there are 
other species which as contaminants of topical pharmaceutical 
preparations, may present a hazard to the user. 
1remewan (1946) reports Clostridium tetani in umbilical 
dusting powder caused infection, but there have been no more 
recent reports of anaerobic infection acquired from topical 
pharmaceutical preparations. However, Finegold et al (1971) 
suggest, that all the conditions in a compromised host which 
predispose to infection in general may predispose to anaerobic 
infection. 
There are other Gram negative bacteria which are of concern, 
such as Fl meningosepticum which can cause disease in the 
newborn infant even by external contact (Bassett 1971). 
Plotkin and McKitrick (1966) describe an outbreak of meningitis 
caused by Fl meningosepticum which contaminated saline 
used to rinse babies eyes. Cabrera and Davis 0961) report 
a similar incident which occurred in a premature baby unit, 
cleaning material was contaminated with Fl meningosepticum 
by a leaking sink trap, ten of the fourteen infected babies 
died. 
--------------------- --- ------------------
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Parker (1971) reported that Acenetobacter anitratus, a soil 
organism commonly found on the skin is the source of occasional 
infection in man, but as yet has not been implicated in outbreaks 
attributed to contaminated pharmaceutical preparations. 
Bruch (1972) considers that this organism, along with Ps aeruginosa, 
E coli, Proteus mirabilis, S marcescens and Klebsiella species 
--
is an objectionable contaminant of genito-urinary tract products. 
It is difficult to know how many other possible microbial 
contaminants of topical pharmaceutical preparations should 
be considered as potentially harmful to the patient. This 
is exemplified by Sabeth (1971) who considers S epidermidis, 
(usually assumed to be a harmless skin commensal) to be 
an 'emerging pathogen'; due to its role in endocarditis of 
prosthetic valves and its ability to infect shunts implanted 
to alleviate hydrocephalus. 
1.5 Microbiological examination of non-sterile pharmaceutical 
preparations 
Over the last 14 years various workers have studied the level 
and type of microbial contamination present in non-sterile 
pharmaceutical preparations and their raw materials. The 
studies were triggered by an increasing awareness of the 
infection risks associated with such preparations and the 
introduction of microbial limits by certain regulatory authorities. 
A summary of 24 studies into the microbiological contamination 
of raw materials and final products is presented in Tables 
5 and 6, samples examined were from commercial sources 
and hospital pharmacies. 
AUTHOR 
, Kallings et al 1966 
! Fuglsang-Smidt et al 
I and Fisher et al 1968 
' 
Ludhorf and Tybring 
1969 
Ulrich et al 1971 
Desvignes et al 1973 
Public Health 
Laboratory Service 
1971 
SUMMARY OF STUDIES ON THE MICROBIOLOGICAL CONTAMINATION 
OF NON-STERILE PHARMACEUTICAL PREPARATIONS 
TABLE 5 
. COUNTRY WHERE 
STUDY PERFORMED 
Sweden 
Denmark 
Denmark 
Denmark 
France 
Great Britain 
PREPARATIONS 
EXAMINED 
Topicals, tablets 
and orals 
Tablets 
Oral Liquid 
Topical 
Topical and oral 
Topical and oral 
AIM OF STUDY 
Survey of microbial contamination of 
purchased drugs. 
Samples mainly from Danish pharmacies 
examined for tvc and contamination with 
E coli and Salmonella. 
--
Samples from Danish pharmacies 
examined for tvc and contamination 
with E coli and Salmonella. 
Samples from Danish pharmacies 
examined for tvc and contamination 
with E coli, S aureus and Ps aeruginosa. 
Market samples examined for tvc and 
specific pathogens. 
Ward samples examined for tvc and 
specific pathogens. 
RESULTS 
Ps aeruginosa detected in one batch of 
eye ointments. S aureus. Candida and 
E coli !sola ted from other preparations. 
saiiiiOnella isolated from thyroid tablets. 
Majority of tablets ha~1 tvc between 
< 10 - 300 organisms g 4 cer.rfi~ ~a tches . had counts between 10 - 10 g • E colt 
and Salmonella not detected. 
Majority of sa1_11ples had tvc of< I Omicro-
organisms mC • 06casi~nal batches had 
counts reaching 10 ml- • E coli isolated 
from, one batch, Salmonella not detected. 
Those specific pathogens not isolated, 
majority of the sample1 had tvc of 
< 1 Omicro-organisms g- , osca:)ional 
batched were as high as 10 g- • 
69% o) samples found to have a tvc of 
< 10 g- • Enterobacteria and Ps aeruginosa 
isolated from one batch. 
Ps aeruginosa isolated from 2.7% of 
samples, Salmonella not deteped. 68% 
of samples had tvc of 500 f /~1-1, but 
18% had counts of> 104 g- /ml- • 
AUTHOR 
Beveridge and Hope 
1971 
Gallien 1972 
Bruch 1971 
Bowman et al 1970 
Bowman et al 1970 
Bowman et al 1972 
Wargo 1973 
Libanska and Navratil 
1972 
COUNTRY WHERE 
STUDY PERFORMED 
Great Britain 
Germany 
USA 
USA 
USA 
USA 
USA 
Czechoslovakia 
PREPARATIONS 
EXAMINED 
Pharmaceutical 
solutions 
Tablets 
Topical drugs and 
cosmetics 
Antibiotic 
ophthalmic 
ointments 
Antibiotics 
Ophthalmic 
ointments 
Ointments 
Ointments and 
tablets 
AIM OF STUDY 
Stocks of solutions from eight hospitals 
pharmacies examined for tvc and 
specific species. 
A limited range of commercial tablets 
examined for tvc. 
Market samples examined for tvc and 
specific pathogens. 
Market samples examined for level and 
type of contamination. 
Market samples examined for level and 
type of contamination. 
Market samples examined for level and 
type of contamination. 
Commercially available samples 
examined for level and type of 
contamination. 
Market samples examined for level and 
type of contamination. 
TABLE 5 Cont'd 
RESULTS 
Majority of samples had fvc of 
<lOmicro-organisms mC but some dyes, 
waters and ~her ~reparations had counts 
reaching 10 mr • Pseudomonads were 
isolated from some samples. 
Major!ty of ~rmples had tvc of<lOmicro-
orgamsms g • 
19.5% of samples were contaminated, 
3.6% of these with pseudomonads. 
S aureus was not detected. 
Only 7% of batches were contaminated 
Gram positive rods and fungi were 
isolated. 
25% of samples c~ntaminated, but all 
had a tvc of 50g- • 
20% of samples contamina!jd, but most 
with<IOmicro-organisms g • 
11% of samples contaminated before use 
and 93% after use. Gram negative rods 
isolated from all used samples. 
5 -l . Tablets with tvc of I 0 g r~orded, 1the majority within the range 10 -IOJg- , no 
pathogenic species isolated. All ointments 
had tvc of<50. 
AUTHOR 
Hirsch et a11969 
Baird et al1976 
Carrington & 
Terry 1980 
COUNTRY WHERE 
STUDY PERFORMED 
USA 
Great Britain 
Great Britain 
PREPARATIONS 
EXAMINED 
Oral Liquids 
Topical 
Oral Liquid 
AIM OF STUDY 
Commercial and hospital preparations 
examined for level and type of 
contamination. 
Samples prepared in hospital pharmacies 
examined for contamination with 
Ps aeruginosa. 
Magnesium trisilicate mixture examined 
for level and type of contamination. 
TABLE 5 Cont'd 
RESULTS 
The majority of samples had tvc below 
500. E coli detected in one sample but 
other enterobacteria were more commonly 
isolated. 
996 of the samples examined were 
contaminated with Ps aeruginosa. 
Counts initially less tha~ 100, during use 
could increase to 3 x 10 , isolates tna!nly 
Gram positive bacilli and cocci or moulds. 
...................... ------------------------------------------
I AUTHOR 
Kallings et al 1966 
Pedersen and Ulrich 
1968 
Shiller et al 1968 
Harrewijn et al 1972 
Westwood 1971 
Gallien 1972 
TABLE 6 
SUMMARY OF STUDIES ON THE MICROBIAL CONTAMINATION OF RAW MATERIALS 
COUNTRY WHERE 
STUDY PERFORMED 
Sweden 
Denmark 
Switzerland 
Netherlands 
Great Britain 
Germany 
TOBE USED IN 
Tablets 
Oral and topical 
Tablets 
Oral 
Oral and topical 
Tablets 
AIM OF STUDY 
Starches and thyroid examined for 
tvc and specific pathogens. 
To examine a wide range of raw 
materials for tvc and contamination 
with E coli and Salmonella. 
-· 
Examine effect of processing on tvc 
of natural raw materials. 
Pharmaceutical grade lactose examined 
for tvc and specific pathogens. 
A range of raw materials examined for 
tvc and specific !>athogens, (samples 
from pharmacies). 
A range of raw materials examined for 
tvc and specific pathogens. 
RESULTS 
Potato starch found to be contaminated 
wi)h c?liforms and tvc was typically 
10 g- • Salmonella detgctep in thyroid 
powder, tvc typically 10 g- • 
Salmonella not detected, E coli detected 
in 10 different batches, w~de1 ran~ I of tvc ranging from<lo- 10 gl /ml the 
majority of batches(!OO g . 
Certain active ingredientsdr~T veget?ble 
sources had tvc of over 10 g , chemical 
processes can reduce the count. 
Enterbocateria isolated from 1 Og but not 
from lg samples. No E coli, Salmonella, 
S aureus detect~, Ihe tvc in 90% of 
samp}fs was<). 0 g- • No samples exceeded 
600g .• 
-1 80% of samples had a tvc of<l OOg , 
rhubarb powder, tragacanth powder and 
a few otyer materials had counts ranging 
up to 10 g- • Pseudomonas, E coli, 
Salmonella and Proteus not detected. 
Pseudomonas and Enterobacteria including 
E coli isolated from some raw materials 
--- 5 1 tvc up to 2 x 10 g- recorded. 
I 
i 
I 
I 
[AUTHOR 
Kruger 1973 
Buhlmann et al1972 
COUNTRY WHERE TO BE USED IN 
STUDY PERFORMED 
Germany Oral and topical 
Germany Oral and topical 
AIM OF STUDY 
A wide range of raw materials examined 
for tvc and specific pathogens. 
Survey of results from 4 companies 
examined for tvc, Ps aeruginosa and 
enterobacteria. 
TABLE 6 Cont'd 
RESULTS 
E coli and Ps aeruginosa isolated 
from pancreatin, no pathogenic species 
isolated from ~ther materials. Majority 
of tvc's<500g- • 
Majority of samijl':.1 had tvc of<l02g - 1, 
but count of l 0 g recorded. 
Enterobacteria isolated from some natural 
materials, and a small number contained 
Ps aeruginosa. 
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Significant points to emerge. 
(a) Most workers found levels of contamination were low, 
in at least 90% of the samples studied total viable 
counts were less than lOOg -l but there were certain 
raw materials and final product samples with much 
higher counts. Pedersen and Ulrich (1968) and Schiller 
et al (i968) both reported counts of over 106 g-1 in 
certain raw materials of natural origin such as digitalis 
and senna. More common excipients such as starch, 
gelatin, gum acacia and agar were regularly found 
to have counts in the range 10~- 105 g-l (Buhlmann 
et al (1972), Westwood (1971) and Pederson and Ulrich. 
(1968)). Tablets and other oral preparations were 
reported with counts reaching 105 g -l by Desvignes 
et a! (1973), Kallings et a! (1966), Beveridge et al (1971), 
Fuglsang-Smidt et al (1968), Luhdorf and Tybring (1969) 
and Libsanska and Navratil (1972). Fewer high counts 
were reported for samples of topical preparations, 
but Ulrich et a! (1971) and the Public Health Laboratory 
Service (1971) reported counts in the range 104 - 105 
g -1. 
(b) The studies demonstrated that at least 95% of the 
samples tested were free from Salmonella, E coli, 
Ps aeruginosa and S aureus. 
Salmonella was isolated in only one instance, this was 
from thyroid powder (Kallings 1966), and S aureus 
was isolated in just three instances each from unspecified 
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topical preparations (Kallings 1966). E coli and Ps 
aeruginosa were isolated more frequently from raw 
materials and in the case Ps aeruginosa also from 
final products. 
E coli was typically detected in raw materials of natural 
origin such as pancreatin (Kruger 1973), gum acacia, 
digitalis and lactose (Pedersen and Ulrich 1968), there 
are only three reports of the isolation of this organism 
from final products,all were oral liquid preparations 
(Kallings (1966), Hirsch et a! (1969), Luhdorf and Tybring 
(1969)). Buhlmann et a! (1972), Kruger (1972), Gallien 
(1972) all reported detection of Pseudomonas or Ps 
aeruginosa in one or more raw materials, these included 
gelatin, pancreatin, gum acacia and talc. A number 
of studies report Ps aeruginosa, isolated from final 
products. Probably of most significance is the work 
of Kallings (1966) who reported eye infections due 
to use of contaminated eye ointment. British workers 
have also reported isolation of Ps aeruginosa from 
oral and topical preparations manufacturered in hospital 
pharmacies. (Public Health Laboratory Services (1971), 
Beveridge (1971), Baird (1976)). 
(c) The microbiological data generated by British workers 
is largely confined to preparations, manufactured 
in hospital pharmacies (Public Health Laboratory Service 
(1971), Beveridge (1971), Baird (1976) and Westwood 
(1971)). There is little data on preparations produced 
commercially or concerning raw materials used. 
----------------------
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(d) In relation to the massive world-wide production and 
use of non-sterile pharmaceutical preparations the 
amount of data published on microbial contamination 
is small. 
To obtain a meaningful assessment of the microbiological 
contamination of a raw material or a final product, appropriate. 
microbiological test procedures must be followed. Techniques 
are recommended in pharmacopoeias such as the USP XIX 
and BP 1973 and include procedures for estimation of total 
viable counts and detection of named pathogens such as Salmonella 
and Ps aeruginosa, also detailed are alternative methods 
for testing materials which cannot be examined effectively 
by the standard techniques, eg gum tragacanth (BP 1973) and 
petrolatum based ointments (USP XIX). 
A range of techniques has been suggested by various authors 
many of which are similar to those specified in pharmacopoeias 
notably the USP XVIII and XIX. Miller and Korczynski (1972) 
outline fuller details of procedures given in the USP XVIII, 
they suggest the use of filtration to examine liquids, and 
that membranes be placed directly on selective media without 
pre-enrichment in a non-selective media. Kruger and Zimmermann 
(1975) suggest EE broth for enrichment of E coli, Salmonella 
and other Enterbacteriaceae, instead of lactose broth (USP 
XIX) or nutrient broth (BP 1973). They further recommend 
enrichment of samples in thioglycollate broth to detect obligate 
anaerobes. Buhlmann (1968) and Buhlmann et al (1970) suggest 
that membrane filtration be used to examine appropriate 
samples and advise the use of violet red bile dextrose agar 
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instead of MacConkey agar (USP XIX BP 1973) for detection 
of enterobacteria. Henning and Cos tin (1972) suggest a test 
for Enterobacteriaceae be used in conjunction with the USP 
XVIII test for E coli. Oli ver (1972) and Abdou (1973) outline 
procedures for detection of Ps aeruginosa and other named 
pseudomonads, these are more detailed than the procedures 
specified in Pharmacopoeias (USP XIX and BP 1973). They 
further suggest a series of media for detection of Ps aeruginosa 
which differ from those specified in the USP and BP. 
Various methods are suggested for examining ointments, 
the USP XIX recommends isopropyl myristate as a solvent 
and vehicle for petrolatum based ointments which can then 
be filtered through a membrane. The BP 1973, Nordic Pharmacopoeia 
and Buhlmann (1968), each suggest pre-treatment of the ointment 
with a surfactant such as Tween 80, the ointment is emulsified 
and a sample withdrawn for culture. 
There is little data available as yet on the effectiveness of 
the techniques suggested by either regulatory authorities 
or other workers to examine raw, materials and final preparations. 
Abdou (1973) suggests there are shortcomings in the cetrimide 
agar media recommended in the USP XVIII to detect Ps aeruginosa, 
he noted that other organisms such as certain Enterobacter 
species and Proteus species could also be isolated on this media. 
Hart et a! (1976) studied the isolation of Ps aeruginosa and 
other named pseudomonads using the procedures proposed 
in the BP 1973 and USP XIX and suggested that the cetrimide 
media recommended by both compendia was unsuitable for 
the detection of low numbers of pseudomonads. 
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The use of isopropyl myristate as a vehicle for ointments 
and oils was first suggested by Sokolski and Chidester (1964), 
then further detailed by Tsuji et a! (1970) and Tsuji and Robertson 
(1970). Allwood and Hambleton (1972 and 1973) compared 
isopropyl myristate with a range of ointment solvents and 
found it to give problems with detection of E coli but not 
B megaterium. Hart and Ratansi (1975) in contrast found 
no problems in the recovery of Ps aeruginosa from oily creams 
using isopropyl myristate. Table 7 gives a summary and 
comparison of filtration techniques for microbiological examination 
of ointment preparations. 
This study examined levels and types of microbial contamination 
in raw materials and non-sterile pharmaceutical preparations . 
. 
Appropriate techniques were critically evaluated and if necessary 
alternatives developed, preference was given to membrane 
filtration procedures. Where necessary microbiological aspects 
of pharmaceutical manufacturing processes were examined. 
Emphasis was given to non-sterile products but any points which 
emerged relating to sterile products were also given consideration. 
TABLE 7 
COMPARISON OF PUBLISHED MEMBRANE FILTRATION TECHNIQUES 
FOR THE MICROBIOLOGICAL EXAMINATION OF OINTMENT PREPARATIONS 
Solvent or dispersant Materiaf under Quantity Test organism Recovery Author 
examination filtered (g) efficiency (96) 
Light liquid paraffin Oily cream 0.2 Ps aeruginosa 
(NCTC 7244) 
2 Hart & Ratansi (197.5) 
White soft paraffin 0.01 E coli (NCTC 64 Allwood & Hambleton (1973) 
9001) 
White soft paraffin 0.5 E coli (NCTC 0 All wood &: Hambleton (1973) 
9001) 
White soft paraffin 0.025 E coli (NCTC 23- 39 Walsh & Allwood (1973) 
9001) 
J 
n Hexane Oily cream 0.2 Ps aeruginosa 2 Hart & Ratansi {197.5) ! 
(NCTC 7244) 
White soft paraffin not specified B megaterium 29-56 Allwood &: Hambleton (1972) 
but<0.5 (ATCC 8245) 
White soft paraffin 0.025 E coli (NCTC 8 Walsh & Allwood (1973) 
9001 
White soft paraffin 0.025 E coli (NCTC 5 Allwood &: Hambleton (1973) 
9001) 
Isopropyl myristate Oily cream 0.2 Ps aeruginosa 
(NCTC 7244) 
56 Hart&: Ratansi (!975) 
White soft paraffin not specified B megaterium 100 Allwood &: Hambleton (1972) 
but<0~5 (ATCC 8245) 
White soft paraffin 0.025 E coli (NCTC 5 A!Jwood & Hambleton (1973) 
9001) 
White soft paraffin 0.025 E coli (NCTC 9- 11 Walsh & Allwood (1973) 
9001) 
Ophthalmic ointment 0.5 E coli (NCTC 49 Tsuji et al (1970) 
31!4) 
Ophthalmic Ointment 0.5 Ps aeruginosa 
(Clinical 
80 Tsuji et a! (1970) 
isolate) 
Isopropyl myristate, Ophth.a~mic ointment ( 0.5 Ps aerUginosa 71 Tsuji & Robertson (1970) 
carbon disulphide contammg (ATCC 0145) 
xylene, mixture wax ( 
( 0.5 B subtilis 78 Tsujl &; Robertston (1970) (ATCC 6633) 
Peptone water + 
I% (w/v) Tween 80 
Oily cream 0.2 Ps aeruginosa 
(NCTC 7244) 
52 Hart & Ratansi (1975) 
White soft paraffin Not specified B megaterium 9 Allwood & Hambleton (1972) ! 
but 0.5 (ATCC 8245) 
White soft paiaffin 0.01 E coli (NCTC 75 Allwood & Hambleton (1973) 
900!) 
White soft paraffin 0.5 E coli (NCTC 0 Allwood & Hambleton (1973} 
900!) 
White soft paraffin 0.025 E coli (NCTC 54- 82 Walsh & Allwood (1973) 
9001) 
Peptone water + Ophthalmic ointment Not specified E coli (UC 23 .Tsuji et a! (1970) 
0.196 polyethylene, 3114) 
glycol ether 
(Millipore Application Ophthalmic ointment Not specified Ps aeruginosa 8 Tsuji et a! (1970) 
Report AR16) (Clinical 
isolate) 
2 MATERIALS, METHODS & EXPERIMENTAL 
2.1 MATERIALS 
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2.1 Materials 
2.1.1 Inorganic and organic laboratory chemicals and solvents 
Unless specified otherwise, these were purchased from BDH and 
were of Analar grade. 
2.1.2 Non-ionic surface active agents 
Triton X 100 (Scintillation grade) was obtained from BDH, 
Tergitol 15-S-9 from Union Carbide UK and Tween 80 from 
Honeywell Atlas. 
2 .1.3 Oils and waxes 
These were all of pharmaceutical grade, liquid paraffin and light 
liquid paraffin were purchased from Fina UK, isopropyl 
myristate from Givauden and Fluka, white soft paraffin from Silkolene, 
almond oil from Evans, coconut oil from Alpha Chemicals, propylene 
glycol from Durham Chemicals, arachis oil from London Oil Medina 
and ethyl oleate from BDH. 
2.1.4 Gelatin 
Gelatin of various grades including pharmaceutical edible and 
non-edible were supplied by P Leiner and Sons, Rousselot 
Gelatine, Alfred Adams, Davis Gelatine and Croda Food 
Ingredients. 
----------~---~- -----
1 
I 
I 
I 
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2.1.5 Enzymes 
A protease ('Proteinase') was purchased from Nutritional 
Biochemicals (USA) via Calbiochem. 
2. 1.6 Tablet ingredients 
Maize starch was supplied by L J Rickards, .dried yeast powder 
by Bovril, tribasic calcium phosphate and magnesium stearate by 
Albright and Wilson, lactose by Whey Products, gelatin by P 
Leiner and Sons. 
2.1.7 Antimicrobials 
Phenol and chlorocresol were obtained from Evans, cetrimide. 
from !Cl and sodium penicillin from Glaxo Operations 
( Crystapen). 
2.1.8 Diagnostic reagents and aids 
Kovac's Reagent and 'Enterotubes' were purchased from Roche 
Diagnostics, Salmonella polyvalent H specific and non specific 
antisera from Wellcome Laboratories, hydrogen peroxide solution 
and ammonium oxylacetate from BDH, rabbit plasma, antibiotic 
sensitivity discs and defibrinated horse blood from Oxoid, 'Gas 
Packs' (C02) and indicators from BBL. 
2.1.9 Media 
All media and media constituents with the following exceptions 
were supplied by Oxoid. Pseudosel was purchased from BBL, 
XLD, bismuth sulphite and OF basal medium from Difco, Ringers 
powder and Sabouraud agar from LIP. 
2.1.10 
2.1.11 
2.1.12 
Oxoid 'Number 1' agar was used at a concentration of 1.5% w/v 
to prepare agar media. Nutrient agar was prepared using 
nutrient broth (BP 1973). Tryptone soya agar and tryptone soya 
broth were purchased to USP XIX specification (soybean - casein 
digest, agar and medium). 
MacConkey agar used was Oxoid No 2, Medium 'A' and 'B' were 
prepared as given in the Appendix. 
Sterile disposable equipment 
Ventilated plastic petri dishes (90mm and 150mm) were supplied 
by Sterilin, syringes and needles were from Beckton and 
Dickenson and GilJet. 
Membrane filtration equipment 
Unless specified otherwise membrane filters used were supplied 
by Sartorius (V A Howe London) and were of 1;7mm diameter, 
0.1;5)J pore size and with a gridded surface, these membranes 
were supplied ready sterilised (Sartorius code 137 56). 
The membranes were mounted in nickel plated 3 part assemblies 
(GaiJenkamp) which included a cylindrical funnel. 
Cultures used 
The following organisms were obtained from the respective 
collections: 
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Salmonella abony NCTC 6017, Salmonella typhimurium NCTC 
10251, Escherichia coli NCTC 9002, Pseudomonas aeruginosa 
NCTC 67 50, Bacillus subtilis NC!B 80511. Bacillus subtilis var 
globigii NCTC 10073, Streptococcus faecalis NCTC 61159. 
The following organisms were obtained from Glaxo Operations 
culture collection: 
Staphylococcus aureus PRIV, Serratia marcescens 922, 
Clostridium sporogenes 1191 E, Klebsiella pneumoniae 308E, 
Bacillus subtilis 81E, laboratory isolates used as positive controls 
for sterility tests included Candida albicans, Saccharomyces 
species, Penicillium species. 
The following organisms were isolates collected and used during 
the course of this study: 
Bacillus species 201 a laboratory isolate which produces rusty 
red colonies on nutrient agar, Pseudomas aeruginosa 228 and 245 
isolated from contaminated creams, Ps aeruginosa 75 isolated 
from a sink, Pseudomonas species 101 and 102 isolated from distilled 
water, Pseudomonas species 1,3,4,5,6,7, environmental isolates 
detected in damp situations. 
2.2 to 2.11 ,METHODS 
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2.2 General methods 
2.2.1 Staining 
Gram stains (Lillie's modification) and spore stains were carried 
out as specified in Cowan (1974). 
2.2.2 Microbial dilutions 
2.2.3 
2.2.3.1 
2.2.3.2 
All serial dilutions were performed in 0.1% peptone water pH 6.2 
as specified by Straka and Stokes (1957). 
Estimation of total viable counts 
Unless specified otherwise all plates were incubated at 31 °C for 
at least 48 hours. 
Pour plates 
The procedure specified in the USP XIX was followed, except 
that tryptone soya agar was not necessarily used and samples 
plated in at least triplicate rather than duplicate. The test 
sample was diluted such that a lml inoculum yielded between 30 
and 300 colonies. 
Most probable number 
The procedure specified in the USP XIX was followed but using 
nutrient broth rather than tryptone soya broth. 
2.2.3.3 
2.2.3.4 
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Spread plate 
Agar plates were inoculated with O.lml of sample appropriately 
diluted, this was spread over the agar surface using a sterile 
glass 'hockey stick' until the plate appeared dry. 
Samples were diluted so that plates would be expected to yield 
30 to 100 colonies and then plated out in at least triplicate. 
'Swab plates' 
Dry 'Q' Tips (Johnson & Johnson) were used to swab sample a 
surface, immediately after, the swab was streaked across the 
entire surface of an agar plate. 
2.2.4 Sterility tests 
These were performed in a purpose built aseptic area comprising 
of testing laboratory, incubator room, and changing room. These 
areas were supplied with HEPA filtered air to class 100 of 
Federal Standard 209b. The testing laboratory was maintained at 
a positive pressure of 0.15 inches of water with respect to the 
outside uncontrolled environment and at a slight positive 
pressure with respect to the other two rooms. The testing 
laboratory was subjected to 15 room air changes per hour, the air 
entering from ducts in the ceiling and extracted close to floor 
level. 
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The complete area was regularly cleaned and disinfected 
and was also monitored for microbial contaminants, using nutrient agar 
settle plates, a slit sampler, and swabs plated onto nutrient agar. 
All sterility tests were performed in horizontal!aminar flow 
cabinets (Pathfinder and Siroco) sited in the testing laboratory. The 
cabinets were left running for approximately I hour prior to use. After 
each sterility test the working surface of the cabinet was swabbed with 
a solution of 70% industrial methylated spirits. 
The laminar flow cabinets were regularly checked to ensure, 
air velocities were approximately 90ft minute, using an anemometer, 
and the HEPA filters were not leaking, using a Royco Particle Counter 
Model 245 (Ge!man Hawkesley). A 'boiler suit' type tunic and separate 
hood both made of calendered terylene, (Micro Science Services) plus 
face mask and surgical gloves were always worn in the aseptic area. 
All equipment and media was sterilised by dry heat or autoclave 
immediately prior to transfer into the aseptic area. 
Two media were used, tryptone soya broth (USP) and fluid 
thioglycollate medium (USP). 
All media were incubated for 14 days, tryptone soya broth at 25°C and 
fluid thioglyco!late medium at 31 °C. 
2.2.5 
2.2.5.1 
2.2.5.2 
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Sterility test techniques 
Membrane filtration 
An appropriate aliquot of test liquid was filtered through 
a 0.45Jl membrane which was then rinsed with 250mls of 0.1% peptone 
water. The membrane was bisected using sterile scissors and tweezers 
and one half placed into 1 OOmls of fluid thioglycollate medium, 
and the other into lOOmls of tryptone soya broth. 
Direct addition 
The required quantity of test material was placed directly 
into the required number of bottles each containing 1 OOmls of medium. 
2.2.6 Sterility test controls 
Each autoclave batch of media was checked for growth promoting 
qualities by challenging with less than 50 viable cells of various species, 
the only exception being Penicillium, in this case 0.1 ml of culture medium 
was inoculated directly. 
To test fluid thioglycollate medium, 24h cultures (in thioglycollate 
medium) of B subtilis 81E, S aureus PRIV, Cl sporogenes 491E, and K 
pneumoniae 308E, were used. 
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To test tryptone soya broth, 2lih cultures (in tryptone soya 
broth) of B subtilis 81 E, S aureus PRIV and l!8h cultures C albicans (laboratory 
isolate), Saccharomyces (laboratory isolate) and 
Penicillium (laboratory isolate) were used .. 
To ensure that the pharmaceutical preparations examined using 
the sterility test procedures described had no growth inhibiting 
effect on contaminants present, regular positive controls were 
performed on inoculated sterility test media. The challenge 
organisms and challenge levels were as described above for 
verification of media growth promoting properties. 
Negative controls were carried out with each sterility test or 
after every fourth test if a sequence of replicate tests was 
performed. 
2.2.7 Identification of bacteria 
2.2.7.1 
The tests specified in the BP 1973 and USP XIX were used for 
the identification of possible E coli, Salmonella, Ps aeruginosa or 
S aureus isolates. However, there were other organisms 
requiring characterisation. 
Faecal streptococci 
Isolates with the following characteristics were considered as 
faecal streptococci. 
2.2.7.2 
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Gram positive cocci, tending to be ovoid and occurring in short 
chains or pairs, non-motile, growing on MacConkey agar giving 
small intensely red colonies with a pale periphery about 1 mm in 
diameter (Oxoid Manual 1973 and personal communication with 
Oxoid Technical Department), growth in 6.5% sodium chloride 
broth and production of slight acid and gas in MacConkey broth. 
Additional tests were carried out to characterise isolates as 
Streptococcus faecalis; production of acid from mannitol and 
sorbitol but not from arabinose, growth at pH 9.6 and at ~5°C, 
survival at 60°C for 30 minutes. (Cruickshank et all973, Cowan 
197~, Bergeys Manuall976). 
Enterobacteria 
" The organisms included in this group were as defined by Co"t' 
(197~), namely Citrobacter, Edwardsiella, Enterobacter, Erwinia, 
Escherichia, Hafnia, Klebsiella, Morganella, Proteus, Salmonella, 
Serratia, Shigella, Yersinia. The characteristics as defined by 
Cowan (197~) were used ie Gram negative rods, aerobic and 
facultatively anaerobic, oxidase negative attack sugars 
fermentatively, nitrate reduced to nitrite. 
However, for routine studies the followig characteristics were 
used: 
Gram negative rods, producing acid from glucose, oxidase 
negative, with growth on MacConkey agar. 
2.2.7.3 
2.2.7.4 
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Isolates not conforming to characteristics of E coli or Salmonella 
were characterised into one of the genera listed using the 
'Enterotube' test system. The numerical taxonomy identification 
key rather than the alternative 'diagnostic key' was used to make 
the assessment. 
Pseudomonas 
Isolates were identified as belonging to this group using the tests 
specified by Cowan (1974) namely, Gram negative rods, motile, 
aerobic, catalase positive, oxidase positive and attack sugars by 
oxidation. 
No isolates in this genus were identified further except those 
suspected of being Ps aeruginosa. 
Bacillus 
Isolates were identified as belonging to this genus using the 
description specified by Cowan (1974). Gram positive rods, 
producing heat resistant spores, catalase positive. 
However, for routine purposes most Bacillus isolates were 
readily recognised by their characteristic dry rough spreading 
colonies, large Gram positive to variable cells and the presence 
of endospores. Only doubtful isolates were examined further. 
2.2.7.5 
, 
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Fungi 
Detailed studies of isolates were not attempted, any 
identification was carried out to genus level only, using keys and 
descriptions given by Smith (1969). 
---------
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2.3 Sampling procedures used 
2.3.1 Raw materials bulk batches of tablets/capsules and tablet 
intermediates 
All samples were taken aseptically, from the square root plus 
one of the number of containers in the batch, taking up to a 
maximum of 10 samples. 
A sample of lOg was taken from each container and a composite 
sample prepared from all the material, this was mixed well 
before testing. 
All aqueous samples were tested- immediately, solids and oils 
usually within 24 h, but within a maximum limit of 72 h. 
Solid materials held in paper sacks were sampled by cutting a 'V' 
shaped flap with I" sides into an area of the sack which had been . 
swabbed with 7096 industrial methylated spirits. A sterile 12" 
spatula was inserted into the sack to a minimum depth of 4" to 
withdraw the sample. 
Solid materials held in drums or boxes were sampled by opening 
the containers and inserting a sterile 12" spatula to a minimum 
depth of 4" to withdraw the sample. 
Liquids were sampled using a wide bored pipette. 
-------------------------------------------------------------------------------- -
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Most samples were taken from sealed containers held in stores or 
production departments. 
2.3.2 Topical preparations 
Bulk quantities of creams or ointments held in 250 or 500 litre 
conical vessels were sampled by taking 20g quantities, from up 
to 12" below the surface of the cream and from the outlet at 
base of the vessel. 
Filled topical preparations were sampled directly off the filling 
line taking the first 10 and last I 0 units to be filled, each 
working day. If a batch change occurred, 10 units were also taken 
from the start and end of the batch. 
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2.4 Microbiological test procedures 
2.4.1 Insoluble samples of raw materials, tablets/capsules and tablet 
2.4.1.1 
intermediates 
The procedures suggested in the BP 1973 or USP XIX were 
followed for the routine analysis of samples. Typically lOg 
samples were examined, lesser quantities only being tested if 
more detailed information on levels of contamination was 
required. After addition to liquid media the sample was shaken 
to ensure good dispersion, tablets usually required a period of 
soaking before dispersion was possible. 
Detection of Escherchia coli 
BP 1973: 
SAMPLE _,.. Nutrient Broth 
37°C/24h 
lml 
_,.. 
MacConkey Broth 
MacConkey Brott! 
37°C/48h \. 
1% Peptone Water 
44°C/24h 
Secondary enrichments in MacConkey broth were only prepared 
if acid and gas was detected in the first MacConkey enrichment, 
a loop, rather than the lml quantity specified in the BP (1973), 
was used to do this inoculation. The presence of E coli was 
indicated by acid and gas production in MacConkey broth and 
indole production in peptone water, after incubation at 44 °C. 
2.4.1.2 
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USP XIX: 
SAMPLE..,. Lactose Broth--MacConkey Agar-- Levine Eosin 
' 31°C/48h 31°C/21th Methylene Blue Agar 
31 °C/24h 
Gram negative rods showing E coli colony characteristics on 
MacConkey agar ie brick red colonies (often surrounded by a 
zone of precipitated bile) were further cultured on Levine eosin 
methylene blue agar, colonies on this media appear blue black 
under transmitted light and have a metallic sheen under 
reflected light. Colonies suspected positive were confirmed by 
testing for acid, and gas and indole production as specified in the 
BP (1973). 
Detection of Salmonella 
BP 1973: 
Selenite F Broth 
SAMPLE-,.. Nutrient Broth/ 
37°C/24h "'-retrathionate 
Brilliant Green 
Agar 
streak 
plates ,.. Desoxycholate 
Citrate Agar 
Bismuth Sulphite Aga 
37°C/24h 
If colonies conforming to the description given for Salmonella were 
isolated on the selective media, isolates were further cultured in 
triple sugar iron agar (surface and stab cultures) and urea broth 
Salmonella are indicated by acid and gas production in the stab 
2.4.1.3 
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with or without blackening and absence of acidity from the 
surface growth, together with absence of red colour in the urea broth. 
Enterotubes were used as a further confirmatory test. 
USP XIX: 
Fluid Selenite 
Cystine medium 
SAMPLE _,..Lactose Broth_.,. streak,.. 
31°C/48h '-' plates 
Fluid Tetrathionate medium 
31°C/12-24h 
Brilliant Green Agar, 
Xylose-Lysine Desoxycholate Agar, 
Bismuth Sulphate Agar 
31 °C/24h. 
Colonies conforming to the description given for Salmonella 
isolated on the selective media were further examined using triple sugar 
iron agar. The test was performed and interpreted as specified in the 
USP XIX. Suspect colonies were further examined using Enterotubes. 
Detection of Pseudomonas 
BP 1973: 
SAMPLE- 0.03% Cetrimide Broth streak 
31 °C/72h plates 
0.03% Cetrimide Agar 
31°C/48h 
2.4.1.4 
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After initially adopting this procedure, Pseudosel agar was 
used in place of cetrimide agar and nutrient broth in place of cetrimide 
broth. Gram negative, oxidase positive, bacilli isolated on either of 
these selective media, were_ considered as Pseudomonas species. The 
oxidase test was carried out as specified in Cowan (1974). 
USP XIX: 
SAMPLE -Tr6ptone Soya Broth----1~'Pseudosel Agar' 
31 C/48h 3!°C/48h 
Gram negative, oxidase positive, bacilli isolated on Pseudosel 
were-considered as Pseudomonas species. The oxidase test was carried 
out as specified in Cow an (197 4 ). 
Using either procedure, the isolation of Ps aeruginosa was 
confirmed by growth at 42°C in nutrient broth and by biochemical tests 
specified by Cow an (197 4 ). 
Detection of Staphylococcus aureus 
BP 197 3 - Not specified 
USP XIX: 
SAMPLE ___ .,.Tr6ptone Soya Broth ___ Baird Parker Agar 
31 C/48h 31 °C/48h 
2.4.1.5 
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Baird Parker agar was used in place of Vogel Johnson agar, 
any Gram positive cocci isolated, demonstrating black shiny colonies 
surrounded by opaque zones (as shown in Plate I) were examined by 
secondary tests. The test specified is the 'coagulase test' and the procedure 
given by Wellcome Laboratories for the 'tube method' was followed. 
Further checks of suspect colonies were made using mannitol 
salt agar with S aureus appearing as yellow colonies, causing the media 
to turn yellow over the whole plate or surrounding the colonies (Plate 
2). 
Total viable counts 
All samples examined using the USP or BP procedure were 
tested for total viable count using the pour plate technique although 
no test is specified in the BP. A 10g/10ml sample was shaken by hand 
with 90ml of nutrient broth and triplicate 1 m! samples of 
an appropriate dilution, plated out. 
2.4.2 Soluble raw materials 
Aqueous solutions and soluble solids were dissolved in 0.1% 
peptone water and examined by filtering through a 0.45Jl 
membrane. Before placing the membrane.on the required 
agar medium the membrane was rinsed with 200ml of 0.1% 
peptone water. 
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Selective agar media were used to recover, Pseudomonas species 
(Pseudosel), S aureus (Baird Parker), Salmonella (MacConkey, 
Brilliant Green, Bismuth Sulphite), E coli (MacConkey) and other 
enterobacteria (MacConkey, Brilliant Green, Bismuth Sulphite). 
The membranes were incubated at 37°C (Pseudosel 31 °C) for up 
to 72h, examining for growth daily. 
To estimate total viable counts membranes were incubated on 
nutrient agar at 31 °C for 72h. 
All colonies isolated on selective or nutrient agar suspected of 
being, E coli, Salmonella, Pseudomonas or S aureus, were further 
examined using the tests specified for insoluble materials 
(2.4.1.). 
Routinely lOml/ lOg samples were examined using 200mls of 0. 1% 
pepto~:~e water as a vehicle. 
2.4.3 Oils 
Samples were filtered through dry 0.45)-1 membranes which were 
then rinsed, first with 200m1s of 0.1% peptone water containing 
0.1% of Triton X 100 (warmed to 37°C) and finally with 200mls 
of 0.1% peptone water. 
Membranes were incubated on the agar media as specified for 
soluble samples (2.4.2. ). 
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2.4.4 Creams 
'Standard' procedure for routine analysis (A Davison, personal 
corn munlca tion) 
Sample (lOg). _ __,~Dispersed in 90mls 3 x lml 
Quarter Strength 
Ringers Solution ~ 
at 37°C 
J !Omls 
90mls Tygtone Soya streak 
Broth 37 C/48h plates 
Pour Plates using 
Tr6ptone Soya Agar 
31 C/72h 
Pseudosel Agar 
31 °C/48h 
Tryptone Soya Agar 
MacConkey Agar 
Baird Parker Agar 
37°C/48h 
Isolates suspected of being Pseudomonas, S aureus, E coli, or 
Salmonella were examined as described for insoluble materials 
(2.4.1.). 
2.4.5 Positive controls 
The procedure as outlined in the BP (197 3) was followed to 
evaluate all the test procedures specified. Approximately 10-15 
viable cells from a 24h nutrient broth culture were added to 
primary or secondary enrichments containing the appropriate 
quantity of sample or subcultured material. Tests were 
considered invalid if control organisms were not detected. The 3 
test organisms specified by the BP (1973) were used ie E coli 
NCTC 9002, S abony NCTC 6017 and Ps aeruginosa NCTC 6750 
and in addition S aureus PRIV. 
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Positive control tests on samples examined by membrane filtration 
were carried out by adding the control organisms to the liquid 
filtered. 
2.5 to 2. 13 EXPERIMENTAL 
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2.5 Type and level of microbial contamination in raw materials, 
intermediates and finished products 
2.5.1 Raw materials 
Over 600 samples from 29 different types of raw material were 
examined over a 3 year period. 
The techniques used for insoluble materials were those outlined 
for either BP or USP procedures (2.4.1.). The majority of 
samples being tested by the BP procedure. In addition certain 
samples were also examined by further techniques. 
The 37°C nutrient broth enrichment prepared for the BP test 
was also used to inoculate streak plates of selected agar media, 
namely, nutrient, MacConkey, Pseudosel, Baird Parker and 
Sabouraud. 
A further enrichment of certain samples (lOg) was prepared in 
90ml of MacConkey broth (incubated at 37°C for 24 hours) this 
was examined by streak culture on MacConkey agar. 
Soluble raw materials and oils were examined as specified using 
the membrane filtration procedures (2.4.2 and 2.4.3). 
In addition to the pathogenic species suggested in the BP (1973) 
and USP XIX, samples were examined for other contaminants. 
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The organisms included were, fungi (including yeats), faecal streptococci, 
enterobacteria other than those specified, including species of 
Klebsiella, Proteus, Ci trobacter, Enterobacter and Serratia. Not all 
enterobacteria isolated were identified down to genus or species 
level if shown not to be Salmonella or E coli. 
2.5.2 Soft capsules, tablets and tablet intermediates 
A range of these oral dosage forms and 7 different tablet 
intermediates were examined according to the BP procedures 
specified (2.4.1) except for a veterinary steroid tablet which 
was examined according t o the USP procedure (2.4.1 ). 
2.5.3 Final containers for packaged tablets 
A range of empty containers and their closures were examined, 
five samples of each type were half filled with 0.1% peptone 
water containing 0.1% Triton X 100. After manually shaking, 
the container for 30 seconds the Triton peptone was filtered 
through a membrane, this was rinsed with 0.1% peptone water 
and incubated on nutrient agar at 31 °C for 72h. 
2.5.4 Creams 
Samples were examined according to the procedure detailed (2.4.4). 
All the creams were from one factory's commercial production and 
included three types of corticosteroid creams designated 'a', 'b' 
and 'c'. 
---- -- ----------------------------- --------
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Samples were tested within 72h of filling using a composite sample 
made up of lg samples taken from each of 10 tubes selected 
from the 20 tubes sampled. 
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2.6 Comparative study of selected enrichment and plating medias 
A study was made of the relative sensitivity of selected 
enrichment systems to detect E coli and other enterobacteria, 
faecal streptococci, Pseudomonas species and Salmonella. 
Replicate 90ml quantities of the liquid media studied were 
inoculated, in a random manner, with lOml aliquots from a single 
stock solution or suspension of a raw material in 0.1% peptone 
water. The raw materials used were gum acacia, shellac orange, 
empty gelatin capsules and dry yeast powder, one or more of 
which was known to be contaminated with at least one of the 
organisms specified. Shellac orange is insoluble and difficult 
to suspend, so the required quantity, powdered in a mortar and pestle, 
was mixed with peptone water, shaken and the supernatant liquid used. 
2.6.1 Escherichia coli, other enterobacteria and faecal streptoccoi 
The following broth media were used, MacConkey purple, EE, 
lactose, tryptone soya and nutrient. After inoculation and 
incubation at 37°C for 24h, streak plates were prepared on 
MacConkey agar and in certain cases on violet red bile dextrose 
agar. The nutrient broth enrichments were also examined as 
specified in BP (1973) for detection of E coli (2.4.1.1). Streak 
plates were incubated at 37°C for 24h but for detection of 
faecal streptococci 48h was required. 
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2.6.2 Pseudomonas species 
The following broth media were used, MacConkey purple, EE, 
lactose, tryptone soya, nutrient and 0.03% cetrim ide . After 
inoculation and incubation at 31 °C for 72h, streak plates we re 
prepared on Pseudosel and 0.03% cetrimide agar. All plat es were 
incubated at 3l?C for 72h. 
2.6.3 Salmonella 
No raw materials were available naturally contaminated with 
Salmonella, so laboratory cultures of S typhimurium NCTC 1025 1 
and S abony NCTC 6017 were used, cultured in 0.1 % peptone 
water at 37°C for 24h. 
A stock solution of raw material was prepared, this was 
inoculated with one species of Salmonella such that lOml 
aliquots taken from the solution, contained the required numbe r 
of test organisms, which was less than 10 viable cells. 
The following broth media were examined, MacConkey purple, 
EE, lactose, tryptone soya and nutrient. After incubation at 
37°C for 24h all enrichments were plated onto desoxycholate 
citrate agar either directly or after secondary enrichment in 
selenite broth, plates were incubated at 37°C for 24h and 
secondary enrichments at 37°C for 48h. 
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2.7 Development and validation of an enzymic technique for 
the microbiological examination of pharmaceutical grade gelatin 
2.7 .1 Preparation of laboratory fermented protease 
Conical flasks (250ml) containing 50ml of medium 'A' were 
inoculated from a slope culture of B subtilis NCIB 8054. The flasks 
were shaken for 18 hours at 37°C, after which time dense growth could 
be seen. The contents of the flasks were combined to give a total of 
1 litre of fermentation liquor. 
The liquor was passed through a filter pad (Carlson Ford 
grade EK4032) and then sterilised by refiltering through a 0.22)J membrane 
filter (Millipore). The filtrate was collected aseptically in lOOm! quantities 
under the protection of vertical laminar flow air and then stored at 
4°C. 
The sterile liquor was purified no further and used in this 
form as the working protease solution for gelatin solubilisation and filtration 
studies. 
A second proteolytic solution was obtained from the liquor 
of a penicillinase fermentation. The fermentation medium used was 
medium 'B' held in !Olitre quantities in a 501itre aspirator. After inoculation 
from a slope of B subtilis 81E, the medium was incubated at 31 °C for 
72 hours, then after the addition of 5ml of silicone antifoam agent was 
vigorously aerated, via a sparger fitted in the vessel, for 48h while 
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incubating at 27°C. During this time lOlitres of medium 
'B' containing 3 mega units of sodium penicillin G was added in a dropwise 
manner. 
The liquor was prefiltered through a slurry of 'Hyflo' then, 
sterilised and collected as described for the previous preparation. 
The working solution of protease was the sterilised liquor 
stored at 4°C. 
2.7 .2 Preparation of the working solution of commercial protease 
A 5% w/v aqueous solution of the enzyme (Proteinase) was 
sterilised by membrane filtration. The filtrate was collected 
and filled aseptically into separate lOml quantities under the 
protection of vertical laminar flow air, before storage at 4 °C. 
2.7 .3 Enzymic and non-enzymic methods for solubilisation and 
filtration of gelatin 
In both methods; gelatin powder (lOg) was added to 0.196 peptone 
water (lOOm!) to give a 1096 w/v solution; during solubilisation 
regular hand shaking of the mixture was necessary to prevent 
clumping of the gelatin. 
The weight of gelatin filtered through a single 0.45p membrane 
was estimated from the volume of gelatin solution filtered. 
2.7.3.1 
2.7.3.2 
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Non-enzymic procedure 
The peptone-gelatin suspension was held at 8-10° for 1 hour then 
at 45°C for 30 minutes, or longer if the gelating failed to 
dissolve. The resultant viscous solution was diluted 1 t times in 
0.196 peptone water (45°C) containing tween 80 (0.196) before 
attempting filtration. 
Enzymic procedure 
A sterile solution of a protease (Proteinase) was added to the 
peptone-gelatin suspension, and incubated at 37°C for between 
25 and 45 minutes, depending upon the rate at which the gelatin 
sample dissolved. The solution obtained was diluted 1 t times 
with peptone-tween solution (37°C) and filtered. 
Protease 1 0-20mg g -l of gelatin, adequately solubilised most 
gelatin samples. However, some samples required up to 50 mg g-l 
of gelatin. Thus 5mg mC1 was the maximum protease concentration 
used in the stated method. 
The procedure for the solubilisation and filtration of gelatin 
samples using laboratory fermented enzyme was as described, 
except that, the gelatin was suspended directly in the 
fermentation liquor, instead of in peptone water. 
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2.7 .4 Validation of the enzymic procedure 
2.7.4.1 
2.7.4.2 
To ensure the enzymic procedure had no adverse affect on 
the recovery of bacteria control tests were carried out using, E coli 
NCTC 9002, S abony NCTC 6017, Ps aeruginosa NCTC 6750 and S aureus 
PRIV. The organisms were cultured in tryptone soya broth at 37°C 
for 24 hours and appropriate dilutions prepared. 
The recovery of the natural contaminants of gelatin was 
also studied. 
Examination of protease solutions for antimicrobial activ ity 
The test organisms specified were each added to a 5mg mC1 
solution of 'Proteinase' in 0.1% peptone water and to the laboratory 
fermented protease liquor. Controls of 0.1% peptone water only were 
inoculated at the same time. The solutions were held at 37°C and viable 
counts made at 15 minute intervals for 60 mins. Counts were estimated 
from 1ml samples diluted immediately in 0.1% peptone water and plated 
out on nutrient agar using the Miles and Misra technique (Miles and 
Misra 1938). All plates were incubated at 37°C for 24h except when 
Ps aeruginosa was the test organism, in this case 31 °C for 48h was used. 
Recovery of test organisms using the enzymic procedure 
To demonstrate that the four test organisms specified could 
be recovered by the enzymic technique, approximately 50 viable cells 
2.7.4.3 
84 
of each type were inoculated into a protease gelatin mixture and the 
solubilisation and filtration procedures followed. 
The membrane filters obtained were either cultured in accordance 
with the BP 1973 method or placed directly on 
selective agar media: for S abony - bismuth sulphite; for Ps 
aeruginosa - Pseudosel; for S aureus - Baird Parker and for E coli 
- MacConkey. 
The test was repeated to obtain a quantitative estimation of the 
recovery of S abony and E coli. The counts on the selective 
media were compared with the control counts obtained by 
inoculating 0,1% peptone water. 
The required inoculum was added using a platinum tipped 
pipette, the count was checked by using the same pipette to 
inoculate nutrient agar plates by the Miles and Misra technique. 
Recovery of the natural contaminants of gelatin by enzymic and 
non-enzymic procedures 
Samples of gelatin (lOg) were tested for contamination with~ 
coli and other enterobacteria using the BP 1973 procedure. 
Equivalent samples of gelatin were solubilised enzymatically and 
filtered, the membranes were then either enriched according to 
the BP procedure or incubated on MacConkey agar. Before 
placing the membranes on MacConkey agar, they were 
incubated on a pad soaked in 'Resuscitation Membrane Broth' 
(Oxoid) for 2 hours at 37°C. 
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A similar set of comparative recoveries were carried out based 
on the USP XVIII procedure (and 1st Supplement 1971) for 
microbial examination of gelatin. No detailed method is 
included in the more recent USPXIX. 
2.7 .5 Comparison of pour plate and enzymic filtration techniques to 
obtain total viable microbial counts of gelatin 
Samples of gelatin (lOg) were solubilised both enzymatically and 
non-enzymatically. Pour plates were then prepared with five 
replicate lmt samples of the non-enzymatically solubilised 
gelatin, a similar set of enzyme treated samples were examined 
by membrane filtration, tryptone soya agar was used for these 
studies and plates incubated at 31 °C for 72h. 
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2.8 Application of membrane filtration techniques to microbial 
examination of selected insoluble powders and viscous solutions 
A membrane filtration procedure for maize starch was 
examined, suspensions of starch in 0.1% peptone water were 
shaken and then allowed to settle for up to ~h in upright 250ml 
medical flats. The supernatant was gently removed and passed through 
a 0.~5)-1 membrane. 
When the optimum settling time had been determined, the 
technique was compared with the MPN (nutrient broth) and pour 
plate (nutrient agar) techniques, for estimation of the total 
viable counts of 3 maize starch batches. 
Suspensions of maize starch in 0.1% peptone water were also 
examined by filtering through an 8f1 membrane, separated from a 
0.~5)J membrane below be a Dacron (Millipore) separator. The 
0.45)1 membrane was incubated on nutrient agar and total viable 
counts obtained compared with counts from supernatant filtered 
through just a 0.45)-1 membrane. 
Attempts were made to filter suspensions of dry yeast powder 
through a 0.45p membrane, the vehicle used was 0.1% peptone 
water. The maximum quantity of suspension filtered was 
estimated using both pressure and vacuum filtration. 
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Solutions of gum acacia prepared in 0.1% peptone water (with 
and without 0.1% Tergitol 15-S-9) were examined to determine 
the maximum quantity of gum acacia which would pass through a 
0.45)-l membrane. 
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2.9 Development and validation of techniques for the detection of 
micro-organisms in ointments and comparison of these with 
existing techniques 
2.9.1 Procedures for contamination of ointments and oils 
2.9.1.1 
To evaluate both the recovery efficiency of techniques for 
detection of micro-organisms in ointments and the survival 
of micro-organisms in oils that are used in such techniques, 
a procedure for contamination with dry organisms was 
developed. 
Aqueous inocula were also used in certain studies. 
With dry airborn mirc6-organisms 
The procedure developed in this study was as follows. Liquid 
paraffin or almond oil were contaminated using a 'slit sampler' 
to force air onto a 14cm plastic petri dish smeared with 
a thin film of the oil, organisms trapped on the plate were 
eluted with a further quantity of oil. In these studies the 
slit sampler, was sited in a room used as a cloakroom and 
store room. 
To prepare contaminated ointment, a known weight of an 
appropriate dilution (prepared in liquid paraffin) of contaminated 
liquid paraffin was blended into sterile ointment base previously 
warmed to 44°C. The addition of liquid paraffin being sufficient 
to complete the formulation of the ointment, as specified 
in the BP 1973 for eye ointment base, namely, 80% white 
soft paraffin, 10% wool fat and 10% liquid paraffin. 
2.9.1.2 
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With micro-organisms in an aqueous phase 
The procedure suggested by Allwood and Hambleton (1973) was 
adopted, using a spatula the inoculum was dispersed in ointment 
at 44°C. Inocula used included appropriate dilutions of, E coli 
NCTC 9002 and S aureus PRIV cultured in tryptone soya broth 
(31 °C for 48h) and water samples containing Pseudomonas 
species. The water samples, collected from a distilled water 
holding tank and the drain pipe of a sink, were allowed to stand 
at room temperature for 28 days in sealed bottles, to increase 
viable count. The distilled water contained two morphological 
types of non-pigmented Pseudomonas (strains 101 and 102) 
and the drain water Ps aeruginosa. 
2.9.2 Evaluation of dry airborn micro-organisms as a challenge 
inoculum for studies with ointments and oils 
Samples of light liquid paraffin and almond oil were 
contaminated as described (2.9.1.1), replicate samples were then 
taken from a batch of contaminated oil and filtered over a 0.45(1 
membrane. Membranes were incubated on nutrient agar at 31 °C 
for 72h after first rinsing with, 250mls of 0.1% peptone water 
containing 0.2% Tergitol 15-S-9 and lOOmls of 0.1% peptone 
water, both rinses at 35°C. Viable counts from the replicate 
samples were compared statistically. 
The exercise was also carried out using a sample of 0.196 peptone 
water which had been contaminated with airborn micro-organisms 
as described for oils (2.9.1.1). 
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2.9.3 Methods developed in this study for examination of microbial 
contamination of ointments 
2.9.3.1 
2.9.3.2 
Four membrane filtration techniques, designated 'A', 'B', 'C' 
and 'D', were developed and evaluated. After filtration, membranes 
were either placed directly on nutrient agar for estimation of viable 
counts or bisected and placed in tryptone soya broth and fluid thioglycollate 
medium for sterility tests. The isopropyl myristate used was sterilized 
by membrane filtration. 
Technique 'A' 
A 6g sample of ointment was shaken vigorously for 30 seconds 
with 25mls of isopropyl myristate (44°C) held in a 150ml medical flat. 
One hundred mls of 0.1% peptone water was then added and the mixture 
shaken gently for 2 minutes. On standing for 2 minutes the oil phase 
separates leaving a clear solution below, this was drawn off by vacuum 
and filtered through a 0.45}1 membrane. The membrane was rinsed with 
500mls of Triton peptone (0.1% peptone water containing 0.196 Triton 
X 100) and then with 250mls of 0.1% peptone water. 
Technique 'B' 
A 6g sample of ointment was shaken vigorously for 30 seconds 
with 25mls of isopropyl myristate (44-°C) held in a 150ml medical flat. 
The mixture was added immediately to a 500ml infusion bottle containing 
450ml of 0.1% peptone water (31 °C), the mixture was shaken gently 
- -----------
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for two minutes. The cap from the infusion bottle was replaced 
by a simple infusion giving set and the bottle inverted and allowed to 
stand for 20 minutes. During this time the oil phase separates leaving 
a clear solution below. The aqueous phase was drained off directly to 
the filtration apparatus using the giving set and passed through a 0.45p 
membrane. The filter was rinsed with lOOmls of Triton peptone and 
finally with 50mls of 0.1% peptone water, both rinses being at 31°C. 
T echnigue 'C' 
As for 'B' except a 20g sample of ointment was added to 
50mls of isopropyl myristate. 
Technique 'D' 
As for 'C' except the ointment isopropyl mixture was extracted 
with 450mls of Triton peptone instead of 0.1% peptone water. In t his 
case the aqueous phase does not clear.completely leaving a slight cloudiness. 
2.9.4 Recovery efficiencies of techniques for detection of micro-
organisms in ointments 
A comparative assessment was made of the membrane filtration 
procedures developed in this study namely techniques 'A', 'B', 'C' and 
'D' and the non-filtration sterility test procedures described below 
(2.9.4.1 and 2.9.4.2). The techniques were used to examine 
BP eye ointment base contaminated with a known number of micro-organisms. 
2.9.4.1 
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Accurately weighed samples of sterile ointment base were inoculated 
with a known weight of liquid paraffin contaminated with, dry airborn 
micro-organisms (2.9.1.1) or a known volume of an aqueous inoculum 
of a laboratory culture or water sample containing pseudomonads (2.9.1.2). 
The viable count resulting in the ointment was estimated by 
examining replicate aliquots of the inocula used. These were 
examined using membrane filtration. 
All membranes were incubated at 31 °C on nutrient agar for 72h 
· and sterility ·tests incubated as specifi.ed (2.2.4). Negative 
controls were prepared by testing samples of sterile ointment. 
BP (1973) procedure for eye ointments 
The procedure specified was followed inoculating the 
ointment/arachis oil/tween 80 mixture into a 100mls of, tryptone 
soya broth or fluid thioglycollate media. This was repeated 10 
times for each medium so that 20g of ointment was examined. 
After seven days incubation all test bottles were subcultured 
(0.1 ml) into lOOm! quantities of the same media, these bottles 
were examined for growth after 7 days incubation. Subculture 
was essential as initial enrichment media were too cloudy for 
microbial growth to be visible. 
2.9.4.2 
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Direct addition 
Samples of ointment, lg or l50mg, were added directly to, 
l 0 bottles containing lOOmls of tryptone soya broth and a further 10 
containing 1 OOmls of fluid thiog1yco11ate media. 
2.9.5 Evaluation of other membrane filtrat ion techniques for microbial 
examination of ointments 
2.9.5.1 
2.9.5.2 
The quantity of ointment which could be filtered through 
a single 0.45)-l membrane was estimated for techniques 'A', 'B', 'C' and 
'D' and the other techniques described below. The ointment used was 
BP eye ointment base, in certain specified cases the wool fat was omitted 
from the formulation. 
Modifications to technique 'D' (2.9.3.4) 
Alternative ointment solvents to isopropyl myristate were 
evaluated, these ir.c!uded light liquid paraffin, ethyl oleate, almond 
oil, arachis oil and coconut oil. Similarly Tergitol 15-S-9, was examined 
as an alternative dispersal agent to Triton X 100. 
USP XIX technique 
The procedure specified for sterility testing of ointments 
and oils soluble in isopropyl myristate was followed. In addition to vacuum 
filtration, pressure filtration was attempted, using a syringe to force 
the ointment isopropyl myristate mixture through a disposable filter 
housing (Sartorius 500mm), containing a 0.45J-1 membrane. 
2.9.5.3 
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The USP procedure was also followed substituting light liquid 
paraffin for isopropyl myristate. 
Modification of the USP XIX procedure 
The procedure for filtration of ointments containing waxes 
as specified by Tsuji and Robertson (1970) was attempted. 
This is similar to the USP procedure except the ointment 
solvent consists of a mixture of isopropyl myristate, carbon disulphide 
and xylene in the ratio 92:6:2 respectively. 
Procedure based on the technique suggested by A11wood 
and Hambleton (1973) 
This involved blending 0.25g of ointment with 10mls of isopropyl 
myristate (42°C), lml of the mixture was added to lOOmls of filtration 
vehicle (0.1% peptone water containing 0.1% Tergitol 15-S-9 at 42°C) 
and filtered. 
Procedure based on the technique suggested in Millipore 
Application report AR-16 for filtration of petrolatum based products 
A sample of ointment (6-10g) was homogenised (approximately 10,000 rpm) 
for 1 minute with 100mls of 0.1% peptone water containing a 
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dispersal agent (40°C). After settling for 1 minute aliquots 
were withdrawn from below the floating petrolatum material and filtered. 
The dispersal agents used were 0.1% Tergitol 15-S-9, 0.1% tween 80 
and 1.0% tween 80. 
2.9.6 Examination of the antimicrobial activity of non-ionic surface 
active agents used to rinse membrane filters 
Test organisms S aureus PRIV, S marcescens 922, and C albicans 
(laboratory isolate) were prepared as static cultures in tryptone 
soya broth incubated at 31 °C for 48h. 
Appropriate dilutions of these organisms were filtered through 
a 0.45)l membrane which was then rinsed with 500mls of 0.196 peptone 
water containing a 0.1% concentration of the surfactant under test. 
The membrane was finally rinsed with 250mls of 0.1% peptone water 
then incubated on nutrient agar at 31 °C for 48h. Total viable counts 
form repLicate tests were estimated and compared statistically with 
control counts prepared by omitting the surfactant. Details of significance 
tests used are given in the Appendix. 
2.9.7 Survival of micro-organisms in selected oils and BP eye ointment 
base 
Test organisms were added as described previously (2.9.1) 
using either liquid paraffin, containing dry airborn micro-organisms, 
or 0.196 peptone water, containing S aureus PRIV. The relative quantities 
2.9.7.1 
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of inoculum vehicle added were 2.796 w/w and 0.1796 v/v respectively. 
All samples taken from the inoculated systems were examined 
by membrane filtration, and membranes were incubated on nutrient 
0 
agar at 31 C for 72h. 
Isopropyl myristate and all oils studied were sterilised by 
membrane filtration, BP eye ointment base was sterilised by dry heat 
Survival of S aureus and dry airborn micro-organisms in isopropyl 
myristate and light liquid paraffin 
Test systems were maintained at 40°C and aliquots taken 
with time, a known weight was examined by direct membrane filtration, 
membranes were rinsed with 200mls of Triton peptone (31 °C) and then 
lOOmls of 0.196 peptone water (31°C). 
Prior to filtering ?amples of isopropyl myristate, the membrane 
was wetted with Triton peptone, dry membranes were used to filter 
light liquid paraffin. 
In the S aureus survival studies; the inoculated system was 
agitated with a magnetic stirrer prior to sampling; zero time readings 
were prepared by inoculating 0.196 peptone water. To equate the survival 
2.9.7.2 
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curves prepared with dry and aqueous inocula more closely, 2.7% 
w/w of sterile liquid paraffin was added to isopropyl myristate 
and to light liquid paraffin prior to inoculation with S aureus. 
Survival of dry airborn micro-organisms in BP eye ointment base 
and in liquid paraffin 
After inoculation, systems were maintained at ambient 
temperature. Samples of known weight were examined with 
time, ointments using technique '0' (2.9.3.4) and liquid paraffin by 
direct filtration. 
Survival of S aureus and dry airborn micro-organisms in almond 
oll and almond oil containing 5% phenol 
Almond oil containing dry airborn micro-organisms and 0.1% 
peptone water containing S aureus PRIV were each used to inoculate 
the two systems. 
The systems were held at ambient temperatures in the dark and 
samples of known weight were examined with time by direct 
membrane filtration. Membranes were rinsed with 250mls of 
0.1% peptone water containing 0.2% Tergitol 15-S-9 (35°C) and 
lOOmls of 0.1% peptone water (35°C). 
2.9.8 Studies using sterile neomycin (0.5% w/w) eye ointment (Glaxo 
Operations) 
In these studies neomycin sulphate activity was estimated by 
microbiological assay using the agar diffusion technique. 
Nutrient agar was seeded with S aureus PRIV and the zone sizes 
of test solutions compared with standards. Wells cut in the agar 
were 1cm diameter and 4mm deep. 
2.9.8.1 
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Sterility test positive controls 
Samples of neomycin eye ointment were tested for sterility using 
technique 'D' (2.9.3.4) and the BP procedure (2.9.4.1). Tryptone 
soya broth cultures (24h static incubated at 31°C) of either~ 
aureus PRIV, 8 subtills NCIB 8054 or Ps aeruginosa NCTC 6750 
were appropriately diluted and used to inoculate, rinse media 
used in technique 'D' or broth media used in the BP procedure. 
After incubation (2.2.4) checks were made for growth of the 
named species. 
Samples of tryptone soya broth inoculated with ointment 
according to the BP procedure were assayed for neomycin 
activity. 
Examination of retained neomycin activity on membrane filters 
using a bioautographic technique 
Samples of neomycin ointment were examined according to 
technique 'D', the membrane filter was then placed on nutrient 
agar seeded with S aureus PRIV. After incubation at 31 °C for 
48h plates were examined for zones of inhibition under and 
around the edge of the membrane. 
Effect of various compounds on the antibacterial activity 
of neomycin sulphate solution 
Neomycin ointment was examined using technique 'D' and 
a range of compounds were added (1% w/v) to the Triton 
peptone extract. After holding at 31 °C for 60 mins the 
mixtures were assayed for neomycin activity. 
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2.10 Alternative procedure developed for the microbiological 
examination of creams 
A 50g sample of cream was dispersed with 450ml of tryptone 
soya broth (37°C) in a 500ml transfusion bottle. To obtain an 
even dispersion vigorous hand shaking for 30 seconds was 
required. Aliquots of 100mls were withdrawn into 400ml of 
tryptone soya broth for enrichment, subsequent microbial analysis 
was as specified in the procedure for the routine examination of 
creams (2.4.4). 
This alternative technique was compared with that specified for 
routine examination of creams (2.4.4). Both techniques were 
used to examine 'standard' cream (2.12.2) which was inoculated 
with Ps aeruginosa strains 228 or NCTC 6750 as described 
(2.12.4.1 ). Strain 228 was present in a sample of contaminated 
cream and strain NCTC 67 50 was a 24h diluted tryptone 
soya broth culture. 
l OO 
2.11 Effect of specific processing stages on the level and type 
of microbial contamination ln tablets 
2.11.1 Compression 
A study was made using a tablet (tablet 'a') with the following 
formulation: 
Maize starch 
Or ied yeast powder 
Tribasic calcium phosphate 
11% 
84% 
5% 
The granule was prepared by blending the ingredients for 30 
minutes in a mixer (Peerless). 
Within 24h of preparation the granule was compressed on a 
rotary press (Manesty D machine). The tablet temperature after 
compression was estimated by inserting a thermometer into a 
container of freshly compressed tablets. 
Samples from batches of the granule and the final tablet were 
examined for total viable count. All samples (1 Og) were 
suspended in 0.1% peptone water (90ml) and placed on a rotor 
arm shaker (250rpm) for 20 minutes to ensure good dispersion. 
Four 1 ml samples were taken from each suspension and total 
viable counts estimated using the pour plate technique (tryptone 
soya agar). Plates were incubated at 31 °C for 48h to estimate 
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bacterial count and then after a further 72h at 25°C to estimate 
fungal count. 
A second tablet (tablet 'b') was studied having the following 
formulation: 
Lactose 
Gelatin 
Maize starch 
Magnesium stearate 
Gum acacia 
60% 
1% 
16% 
1% 
22% 
The lactose· granule, incorporating all the ingredients except for 
gum acacia, was prepared by a wet granulation process. The 
gum acacia was blended with this granule and the mixture 
compressed on a single punch machine (Manesty F). 
The total viable counts of the granule and tablet were estimated, 
as described for tablet 'a' and a further study was made of 
specific contaminants. 
Viable counts of Bacillus were estimated using pour plates 
(tryptone soya agar) but samples were first 'heat shocked' at 
80°C for . 1 minute (Harrewijn et al 1972). Sabouraud agar was 
used for estimating fungal counts and MacConkey agar for 
lactose fermenting enterobacteria. 
2.11.2 
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Sabouraud agar pour plates were incubated at 25°C for 96h, 
MacConkey agar pour plates at 37°C for 48h and Bacillus count plates 
at 31 °C for 48h. 
A further assessment was made of the survival of lactose 
fermenting enterobacteria. Replicate lg or lOOmg samples were examined, 
using a modification of the BP 1973 test for E coli. The samples were 
enriched in lOOm! of nutrient broth and subcultured into MacConkey 
broth. After this secondary enrichment, all samples showing 
acid, or acid and gas, were subcultured on to MacConkey agar. Following 
incubation at 37°C for 24h, all suspect colonies were examined using 
Enterotubes. 
Over 88 batches were examined, of one particular commercial 
tablet having a similar composition to tablet 'a' but with the active ingredient 
incorporated. Both the raw materials used and the tablets produced 
were examined for total viable counts and contamination with enterobacteria 
and faecal streptococci. The manufacturing process was simple involving 
blending of ingredients followed by compression. 
Solvent granulation 
A slurry of maize starch (70%) and dried yeast powder (30%) 
was prepared in industrial methylated spirits (15% w/v). To produce 
a dry granule the mixture was heated in shallow trays at 50°C 
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for 16h. Prior to use the maize starch had been dried by 
exposure to the same drying cycle. Three batches of granules were 
prepared and examined. 
The total viable counts of the initial untreated raw materials 
and dried granules were compared using the technique described for 
tablet 'a' (2.11.1). 
2.12 
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Studies on Pseudomonas contamination of creams 
Microbiological monitoring of a cream manufacture area 
Studies were made of levels and types of microbial contamination 
in a cream manufacture area, particular attention 
being paid to detec tion of Ps aeruginosa. Surface swab samples 
were taken from equipment and any damp or wet surfaces and 
plated on Pseudosel agar. 
Distilled and tap water used in the cream manufacture area was 
monitored using the Miles and Misra technique or membrane 
filtration, samples were plated on Pseudosel and nutrient agars. 
Manufacture of creams in the laboratory 
The formulation of the 'standard' cream used in these studies was 
as follows:-
Chlorocresol 
Cetomacrogol 1000 
Cetosteary 1 alcohol 
White soft paraffin 
Liquid paraffin 
Disodium hydrogen phosphate 
Sodium dihydrogen phosphate 
Distilled water 
pH of cream 7.6- 7.7 
% weight/ weight 
0.10 
1.80 
7.20 
15.00 
6.00 
0.10 
0.02 
to 100 
2.12.3 
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To provide the aqueous phase of the cream, a solution containing 
chlorocresol and the phosphate buffers was prepared and heated 
to 65°C. 
The mixture of fats was heated to 65°C and added to the 
aqueous phase, the emulsion was then blended for 15 minutes 
using a 'Silverson' mixer for the last 5 minutes the cream was 
cooled in a water bath. The cream was allowed to adjust to 
room temperature and the pH determined using a single 
electrode meter. 
Preparation of creams adjusted to a range of pH values 
Two methods were used. 
Addition of acid or a lkali 
Solutions of phosphoric acid or sodium hydroxide were added t o 
adjust the pH of commercial creams to a range of values. A 
stable pH was obtained by manual blending of the cream, which 
was continued until a constant value was recorded. 
Adjustment of buffering salts 
Different ratios of the two phosphate buffers specified for the 
2.12.4 
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'standard' cream were used to manufacture creams of the required pH. 
The ratios were determined from tables in Cruickshank et al 
(1973). The total concentration of buffers in the cream were 
adjusted to approximate to that of the 'standard' cream. 
Survival of Pseudomonas aeruginosa in various creams 
A range of commercial and laboratory prepared creams adjusted 
or manufactured to different pH values were challenged with a 
contaminated commercial cream and in certain cases with a 
contaminated cream Ringer's solution mixture. 
Most studies were performed with the inoculated cream held in 
glass beakers but limited studies were also performed with the 
inoculated cream held in collapsible tubes. The tubes used were 
aluminium, coated internally with a lacquer and sealed with 
polypropy le ne caps. 
Inoculation of the creams 
Approximately lOOg of the required cream was inoculated with 
500mg of a commercial cream in which Ps aeruginosa was 
actively proliferating. The cream was blended by hand to ensure 
even dispersion. 
2.12.4.2 
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In certain studies the inoculum was prepared by culturing the 
required strain of Ps aeruginosa in a mixture of cream and t 
strength Ringer's solution (10% w/v) at 31 °C. Less than 0.5ml of 
an appropriate dilution of the mixture, prepared in t strength 
Ringers, was used to challenge the cream. 
Monitoring of inoculated creams 
Samples of up to lOg were removed with time from the 
inocu.lated cream, over a period of up to 2 months. These were 
examined by the specified procedure (2.4.4) for total viable 
count and presence of Ps aeruginosa. 
Uninoculated negative controls were similarly tested. 
Examination of the antibacterial activity of a number of creams 
A variety of creams were tested for antibacterial activity 
against a range of pseudomonads. Strains used included 
environmental isolates and isolates from a contaminated cream 
and a contaminated water sample. The water sample was 
collected in the cream manufacture area from a sink drain pipe 
and allowed to stand for 28 days at ambient temperature (in a 
sealed container), to increase viable count. 
Petri dishes were poured to a depth of 5mm using tryptone soya 
agar seeded with one of the test isolates previously cultured in 
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tryptone soya broth, the contaminated water sample was used to seed the 
agar directly. Circular wells of 1cm diameter were cut into the 
agar using a cork borer. The wells were filled with the required 
cream or a solution of 0.1 % chlorocresol, and the plates 
incubated at 31 °C for 24h. The diameter of any zones of 
inhibition were measured. 
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2.13 Survival of micro-organisms in propylene glycol heated in an 
autoclave 
2.13.1 Preparation of contaminated propylene glycol 
Propylene glycol (1 litre) was contaminated with soil micro-
organisms by addition of 3g of dried soil (50°C for 6h). The 
mixture was shaken and held at room temperature for 2~ hours, 
500ml of supernatant was withdrawn for studies. 
The following procedure was developed, during this study, for 
contamination of propylene glycol with dry spores of a 
laboratory culture. 
Further samples of propylene glycol were contaminated with 
spores of B subtilis var globigii NCTC 10073 or a laboratory 
isolate, Bacillus species 201, which produced distinctive rust red 
colonies on nutrient agar. These organisms were cultured on 
nutrient agar slopes (containing 0.01% manganese chloride) at 
31°C for 7 days. Growth was removed from the slopes and 
suspended in 0.09% saline solution, endospores were separated 
from vegetative cells by centrifuging (4000 rpm for 15 minutes) 
and resuspending, this was repeated 3 times. The spore 
suspensions were heat shocked at 80°C for 30 minutes and then 
stored at 4°C. 
Spore suspension (O.&ml) was added to 9mls of 0.1% peptone 
water containing 30mg of 'Hyflo'. The mixture was shaken and 
2.13.2 
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filtered through a 47mm 0.45p 'Solvinert' membrane (Millipore). 
The membrane was rinsed with lOOmls of 0.1% peptone water and dried 
at 31 °C for 48h in a petri dish, on a sterile absorbent membrane pad. 
To prepare contaminated propylene glycol; the dry membrane 
was placed contaminated side down in a filter holder fitted with a plastic 
membrane support (from a 50mm Sartorius holder), 250mls of propylene 
glycol was passed through the membrane and the contaminated 
filtrate collected. 
Heating propylene glycol in an autoclave 
Al1quots ~50mls) of contaminated propylene glycol were 
filled into 50ml glass ampoules which were then heat sealed. Ampoules 
of uninoculated propylene glycol were prepared as negative controls. 
After heating in the autoclave at either 115°C or 121 °C 
for the required time the contents of each ampoule was filtered through 
a separate 0.45)-l'Solvinert' membrane. Before placing on nutrient agar, 
membranes were rinsed with lOOmls of 0.1% Triton X lOO in 0.1% peptone 
water and finally with lOOmls of 0.1% peptone water. All plates were 
incubated at 31 °C for 96h, those containing soil organisms were then 
incubated at 25°C for a further 48h, to encourage growth of fungal 
and Actinomycete colonies. 
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To determine the level of survival, the total viable count 
and counts of specific groups were compared with those from non-heat 
treated samples. 
3 RESULTS 
- --- ----- --- ----
11 2 
3.1 Type and level of microbial contamination in raw materials, 
intermediates, and final products 
3.1.1 Raw materials 
As shown in Table 8, a total of 610 samples from 29 raw materials 
were examined. Total viable counts recorded ranged from 
less than 10 to 110,000 g -l. Only 13% of samples gave counts 
in excess of 1000 g-1, all these were materials of natural 
origin, with just gum acacia, shellac orange and dry yeast 
powder recording such counts consistently. Empty gelatin 
capsules gave the most variable results with viable counts 
-1 
ranging from less than 10 to 32,800 g . 
Oils, inorganic chemicals, talcum powder and china clay all 
gave consistently low total viable counts usually less than 
10 g-1• Sugar, lactose and glucose gave similar results but 
with occasional higher counts of over 100 g -l. 
Staphylococcus aureus and Salmonella were not detected 
in any of the samples tested, even though controls using 
S aureus PRIV and S abony NCTC 6017 were positive. 
Five types of raw material yielded E coli, but further studies 
on these positive materials using samples of less than 1 Og 
Table 8 Microbiological examination of raw materials used in the 
manufacture of oral and topical pharmaceutical preparations 
a, E, direct enrichment, M, membrane filtration 
b, Includes, Avicel, microcrystalline cellulose, metho~el, sodium 
carboxymethylcellulose, ethylcellulose. 
c, Includes, sodium chloride, sodium citrate, sodium hydroxide, 
potassium chloride, sodium EDTA, calcium carbonate, ferric fumarate, 
sodium phosphate. 
d, Includes tween 80, polyethylene glycol, cremaphore 
e, 6 of these samples contained Ps aeruginosa, 3 batches of gelatin 
capsules, 3 batches of shellac orange. 
Raw Material 
Al hydroxide Mg 
carbonate gel 
Arachis oil 
Betamethasone powder 
Bone meal 
Calcium phos tribasic 
Celluloseb 
China clay 
Ci t ric acid 
Cocoa powder 
Colourings 
Flavourings 
Gelatin capsules 
Gelatin powder 
Glucose 
Glyceryl monostearate 
Gum acacia 
Inorganic chemicalsc 
Lactose 
Liquid paraffin 
Magnesium stearate 
Propylene glycol 
Shellac orange 
Starch maize 
Starch potato 
Sugat 
Surfactantsd 
Talcum powder 
Vitamin Bl2 
Yeast powder dry 
Total 
Samples Methoda 
tested 
7 E 
3 M 
4 M 
E 
29 E 
40 E 
5 E 
2 M 
18 E 
5 E 
2 M 
96 E 
86 E 
M 
4 E 
31 E 
9 M 
36 M 
3 M 
18 E 
18 
17 E 
55 E 
15 £ 
56 M 
8 M 
11 E 
3 M 
21 E 
610 
Total viable count g-1 
Range Mean 
<10 - 200 29 
<10 -< 10 < 10 
<10 - 110 30 
340 
<10 - 280 22 
<10 - .5360 170 
<10 - 70 21 
<10 - <10 < 10 
20 - 2300 500 
< 10 - 1200 310 
<10 -< 10 < 10 
<10 - 32800 1302 
<10 - 3250 143 
<10 - 42 
<10 - < 10 < 10 
320 - 10,000 2989 
<10 - 15 < 10 
<10 - 400 44 
<10 - <10 < 10 
<10 - 600 86 
<10 -< 10 < 10 
20 - 110000 1.5107 
< 10 - 2490 404 
27 - 7720 1978 
<10- 179 22 
<10 -< 10 < 10 
<10 -<10 < 10 
12 - 23 18 
500 - 11600 3360 
Samples 
1000 
0 
0 
0 
0 
0 
0 
0 
4 
0 
8 
0 
0 
21 
0 
0 
0 
0 
0 
15 
5 
4 
0 
0 
0 
0 
17 
77 
Samples positive for 
E coli 
strepto-
pseudomon- entero-
ads bacter ia 
faecal 
cocci 
0 0 0 0 
0 0 0 0 
0 0 0 0 
0 0 0 
0 0 0 0 
0 0 0 0 
0 0 0 0 
0 0 0 0 
0 8 13 
0 0 0 0 
0 0 0 0 
3 16 8 
2 0 38 18 
0 0 0 0 
0 0 0 0 
4 2 27 4 
0 0 0 0 
0 5 10 3 
0 0 0 0 
0 0 0 0 
0 0 0 0 
9 9 16 0 
0 0 9 3 
0 5 14 
0 0 3 6 
0 0 0 0 
0 0 0 
0 0 0 0 
0 0 21 19 
23 24 (e) 163 76 
------------------- --
- - - - ---------
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indicated that, with the exception of certain batches of empty 
capsules the contamination level of E coli was less than 
1 g- 1. In addition toE coli, other enterobacteria were isolated 
from these same five raw materials and also from a further 
five materials also of natural origin. 
Only 9 of the 55 batches of maize starch were positive for 
enterobacteria and none contained pseudomonads. This is 
in marked contrast to potato starch where 14 of the 15 samples 
tested were positive for species of enterobacteria and five 
for pseudomonads. 
Enterobacteria isolated from raw materials were members 
of the following genera, Enterobacter (usually E cloacae 
or E liguefaciens), Citrobacter, Klebsiella, Providencia and 
Proteus, the first two being most regularly detected. Proteus 
species were detected in occasional batches of gum acacia 
and shellac orange but were recovered from 55% of dried 
yeast powder samples examined, occuring as P mirabilis, 
P rettgeri and P vulgaris. 
The 'Enterotube' proved a rapid aid to identifying enterobacteria 
down to genus level and in some cases species level. The 
results using the technique to identify possible E coli or 
Salmonella isolates always agreed with identifications made according 
to the BP (1973) procedures. 
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Faecal streptococci were isolated from 9 of the 10 types 
of raw material which also yielded enterobacteria; cocoa 
and dry yeast powder being the materials most regularly contaminated. 
Isolates examined in detail were all identified as Streptococcus 
faecalis but the majority were examined no further when 
shown by presumptive tests to be faecal streptococci. 
Pseudomonads were isolated from 5 types of raw mater ial, 
all of natural origin, Ps aeruginosa was only detected in 
empty gelatin capsules and shellac orange. Pseudomonads 
not identified as Ps aeruginosa were examined no further. 
The procedures used were not aimed specifically at detecting 
yeasts and fungi but yeasts were isolated regularly from 
sugars examined by filtration on membranes incubated on 
-1 
nutrient agar. No mould counts greater than 200 g were 
recorded on any of the total count plates. 
Gram positive bacilli were not examined in detail but as 
may be expected Bacillus species were common contaminants 
of most raw materials, representing regularly over 50% of 
the total organisms isolated. 
116 
Examining the combined data from 8 raw materials of natural 
origin, enterobacteria were isolated from 90% of batches 
with total viable counts in excess of 1000 g-l, but from only 
38% of batches with counts of less than 100. Further comparisons 
relating detection of, enterobacteria, E coli and pseudomonads 
to total viable count and presence of various marker organisms 
are given in Table 9. 
3.1.2 Soft gelatin capsules, tablets, tablet intermediates and tablet 
containers 
Microbiological data obtained from a range of oral pharmaceutical 
preparations, tablet intermediates and empty tablet containers 
is reported in Tables 10, 11 and 12 respectively. 
Salmonella and S aureus were not detected and E coli was 
isolated from one batch of soft gelatin capsules, pseudomonads 
were isolated from two other batches of the same product. 
Enterobacteria including Klebsiella, Citrobacter, Enterobacter 
and Proteus were isolated from certain intermediates and 
completed preparations. 
Table 9 
Test group 
Percentage correlation between detection of three test groups of bacteria 
and both total viaQle count and presence of other groups, figures estimated 
from the combined data of 8 raw materials of natural origin* 
Total viable count g-l 
Faecal 
0 - 100 100 - 1000 > 1000 E. coli 
Entero-
bacteria streptococci Pseudomonas 
Ente robacteria 38 45 90 100 47 
E coli 1.4 2.3 32 18 4 
Pseudomonas 2.8 1.1 13 31 7 
*Cocoa, gum acacia, empty gelatin capsules, gelatin powder, ma~ze starch, potato starch, shellac orange, 
dry yeast powder. 
73 
60 
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Table 10 Microbiological study of selected commercial table ts and soft ge latin capsules manufactured on one produc tion s ite. 
Preparation 
Multivit.amin capsule 
Multivitamin capsule 
Bronchodilator capsule 
Griseofulvin tablet 
Antacid tablet 
Multivitamin pellet 
Multivitamin table t 
Hydro7ortisone tablet 
Vitamin + iron tablet 
Samples 
tested 
12 
14 
9 
9 
11 
16 
11 
2 
2 
Veterinary steroid tablet 105 
a Klebsiella isolated from 1 batch 
b Proteus isolated 
c Proteus isolated from 14 batches. 
Total viable count g-1 
Range 
20 - 920 
<10 - 1430 
< 10 - 50 
< 10 - 10 
< 10 - 20 
< 10 - 680 
< 10- 620 
16 - 40 
< 10 - 10 
40- 3,700 
Mean 
345 
366 
16 
< 10 
< 10 
89 
116 
28 
< 10 
418 
Sample s 
>1000 
0 
2 
0 
0 
0 
0 
0 
0 
0 
4 
E coli 
1 
0 
0 
0 
0 
0 
0 
0 
0 
0 
Number of samples pos itive for:-
Pseudomonads 
2 
0 
0 
0 
0 
2 
0 
0 
0 
0 
Ente ro-
bacteria 
7 
1 
0 
4a 
1 
0 
0 
1b 
0 
26c 
Faecal 
streptococc i 
3 
0 
0 
0 
0 
0 
0 
0 
0 
100 
Table 11 Microbiological data obtained from a range of tablet intermediates . 
Intermediate 
j Mucilage of acac1a 
Granulating emulsion 
Granulating solution 
Constituent raw 
materials include: 
Acacia, sodium benzoate, 
water 
Flavouring oils, saccharin, 
sodium benzoate, water 
Sodium alginate, methyl & 
propyl hydroxy benzoate, 
water 
Ferric oxide, acacia, sugar, Chocolate acac1a syrup 
colouring, water 
Glucose 5ranulating 
solution 
c Tablet granules 
Shellac orange 
solution 
Glucose syrup, colouring, 
gelatin, water 
Glucose §ranulating 
solution , sugar 
~hellac orange, I.M.S. 
Samples 
tested 
8 
7 
7 
3 
3 
3 
3 
Total viable count g-1 
Range 
< 10 -< 10 
< 10 -< 10 
< 10 -< 10 
4 320-6.8x10 
< 10 - 240 
< 10 - < 10 
Samples 
> 1000 
0 
0 
1 
1 
3 
0 
0 
No . samples positive for: 
E coli Ps e udomonads 
0 0 
0 0 
0 0 
0 0 
0 0 
0 0 
0 0 
Entero- Faecal 
bacteria Streptococci 
0 1 
0 0 
0 0 
0 0 
0 
0 
0 0 
Samples taken up to 72h after manufacture ! a, E cloacae, E aerogenes, Citrobacter, Klebsiella, P rettgeri and yeasts isolated, 
b, Klebsiella and Citrobacter isolated, d, glucose granulating solution, same batches as those include d in this table. 
Table 12 
Type of 
container 
Polypropylene 
securitainers 
types, 1 
2 
3 
Glass bo t tles 
types, 1 
2 
3 
4 
Glass vials 
types, l 
2 
3 
4 
5 
6 
7 
8 
Microbiological examination of the internal 
surfaces of a range of different containers 
used in tablet packaging 
Total viable 
count/5 Isolates 
containers 
10 Bacillus, Gram positive cocci. 
3 Bacillus, yeast, Gram pos1t1ve 
14 Bacillus, fungi, Gram positive 
6 Bacillus, Gram positive COCC1. 
108 Bacillus, fungi, Gram positive 
122 Bacillus, fungi, Gram positive 
41 Bacillus, fungi, Gram positive 
l Bacillus . 
3 Bacillus, Gram positive COCC1. 
4 Bacillus, fungi. 
48 Bacillus, yeast, Gram positive 
0 
13 Bacillus, Gram positive COCC1. 
2 Bacillus. 
42 Bacillus, Gram positive COCC1 . 
cocc 1. 
COCC1. 
COCC1. 
COCC1 . 
COCC1. 
COCC1. 
Containers fitted with closure tested in groups of five by r1ns1ng with 
0 . 1% peptone water containing 0.1% Triton X lOO, the rinse solution was 
filtered and the membrane incubated on nutrient agar. 
--------------- - - -
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Only one type of soft gelatin capsule and a veterinary steroid 
tablet gave counts in excess of 1000 g-1. Two intermediates, 
chocolate acacia syrup and glucose granu1ating solution yielded 
high viable counts which reached 6.8 x 104 and 106 g -l respectively 
(within 72h of manufacture). Before testing, the glucose 
granulating solution was suspected of having a high viable 
count, due to its strong alcoholic smell, in this case the viable 
count was found to have reached 106 g -1 within 48h of manufacture. 
A11 counts obtained from empty tablet containers were low. 
Combining the counts of 5 similar containers, the maximum 
obtained was 122, for 10 t ypes of container counts of less 
than 20 were recorded. As Table 12 shows no pathogenic 
species were isolated. 
3.1.3 Creams 
The results obtained from monitoring filled creams are given 
in Table 13, total viable counts of less than 10 organisms 
g - 1 were obtained from 99.796 of batches, for 7796 of these 
no viable organisms were actually detected. 
Staphylcoccus aureus was not detected in any of the samples 
tested. Oxidase negative, Gram-negative bacilli were isolated 
from 3 different samples, only one isolate was identified 
.................. -------------------------------------
Table 13 Microbiological study of filled commercial creams manufactured on one production site 
Cream Number of batches containing 
Other Other Contaminants 
pH Batches . <lOg - 1 - 1 -1 
Other Gram -ve Type: tested 10-100g 100-lOOOg Ps aerugino sa pseudomonads bacilli 
Bacillus, COCC1 
Steroid 'a' 5.0 283 28"0 2 1 0 1 1 Penicillium, 
yeasts 
*Steroid ' b 1 7. 3 30 26 3 1 7 0 1 Bacillus , COCC1 yeasts 
Steroid 'bl 5.0 48 48 0 0 0 0 0 Bacillus and 
COCC 1 
Steroid 'a' 7. 0 106 Bacillus and 
+ neomycin 106 0 0 0 0 0 yeast 
Steroid I a' 5.0 63 63 0 0 0 0 0 Bacillus + clioquinol 
Steroid I C I + 5.0 68 68 0 0 0 0 0 Bacillus propylene glycol 
Analgesic 5.0 29 29 0 0 0 0 1 Bacillus 
Total 627 620 5 2 7 1 3 
All creams fi lled into collapsible a l uminium tubes. Steroids 'a', 1 b' and 'c' refer to different types of corticosteroid·. 
* Furt her details given in Table 14 and Figure 2. 
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as belonging to the Enterobacteriaceae (Enterobacter species), 
duplicate repeat samples were negative in each case. Only 
one sample of cream yielded a species of Pseudomonas other 
than Ps aeruginosa, duplicate repeat samples were negative. 
The most common isolates were species of Bacillus and Gram-
positive cocci, moulds and yeasts were isolated from only 
occasional batches. 
As shown in Tables 13 and 14, Ps aeruginosa was detected 
in filled samples of 7 batches of steroid cream 'b', but in 
only one batch was the organism also isolated from the 500kg 
of bulk material. In 4 of the batches isolation of Ps aeruginosa 
could not be repeated from either the same or further samples. 
Contaminated batch No 28 was examined in more detail, 
proliferation of Ps aeruginosa (designated strain 228) was 
followed in the tubes of cream over 42 days, during this 
time the mean viable count increased from 50 g -1 to 
20,000 g -1 (Figure 2). No alteration in the, consistency, 
colour or odour of the cream was observed during this time. 
Fig 2 
Table 14 
Batch no 
of cream 
9 
12 
28b 
30 
41 
42 
43 
(opposite) Growth curve of Ps aeruginosa monitored in 
steroid cream type 'b' batch 28, each point plotted 
represent mean count of at least five filled tubes. 
Details of Ps aeruginosa contamination detected 1n 
commercial batches of steroid cream type 'b' 
Ps aerug1nosa detected 1n 
Bulk 1st test Repeat test Further tests 
material filled filled filled material 
material material 
+ (ND)a 
- (ND) 
+ (280) - (ND) After 4 months -ve 
+ (50) + (200) Afte4 ~ 1weeks · tvc 2xl0 g 
+ ( 20 ) - (ND) 
+ (ND) - (ND) 
+ (40) + (ND) 
+ + (< 10) + ( 90) 
a, all figures in brackets represent the viable count recorded (g- 1), non-
detected, b, actua l growth curve given in Fig 2 opposite. 
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3.2 Comparison of enrichment and plating systems for detection 
of E coli, other enterobacteria, faecal streptococci, and pseudomonads 
in raw materials 
The study was conducted in two parts. Firstly, during routine 
microbiological analysis of raw materials (section 3.1.1) by 
the BP or USP procedures, alternative enrichment and plating 
systems were also used to examine samples. Secondly, selected 
enrichment and plating systems were used to examine replicate 
samples of raw materials known to be contaminated with 
E coli or one of the other organisms specified. 
3.2.1 Comparative results obtained from use of various enrichment 
and plating systems for the routine examination of raw materials 
As shown in Table 15 E coli was detected with similar efficiency 
by MacConkey broth enrichments plated onto MacConkey 
agar, and by nutrient broth enrichments plated onto MacConkey 
agar or inoculated into a secondary MacConkey broth enrichment. 
All the four systems compared were equally efficient in 
detecting enterobacteria. 
Faecal streptococci were detected most efficiently by nutrient 
broth enrichments plated onto nutrient or MacConkey agar. 
Table 15 Comparison of enrichment and plating systems used for 
detection of specific bacteria in a number of raw materials, 
the results are expressed as the number of samples tested 
a, 
b, 
c, 
d, 
e, 
to the number positive 
materials include, aluminium hydroxide magnesium carbonate gel, 
china clay, cellulose, calcium phosphate tribasic andmagnesium 
stearate. 
BP (1973) procedure followed suspect positives therefore required 
a third enrichment but a t 44°C. 
Abbreviation~ DCA, desoxycholate citrate agar, BG, brilliant green 
agar, BS, bismuth sulphite agar, TSB, tryptone soya broth. 
only suspec t positives obtained, additional plating on MacConkey 
agar required for confirmation, only confirmed results included 
in the table. 
enrichments incubated at 37°C for 24h, other Pseudomonas enrichments 
incubated at 31°C for 72h. 
..................... -----------------------------------------
Bacteria 
de tected 
E col i 
Prima ry 
enrichment 
broth 
Lactose 
Nutrie nt 
Nutrient 
Nu tr i e nt 
MncConkey 
Enterobacteria Lac t ose 
Faeca l 
Streptococci 
Pseudomonas 
Nutrient 
Nutrient 
Nutrient 
MacConkey 
Lactose 
Nutrient 
Nut rient 
Nutrient 
MacConkey 
Cetrimide 
Nu trient 
Nutrient 
Nutrient e 
MacConkeye 
Secondary 
enrichment 
broth 
MacConkeyb 
tTet rathionate 
(Sellenite 
MacConkeyd 
Plating 
medium 
MacConkey 
Mac Conkey 
Nutrient 
MacConkey 
MacConkey 
DCA,BG,BSc 
MacConkey 
Nutrie nt 
Ma cConkey 
MacConkey 
MacConkey 
Nutrient 
MacConkey 
Pseudose 1 
Pseudose l 
Pseudo se l 
Ma cConkey 
Nutrient 
Mac Conkey 
Combined a 
data from 
5 ma t e ria ls 
20 0 
79 0 
32 0 
79 0 
0 
20 0 
79 0 
32 0 
79 0 
47 0 
20 0 
79 0 
32 0 
79 0 
47 0 
20 0 
48 0 
36 0 
31 0 
79 0 
48 0 
Cocoa 
18 
17 
18 
12 0 
18 8 
7 3 
18 
12 4 
18 6 
3 
18 12 
12 
12 0 
10 0 
7 0 
18 0 
12 0 
Gelatin 
Capsu les 
96 8 
38 0 
96 5 
58 7 
95 15 
38 2 
96 13 
58 12 
96 7 
38 6 
96 6 
58 0 
61 0 
38 3 
38 3 
96 3 
0 
Ce1alin 
!Jowder 
86 
35 
86 0 
47 2 
)6 33 
35 9 
86 26 
47 13 
86 17 
35 8 
86 20 
47 
64 0 
52 0 
35 0 
86 0 
47 0 
Cum 
acdcia 
31 4 
9 2 
31 
24 
31 25 
9 8 
31 18 
24 20 
31 0 
9 0 
31 3 
24 0 
17 
9 0 
31 0 
24 0 
Shellac 
orange 
17 
10 4 
17 4 
9 4 
17 14 
10 9 
17 15 
9 8 
1 7 0 
10 0 
17 0 
9 0 
7 3 
13 5 
10 
17 4 
9 3 
Maize 
starch 
10 0 
39 0 
21 0 
39 0 
18 0 
10 0 
39 6 
21 5 
39 8 
18 4 
10 0 
39 
21 
39 3 
18 
10 0 
22 
21 0 
21 0 
39 0 
18 0 
Potato 
starch 
15 0 
8 0 
15 0 
9 0 
15 ll 
8 
15 10 
9 6 
15 0 
8 0 
15 0 
9 
11 
8 4 
8 4 
15 0 
9 
Yeast 
powder dry 
21 0 
21 2 1 
21 19 
2 1 0 
Total 
51 0 
381 21 
170 8 
381 11 
224 lf• 
51 21 
381 112 
160 43 
381 97 
224 67 
51 19 
381 31 
160 18 
381 44 
224 10 
51 0 
249 5 
195 13 
159 8 
381 7 
225 4 
Percentage 
positive 
5. 5 
4.7 
2. 9 
6 . 3 
29 . 4 
26 .8 
25 .5 
29.9 
8 . 1 
11.3 
11.5 
4 . 5 
2.0 
6.7 
5.0 
1.8 
1.8 
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A slightly lower efficiency was recorded for the nutrient 
broth enrichment inoculated into a secondary MacConkey 
broch enrichment. In the latter case faecal .streptococci 
are only suspected due to slight acid and gas formation in 
MacConkey broth, subsequent plating on MacConkey agar 
was required for confirmation. 
Pseudomonas species were detected most efficiently by 
the nutrient broth enrichment plated onto PseudoseJ agar, 
0.03% cetrlmide and MacConkey broths were less efficient. 
3.2.2 Comparative study of selected enrichment and plating medias 
using raw materials naturally contaminated with the required 
organism 
The comparative efficiences of five enrichment broth media 
in detecting enterobacteria, E coli specifically and faecal 
streptococci are reported in Tables 16, 17, 18 respectively. 
All five media were equally effective in terms of, the mean 
number of enterobacterial isolates recovered per enrichment 
and the total number of different morphological types recorded. 
Escherichia coli was detected most efficiently by the nutrient 
broth enrichment subcultured into a secondary enrichment 
Table 16 Comparison of enrichment media for 
the detection of enterobacteria 
Repl i cate samples of various raw material s were examined 
using 5 enrichment media, A total of 55 enrichments were 
prepared in each med i um. 
Mean number of Total number of 
Enrichment broth isolates per morphological types 
enrichment from 25 enrichmen ts 
MacConkey 3.0 18 
E E 2.7 19 
Lactose 2.9 22 
Tryptone soya 3.0 18 
Nutrient 3.0 18 
Raw materials included, gum acacia, shellac orange, empty gelatin 
capsules and dry yeast powder . 
All enrichments incubated at 37°C for 24h and then plated onto 
MacConkey agar. 
Morphological types recovered inc l uded species of Citrobacter, 
Bnterobacter, Klebsiella and E coli . 
Table 17 
Enrichment 
media 
MacConkey 
E E 
Lactose 
Tryptone soya 
Nutrient 
Nutrient plus 2° 
enrichment MacConkey 
Comparison of enrichment media for the 
detection of E coli 
Number of samples positive for E coli from 10 
replicate sampies of each of 4 batches of raw 
materials 
1 2 3 4 
1 7 6 6 
4 3 3 3 
3 3 3 7 
3 4 7 6 
2 6 9 5 
3 6 8 . 8 
% samples 
positive 
50 
33 
40 
50 
55 
63 
Raw materials used; Batch 1 gum acacia, Batches 2, 3, 4 mixture of gum acac~a 
and shellac orange. 
Enrichments incubates at 37°C for 24h, then plated on MacConkey agar and 
incubated at 37° for 24h, except for the secondary enrichment in MacConkey 
broth, this was subcultured into MacConkey broth and 1% peptone water 
incubated at 44°C for 24h then examined for acid and gas and indole production. 
Table 18 
Enrichment 
broth 
MacConkey 
E E 
Lactose 
Tryptone soya 
*Nutrient 
Detection of faecal streptococci, in dry 
yeast powder, using five enrichment media, 
with MacConkey and violet red bile dextrose 
(VRBD) agars as plating media 
Samples +ve for faecal streptococci 
on each plating medium, from 5 
replicate enrichments 
MacConkey VRBD 
5 0 
0 0 
5 0 
5 0 
5 0 
Enrichments incubated at 37° for 24h and plating media 37°C for 
48h. 
*Nutrient broth enrichment also subcultured into MacConkey broth, 
slight acid and gas production was visible in all five replicates, 
faecal streptococci were confirmed in each case by subculture onto 
MacConkey agar. 
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of MacConkey broth (BP 1973 procedure), EE and lactose 
broths proved least efficient. 
Faecal streptococci were detected using all enrichment media 
except EE broth. 
In the comparison made of two plating media, Table 19, violet 
red bile dextrose agar proved less efficient than MacConkey 
agar in terms of, the mean number of enterobacterial isolates 
recovered per plate and the total number of different morphological 
types recorded. 
Three significant problems were observed with violet red 
bile dextrose agar as compared with MacConkey agar. 
Firstly, isolates producing discrete colonies on MacConkey 
agar, may form large mucoid colonies on violet red bile dextrose 
agar which have little or no differentiating characteristics 
(Plates 3, 4, 5). 
Secondly, E coli forms characteristic red colonies on MacConkey 
agar surrounded by an obvious red pecipitate (Plate 6), on 
violet red bile dextrose agar discrete colonies are formed 
but these are morphologically similar to those produced 
by many other enterobacteria. 
Table 19 Comparison of viole t red bile dextrose agar 
(VRBD) with MacConkey agar , for detection of 
enterobacteria from a range of enrichment medi a . 
Replicate samples of var1ous raw materials were examined using 
5 enrichment media. A total of 20 enrichments were prepared in 
each media , after incubation these were plated on both MacConkey 
and VRBD agars. 
Enrichment 
broth 
MacConkey 
E E 
Lactose 
Tryptone soya 
Nutrient 
Overa ll mean 
Mean no. of isolates per 
pla te 
VRBD MacConkey 
1.4 2.5 
1.4 2.2 
1.8 2.4 
1. 5 2 . 1 
1.7 2.4 
1.6 2.3 
To t a l no. of morphologica l 
types recovered 
VRBD MacConkey 
6 12 
6 15 
9 15 
10 12 
9 12 
8 13 
Raw materia l s included, gum acac1a, shellac orange, empty gelatin capsule s 
and dry yeast powder. 
All enrichments and plates incubated at 37°C for 24h. 
Enrichment of a raw material containing E coli plated onto MacConkey and 
violet red bile dextrose agars. --
Plate 3 
Plate 4 
Plate 5 
MacConkey agar; descrete colonies visible with obvious 
precipitate in the media due to presence of E coli 
Violet red bile dextrose agar; with both descrete and 
large mucoid colonies visible, a light precipitate is visible 
in the media, this if formed by most glucose fermenting 
organisms. 
Violet red bile dextrose agar, close up of colonies depicted 
in Plate 4. 

Plate 6 
Plate 7 
Pure culture of E coli cultured on MacConkey agar, the 
characteristic precij:)Itate formed by this organism is 
clearly visible after incubation at 37° for 24h. 
Pure culture of S faecalis cultured on MacConkey agar, the 
characteristic dark magenta colonies are formed by this and 
other faecal streptococci after incubation at 37° for 48h. 
.. 
-
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Thirdly, faecal streptococci fail to grow on violet red bile 
dextrose agar (Table 18) while on MacConkey agar after 
48h incubation they form characteristic dark magenta colonies, 
about 1 mm in diameter, with a pale periphery (Plate 7). 
It was also noted that occasional enterobacteria isolated 
could be missed on violet red bile dextrose agar through 
absence of the characteristic red or pink colouration in the 
colony or surrounding media. Two isolates from shellac 
orange found to be glucose fermenters and subsequently 
identified as Citrobacter and E cloacae, both failed to demonstrate 
any obvious pink or red colouration on initial isolation. 
In the comparison made of five enrichment broths, (MacConkey, 
EE, lactose, tryptone soya and nutrient) to recover Salmonella, 
S abony NCTC 6017 and S typhimurium NCTC 10251 (no raw materials 
naturally contaminated with Salmonella available) were 
detected in all five media, even though inoculum levels of 
approximately 4 and 8 viable cells respectively were used 
and other competing enterobacteria, from ·the raw material, 
were present. If secondary enrichments in selenite broth 
were prepared an increased number of lactose fermenters 
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were recovered as well as Proteus and Ps aeruginosa. In 
15 replicate tests, only 8 were positive for S typhimurium 
using a secondary enrichment, while all 15 were positive 
using direct plating. Proteus species formed large black 
mucoid colonies and could be differentiated from Salmonella 
but Ps aeruginosa tended to spread over desoxycholate citrate 
agar plates inhibiting the growth of other organisms (Plates 
8 and 9). 
In a comparison of six enrichment broths, reported in Table 20, 
Ps aeruginosa and other pseudomonads were detected most 
effectively using nutrient broth, 0.03% cetrimide broth was 
least effective failing to recover a single isolate. 
As shown in Table 21, detection of Ps aeruginosa and other 
pseudomonads was slightly reduced on Pseudosel agar compared 
with 0.03% cetrimide agar. However, on Pseudosel, Ps aeruginosa 
produced more obvious diffusable pigments (Plate 10), which 
varied from dark brown to dark green to light green or maroon, 
the colour varying for the same isolate even from p-late to 
plate. Due to production of this pigment, in most cases, 
a single colony of Ps aeruginosa was obvious on a Pseudosel 
agar plate containing other pseudomonads. 
- -~ 
Secondary enrichments, in selenite broth, of raw materials artifically 
contaminated with S typhimurium NCTC 10251, enrichments of different 
samples plated onto each half of the desoxycholate citrate agar plates. 
Plate 8 
Plate 9 
Left hand side, the large black mucoid colonies identified 
as Proteus species, Salmonella visible as typical non-lactose 
fermenting 'rabbit eye' colonies. 
Right hand side, presence of large mucoid colonies of a 
lactose fermenting organism makes identification of 
presumtive Salmonella colonies difficult. 
Left hand side, isolation of Ps aeruginosa prevents 
detection of Salmonella. 
Right hand side, Salmonella isolated but colonies do not 
have the characteristic rabbit eye morphology. 
84/S 
l........_ _ ___ _ _ _ ___ _ _ ___ _____ _ _ _ - --- -
Table 20 Comparison of enrichment media for detection 
of pseudomonads in shellac orange 
Samples positive for pseudomonads from 5 
replicate samples of each of 5 batches % Enrichment 
samples 
media 
1 2 3 4 5 positive 
MacConkey 3 2 5 2(2 )* 2 56 (8) 
E E 5(1 ) 3 5 3( 2) 0 64 (1 2) 
Lactose 2( 2) 0 1 0 0 12 (8) 
Tryptone soya 3(1 ) 3 5 2(1) 1 56 (8) 
Nutrient 5(4) 4 5( 2) 4(1) 2 80 (28) 
0 .03% ce trimide 0 0 0 0 0 0 
*All figures in brackets regresent samples pos itive for Ps aeruginosa. 
Enrichments incubated at 31 C for 72h then plated on Pseudosel and 
0.03% Ce trimide agars and incubated at 31°C f or 72h . 
Table 21 
Enrichment 
media 
MacConkey 
E E 
Lactose 
Tryptone soya 
Nutrient 
0.03% cetrimide 
% total +ve 
Comparison of Pseudosel with 0.03% ce trimide agar 
for t he detection of pseudomonads, in particular 
Ps aeruginosa, i~ she llac orange 
Samples positive from 15 examined 
0.0 3% cetrimide agar Pseudasel agar 
pseudomonads Ps aerugino~a pseudomonads Ps aeruginos a 
9 0 . 7 0 
13 1 12 1 
3 2 3 2 
11 1 8 1 
13 6 11 5 
0 0 0 0 
55 11 46 10 
Samples tested comprised of 5 rep l icate samples from each of 3 batches of 
she l lac . Enrichments i ncubated a t 31° for 72h , and plat i ng media at 31°C 
fo r 72h 
Plate 10 Ps aeruginosa cultured on Pseudosel agar, producing dark 
green diffusable pigment. 
. I 
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In contrast, diffusable pigment production by Ps aeruginosa 
growing on 0.03% cetrimide agar was less pronounced, tending 
to be dark brown or dark green. Single colonies of this organism 
on a plate containing other pseudomonads were less obvious 
as compared with Pseudosel. 
Other species of Pseudomonas growing on Pseudosel agar 
usually appeared as white flat, round or slightly irregular 
colonies such that, on a plate containing a number of isolates 
different morphological types were not easily differentiated. 
When cultured on 0.03% cetrimide agar these organisms 
tended to have a similar light brown colouration, but with 
more recognisable characteristics to their colonial morphology. 
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3.3 Development and validation of an enzymic technique for 
the microbial examination of pharmaceutical grade gelatin 
As shown in Table 22 various enzymic preparations were used 
to solubilise gelatin and the quantity of gelatin which could 
be filtered through a 0.45}1 47mm membrane compared with 
gelatin solubilised non-enzymically. Penicillinase fermentation 
liquor and laboratory fermented protease increased the quantity 
of gelatin filtered between 2 and 11 times while the commercial 
protease showed increases ranging from 11 to greater than 
40 times. For a particular sample of gelatin, the quantity 
that c ould be filtered varied according to the batch of penicillinase 
fermentation liquor. Similarly using laboratory fermented 
protease, prepared using the stated incubation conditions, 
8g of gelatin was filtered. However, when the fermentation 
incubation conditions were changed to 31 °C static culture 
(instead of shaking at 37°C) only 3g was filtered. 
Further filtration studies, except where specified, were 
carried out using the commercial protease. 
Gelatin suitable for use in pharmaceutical preparations was 
obtained from five suppliers, 33 samples were obtained and 
included 18 different makes or grades. Each sample was 
solubilized using the enzymic and non-enzymic procedures 
Table 22 
Gelatin 
sample 
a 
b 
c 
d 
without 
enzyme 
0.8 
0.8 
0.7 
0.25 
Comparison of the maximum weights of 
gelatin filtered through a single membrane 
filter after solubilisation 
At45°C • . in 0.1% peptone water. 
At31°C, : in 0.1% peptone w~ter containing. 
a commercial protease or in undiluted 
fermentation liquor. 
Maximum weight (~ filtered 
fermentation 
1 . a 1quor 
2 - 5 
1. 5 - 3 
3 - 4 
fermentgtion 
liquor 
3 & 8 
commercial 
c protease 
>10 
8 
> 10 
a, penicillinase fermentation liquor, b, laboratory fermented 
protease, c, 'Proteinase' 
All samples filtered were high grade gelatins suitable for pharmaceutical 
use, membrane filters were of 0.45p pore size and 47mm diameter. 
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and the quantities of gelatin from each that could be filtered 
through a single membrane were compared. When solubilized 
by the enzymic procedure, the quantity of gelatin filtered 
was greater by weight for all samples than gelatin not enzymatically 
treated. Although in some instances a lOg sample of gelatin 
could not be filtered through one membrane it could all be 
filtered through two separate membranes. The results obtained 
are recorded in Table 23. 
A brief examination of certain non-edible gelatins and confectionery 
grade gelatins demonstrated that enzymic solubilisation 
was not always effective in permitting increased quantities 
of such materials to be filtered. Samples which c ould not 
be filtered formed cloudy solutions and these rapidly blocked 
membranes, usua lly before 0.5g of gelatin had been filtered. 
Increasing the enzyme concentration did not improve the 
filterability. 
Cotrol tests were carried out using E coli NCTC 9002, ~ 
abony NCTC 6017, Ps aeruginosa NCTC 67 50 and S aureus 
PRIV. 
All four species of bacteria did not change significantly 
in t otal viable count after 60 minutes exposure to undiluted 
-1 laboratory ferm ented protease or t o a 5 mg ml solution 
of commercial protease in 0.1% peptone water. 
Table 23 Comparison of the maximum weights of gelatin 
filtered through a single membrane filter 
after solubilisation 
At 45°C in 0.1% peptone water. 
70 . At 3 C ~n 0.1% peptone water containing a 
commercial protease (Proteinase) 
Maximum weight (g) filtered 
Supplier Grade Batch 
without enzyme with enzyme 
A 1 a 2.6 9.4 
b 2.2 14 .5 
2 a 6.8 13.0 
b 4.0 28.7 
3 a 1.4 6.9 
b 2.4 11.0 
c 3.9 7.0 
d 2.6 9.7 
4 a 2. 0 9.5 
b 1.4 7.4 
B 1 a 11.3 31.0 
2 a 1.7 6.5 
c 1 a 10.0 15.0 
2 a 5.0 11.9 
3 a 9.4 18.4 
4 a 4.9 6.1 
5 a 8 . 2 14.3 
D 1 a 4 . 2 7.5 
b 1.6 6.0 
2 a 5.5 10.0 
b 1.7 6.5 
3 a 3.0 6.3 
b 0.5 19.5 
E 1 a 1.1 11.0 
b 1.8 10.4 
c 0.5 5.6 
2 a 5 .0 14.3 
b 1.3 22 .8 
c 1.9 14.9 
3 a 1.6 7.9 
4 a 1.5 6.0 
b 4.0 11.5 
c 0.8 5.6 
All samples wer e high grade ge l atins suitable for pharmaceutical use . 
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All four types of bacteria were recovered after 50 viable 
cells had been inoculated into enzyme gelatin mixtures (5mg 
mC1 of commercial protease or undiluted laboratory fermented 
protease) and the solubilisation and filtration procedures 
carried out. Positive results were obtained by culturing 
membranes according to the BP 1973 method and by placing 
directly on selective agar media. 
The results of a quantitative estimation of the recovery 
of S abony and E coli inoe.ulated into an enzyme gelatin mixture 
(commercial protease), are given in Table 24. The 't' test 
for differences between pairs of results showed no significant 
difference (at the 5% level) between number of organisms 
recovered and replicate control counts obtained from 0.1% 
peptone water similarly inoculated (see Appendix for details 
of statistical test). 
The results in Table 25 show that E coli occuring as a natural 
contaminant of gelatin can be recovered using the enzymic 
procedure, with the same efficiency as the BP procedure 
and more efficiently than. the USP procedure. After 24h 
incubation the USP enrichment had little visible growth 
Table 24 Comparison of viable counts for equivalent 
inocula of E.~oli recovered from 0.1% peptone 
water and from the gelatin enzyme (Proteinase) 
mixture. Similar data is also presented for 
S abony. 
Viable count E coli Viable count S abony 
gelatin enzyme 
mixture 
157 
146 
156 
160 
177 
183 
168 
156 
142 
165 
peptone water 
control 
161 
194 
158 
177 
182 
144 
150 
202 
157 
153 
gelatin enzyme 
mixture 
111 
79 
79 
102 
99 
87 
101 
116 
119 
102 
peptone water 
control 
120 
78 
86 
102 
lOO 
94 
140 
116 
121 
91 
MacConkey Agar No. 2 and Bismuth sulphite agar were used to recover 
E coli and S abony respectively, tryptone soya agar was used for 
the control counts from pep t one water. 
...................... -------------------------------------
Table 25 Replicate lOg samples of gelatin t es ted for E coli contamination 
using BP 1973, USP XVIII and the enzymic technique . 
Re covery procedure 
BP test direct enrichment of 
gelatin 
BP enrichment of membrane 
Incubation of membrane on 
MacConkey agar 
USP test direct enrichment 
of gelatin 
USP enrichment of membrane 
Incubation of membrane on 
MacConkey agar 
*Suspect positive E coli 
Confirmed positive E coli -
No. of 
replicate 
samples 
9 
9 
10 
15 
15 
15 
Samples positive for E coli 
after incubation for 
24 h 48h 
6 
5 
6 
1 4 
6 6 
9 
*Time to obtain (h) 
'suspec t' 
48 
48 
24 
48-72 
48 
24 
'confirmed' 
posjtiye 
72 
72 
48 
72-96 
72 
48 
Mean viable E coli 
count per lOg of 
gelatin 
3 
2 
Considered as colony with E coli characteristics on MacConkey agar, or, in case of BP test, 
acid and gas production from MacConkey broth (37°C) and indole production (37°C). 
Isolates producing acid and gas from MacConkey broth (44°C) and producing indole (44°C) or 
isolates confirmed biochemica lly. 
-- -------------------------------------------------------------------------------------------------------------------------
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compared with either lactose broth containing membranes or 
the BP enrichment technique. 
A quantitative estimation of E coli contamination was obtained 
by incubating membranes directly on MacConkey agar and 
suspect and confirmed positive results were obtained 24h 
sooner than by enrichment techniques. 
Organisms recovered from gelatin samples examined using 
the enzymic procedure, included, Klebsiella, Citrobacter, 
Enterobacter, Streptococcus, Staphylococcus, Bacillus, coryneforms 
fungi and Actinomycetes. 
As shown in Table 26, in a comparison of methods for estimating 
total viable count of gelatin, membrane filtration (using enzymic 
solubilisation) gave higher counts overall than the pour plate 
procedure (non-enzymic solubilisation). 
Table 26 
Sample no. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
Mean 
Comparison of pour plate and membrane filtration 
procedures to estimate total viable count of 
gelatin samples 
Mean total viable count g-1 
Pour plate Filtration 
220 940 
170 550 
1190 1140 
40 100 
160 690 
60 60 
70 10 
80 150 
210 250 
230 180 
220 190 
330 370 
250 210 
% increase in 
count using 
filtration 
327 
224 
-4 
150 
331 
0 
-86 
88 
19 
-22 
-14 
12 
-19 
77 
Enzymic solubilisation used to prepare samples for filtration, pour 
plates prepared with equivalent samples solubilised in 0.1% peptone 
water. The results given represent mean of 5 replicate 1ml samples, 
tryptone soya agar was used and plates incubated at 31°C for 72h. 
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3.4 Application of membrane filtration techniques to microbiological 
examination of selected insoluble powders and viscous solutions 
Maize starch (1 g) dispersed in 0.1% peptone water (200ml) 
partially settled, when held in upright medical flats (250ml) 
for at least 2h. Over 50% of the supernatant was clear by 
this time and if gently withdrawn, could be filtered with no 
visible build up of starch deposits on the membrane. Absence 
of starch was confirmed by flooding the membrane with iodine 
solution, no blue colouration was visible. 
In practice this technique proved satisfactory, providing no 
traces of starch were present on the membrane and the membrane 
was drained of surplus surface water before incubation. Failure 
to comply with either of these requirements, resulted in a 
membrane overgrown even by a small number of spreading 
colonies, typically Bacillus, if incubated on nutrient agar. 
In a comparative study of techniques to estimate the total 
viable count of three maize starch batches, reported in Table 27, 
the lowest result was obtained by the filtration procedure, 
the counts being 64% and approximately 50% lower respectively, 
than the counts obtained using pour plate and most probable 
number techniques. 
Table 27 
Maize 
starch 
batch 
1 
2 
3 
Comparison of techniq~Is to estimate 
total viable count (g ) of maize starch 
Pour plate 
>1100 2600 
>1100 1600 
aoo-qoo 1200 
b Membrane 
filtration 
870 
530 
570 
a, most probable number, b, a suspension of starch in 0.1% 
peptone water was allowed to settle and the clear supernatant 
filtered. 
At l east 5 replicate plates/membranes used to prepare counts. 
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The use of an 8p membrane as a pre-filter for starch suspensions 
prior to filtration through a 0.45}1 membrane caused a 69% 
reduction in total viable count compared with results obtained 
from filtering the clear supernatant, through just a 0.45p 
membrane. 
Only 25mg of dry yeast powder dispersed in 0.1% peptone 
water would filter through a 0.45J.l membrane without causing 
blockage. Organic debris was visible on the filter and on 
incubation their was a tendency for a small number of spreading 
colonies to cover the filter, especially when cultured on 
nutrient agar. Larger quantities of dry yeast powder, in 
suspension, (up to 100mg) could be filtered using pressure 
rather than vacuum, but when incubated on agar media there 
were increased problems with spreading colonies. 
Solutions of gum acacia in 0.1% peptone water proved difficult 
to filter through a 0.45p membrane, at 22°C the maximum 
quantity was 40mg. This could be increased to 1 OOmg by 
adding 0.1% Tergitol15-S-9 to the peptone water and increasing 
the temperature of the solution to 45°C. 
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3.5 Development and validation of techniques for the detection 
of micro-organisms in ointments and comparison of these 
with existing techniques 
3.5.1 Evaluation of dry airborn micro-organisms as a challenge 
inoculum for studies with ointments and oils 
Replicate total viable counts of three liquids contaminated 
with dry airborn micro-organisms, demonstrated that this 
type of inoculum could give consistent data and hence should 
be suitable for future recovery or survival studies with ointments 
and oils. A statistical analysis of the data obtained is given 
in Table 28. 
Organisms present in such inocula were, Gram-positive cocci, 
(usually Staphylococcus epidermidis), Bacillus species, coryneform 
bac teria, Actinomycetes, yeasts, and other fungi (usually 
Penicillium species) and a range of Gram-positive bacilli 
and coccobacilli. Detailed examination of a batch of liquid 
paraffin contaminated in this manner, revealed Gram-positive 
cocci of 7 morphological types, each type having a different 
antibiotic sensitivity pattern. 
Table 28 Statis t ical analysis of replicate recoveries 
of dry airborn micro-organisms suspended in 
various liquids. 
Suspending liquid 
0.1% peptone water 
Light liquid 
paraffin 
Almond oil 
Almond oil 
Replicate tvc/ 
volume tested 
83, 103, 89, 102, 
91, 95, 72 
74, 72, 72, 49, 
84, 65, 71, 71, 
56, 73 
64, 72, 51, 63, 
77, 51, 65, 76 
220, 190' 193, 
155, 207, 223, 
170, 194, 229' 
170 
tvc, total viable counts 
n, number of replicate membranes counted 
X, arithmetic mean of counts obtained 
n X s 
7 91 10.9 
10 69 9 . 9 
8 65 10.0 
10 195 24. 9 
V% 
11.9 
l4.4 
15.5 
12 . 8 
s, estimate of the standard deviation of the counts obtained 
Vi., coefficient of variation (~ x 100) 
%Cl, confidence limits (95%~ of mean for stated number of variates(see 
Appendix for details of calculation) 
%Cl 
~11. 0 
~10.3 
:!:13 . 1 
+ 9.1 -
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3.5.2 Recovery efficiencies of techniques for detection of micro-
organisms in ointments 
The efficiency and/or sensitivity of the 4 membrane filtration 
techniques developed ie techniques 'A', 'B', 'C' and 'D' was 
estimated. Two other procedures were included in the study, 
namely the BP (1973) procedure for eye ointments and a 
simple direct addition technique. These studies were all 
carried out using dry airborn micro-organisms. 
Percentage recovery efficiencies of techniques 'A' - 'D' were 
determined (Table 29), technique 'D' proved the most efficient 
at 21% for 20g test samples. 
The sensitivity of techniques 'A', 'D', the BP 1973 procedure 
for eye ointments and the direct addition procedure, were 
estimated using sterility test procedures (Table 30). Technique 
'0' and the BP procedure proved most sensitive giving positive 
results from 20g ointment samples contaminated with 1-
2 organisms g-1 The other techniques required up to 110 g-1 
to ensure a positive result. 
In all these recovery studies using dry airborn micro-organisms 
a range of organisms were detected suggesting that no one 
particular group, eg Bacillus, was being preferentially selected. 
Table 29 
Lab. batch 
of 
contaminated 
ointment 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
Overall 
recovery 
Technique 
' A' 
4 . 0 
4 . 7 
11.2 
6. 6 
Percentage recovery of dry a i rborn micro-organiams 
from BP eye ointment base (1973), using four membrane 
filtration techniques developed in this s t udy 
Technique ' B' 
Ipm 1 Ipm2 
4 . 1 10.0 
7. 7 6.2 
10 . 0 7. 9 
9. 7 12 . 0 
7. 9 9. 0 
Technique 
•c• 
1.8 
4 . 1 
1.8 
9.1 
1.9 
2. 5 
4 . 1 
3.6 
Technique 
'D' 
22.0 
11.3 
33.2 
19.9 
17.3 
27 . 8 
15 . 0 
20.9 
Techniques 'A' & 'B' 6g samples of ointment tested and Techniques 'C' & ' D' 
20g tested. 
In the case of Techniques 'A' & 'B' the percentage recovery efficiencie s 
quoted for each batch of ointment represent the mean of 5 & 3 replicates 
respectively . 
Two grades of isopropyl myristate (Ipm) were used to assess Technique ' B' 
Ipm 1 , was deltyl extra (Givauden) Ipm 2, ordinary grade (Givauden), this 
latter grade was used in the above and all other studies reported. 
Table 30 Comparison of the sensitivity of five procedures 
used to sterility test BP (1973) eye ointment base 
contaminated with dry airborn mi~ro-organisms. 
Total no. bottles 
Count g-l 
ointment 
Technique* 
used 
No, replicate No. tests 
samples positive 
tested 
in all replicate tests 
0 
l-2 
2-3 
3-4 
6-8 
9-12 
12-18 
80-110 
A 
D 
BP 
BP 
D 
D 
BP 
A 
8 
7 
4 
6 
5 
3 
2 
4 
3 
3 
4 
8 
8 
l 
2 
4 
3 
11 
6 
4 
6 
0 
0 
0 
0 
0 
3 
2 
0 
0 
0 
4 
1 
4 
1 
2 
2 
2 
5 
5 
4 
6 
used 
16 
28 
80 
120 
200 
12 
40 
80 
120 
6 
16 
160 
16 
4 
40 
8 
120 
22 
240 
8 
240 
positive 
0 
0 
0 
0 
0 
12 
29 
0 
0 
0 
14 
1 
4 
4 
37 
3 
4 
10 
10 
7 
25 
*A, Technique 'A' developed in this study, membrane filtration, 6g/test, 
2 bottles media/test. 
D, Technique 'D' developed in this study, membrane filtration, 20g/test, 
4 bottles media/test. 
BP, procedure suggested in the BP (1973) for eye ointment, direct addition after 
blertding with arachis oil and tween 80, 20g/test, 20 bottles media/test. 
DA6, direct addition to broth, 6g/test, 40 bottles media/test. DA20 , direct addition to broth, 20g/test, 20 bottles media/test. 
-------------- ~ ~ - -
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The efficiency of technique 'D' in recovering various aqueous 
inocula from ointment is reported in Table 31, for the different 
species studied the results ranged from 12-20%. 
3.5.3 Evaluation of other membrane filtration techniques for the 
microbial examination of ointments 
In addition to techniques 'A'- 'D' a range of alternatives 
were examined to determine the maximum quantity of ointment 
which could be consistently filtered through a single 0.45p 
membrane, while leaving a filter which could be rinsed free 
of oily patches. As shown in Table 32, procedures suggested 
by, Millipore, Allwood and Hambleton, Tsuji et al and the 
USP XIX only permitted the filtration of small quantities 
of ointment, the maximum being 0.15g (Tsuji and Robertson); 
the reproducibility of these techniques was also poor, the 
membranes often blocking before even these small quantities 
had filtered. Slightly higher quantities would sometimes 
filter, eg 0.5g by a modified USP procedure but this was 
only at the expense of effective rinsing. 
The techniques developed in this study ie 'A'- 'D' allowed 
much greater quantities of ointment to be examined using 
a single membrane, the range being 6g to over 20g while 
still giving a membrane which could be rinsed free of oil 
and grease. Using technique 'D', a number of alternative 
Table 31 
Inoculum 
*Mixed 
Ps aerug~nosa 
Non-pigmented 
pseudomonad 
Non-pigmented 
pseudomonad 
S aureus PRIV 
E coli NCTC 9002 
Recovery of micro-organisms from ointment 
using technique 'D' 
Source of 
inoculum 
Atmosphere 
Sink drain 
Distilled water 
Distilled water 
Lab cultured 
Lab cultured 
Culture media for 
inoculum 
Drain water 
Distilled water 
Distilled water 
Broth 
Broth 
Recovery 
efficiency 
21% 
12% 
14% 
15% 
1 7% 
20% 
Recovery eff i ciencies were determined using 20g samples of ointment. 
All membranes were incubated on_nutrient agar except for Ps aeruginosa 
recoveries, in this case Pseudosel was used. 
*Result from Table 29 included for comparison. 
Table 32 
Method 
Millipore 1969 
Mi l lipore 1969 
Millipore 1969 
Allwood & Ramble t on 
1973 
USP xrxd 
USP (modified) de 
Tsuj~ & Robertson 
1970 
usp xrxd 
·Technique 'A ' 
Technique ' C' 
Technique ' D' 
Technique ' D' 
Technique ' D' 
Technique ' D' 
Technique ' D' 
Technique 'D' 
Comparison of techniques fo r t he membrane 
filtration of BP ( 1973) eye ointment base 
Materia l (g) f il tered 
Solvent a . b 
through one membrane 
D1spersan t 
consist-
max1mum - c ently 
1% t ween 80 40° 0.10 0.05 
0 . 1% t ween 80 40° 0.25 
0.1% Tergi t ol 44° 0.50 0.10 
I pm 42° 0.1% Tergi t o l 44° 0.02 <: 0.02 
I pm 0.30 <: 0.10 
I pm 0.50 0.10 
Ipm, cs2 , Xylene 0 . 35 0. 15 
LLp 0.25 
! pm 0. 1% pep t one wat er > 6 . 0 > 6. 0 
I pm 0. 1% p'eptone water > 20 . 0 > 20 . 0 
I pm 0.1% Tri t on > 20.0 10 . 0 
LLp 0. 1% Tri t on > 6 . 0 6 . 0 
Almond oi l 0.1% Triton > 10.0 8.0 
Ethyl oleate 0.1% Triton > 10 .0 6.0 
Coconut oil 0.1% Tri t on 8.0 5.0 
Arachis oil 0. 1% Triton > 10.0 8 . 0 
a, Abbreviations used, Ipm, isopropyl myristate,LLp, light liqui d paraffin, 
all solvents warmed to 44°C unless stated ot herwise; b , dispersant solutions 
prepared in 0. 1% peptone wa t er and unless stated othe r wise these were warmed 
to 31°C; c, 'consistently ' understood as the maximum quant ity of material 
which coul d a l ways be fi l tered whi le stil l leaving a filter which cou ld be 
rinsed free of oi l y deposits; d, ointments tested by these techni ques did 
not contain wool fat; e, pressure rather than vacuum filtration used. 
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solvents to isopropyl myristate were found effective, these 
permitted 5-8g quantities of ointment to be examined using a 
single membrane. 
3.5.4 Antimicrobial activity of non-ionic surface active agents 
used to rinse membrane filters 
As detailed in Table 33, two membrane filter rinse media, 
composed of either 0.196 Tergitol 15-S-9 or 0.196 tween 80, 
in 0.1 % peptone water, were found to have no antimicrobial 
activity when compared to 0.196 peptone water alone ('t'-
test for paired variates, at the 5% level). 
3.5.5 Survival of micro-organisms in selected oils and BP ointment 
base 
The range of survival studies performed are reported in Table 34 
and Figures 3-6. 
Both light liquid paraffin (40°C) and isopropyl myristate 
(40°C) caused a rapid reduction in the viable count of an 
aqueous inoculum of S aureus PRIV dispersed in these liquids. 
The rate and extent of kill was different for the three batches 
of isopropyl myristate studied. Material supplied by Fluka 
causing the most rapid and extensive reduction, the D value 
being 6 (see Appendix for calculation of D value). 
Table 33 Antimicrobial effect of non-ionic surfactant s 
used as membrane fi lter rinse media 
Solutions (0.1%) of tween 80 and Tergitol 15-S-9 prepared 1n O.li. 
peptone water were used to rinse membranes inoculated with one of 
the 3 test organisms. Total viable counts were compared with 
equivalent membranes rinsed with 0.1% peptone water only. 
Tergitol Tween 80 
Test organ1sm 
-
-
n D sd It I n D sd 
S marcescens 18 94 17 . 9 1. 28 36 98 11.9 
S aureus 36 97 17. 7 1. 01 36 98 11.8 
C albicans 30 102 22 . 8 0.55 48 101 15 . 8 
~' number of replicated tests 
D, arithmetic mean of percentage difference between count on surfactant 
and peptone water, rinsed membranes 
sd, e~timate of the standard deviation of the population of percentage 
d1fferences 
It I 
I. 01 
1. 25 
0 . 53 
't', calculated Students " 't' value which is compared with 'to 5
1 from tables 
(see Appendix for details of calculation) • 
Table 34 
Survival of 
.. 
Bacillus species 
Fungi 
Survival (%) of dry airborn micro-organisms 
in almond oil and almond oil containing 5% 
phenol 
5% phenol 1n a lmond oil 
Almond oil 
28 days 
7 days 28 days contact 
contact contact 
51 23 65 
46 11 62 
;.;· Vegetative species 20 2 12 
only 
All co lony forming 23 4 18 
units 
*All species other than speci es of Bacillus, fungi and Actinomycetes. 
Figs 3, A,B,C,D 
Survival of S aureus in light liquid paraffin and isopropyl 
myristate at 40°C. 
Fig A 
8 
c 
D 
Light liquid paraffin 'D' value 27 
Isopropyl myristate (Givauden) lot 1, 'D' value 16 
Isopropyl myristate (Givauden) lot 2, 'D' value 46 
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In comparison little reduction in total viable count or viable 
count of non-sporulating species occurred in a similar study 
using an inoculum of dry airborn micro-organisms, even after 
90 minutes exposure to isopropyl myristate (40°C) or light 
liquid paraffin (40°C). 
In longer term survival studies (?Oh) using dry airborn micro-organisms 
dispersed in liquid paraffin or ointment, only a slight reduction 
in total count was observed. 
As shown in Table 34 increased survival of dry airborn micro-organisms 
was observed in almond oil compared to almond oil plus 596 
phenol, but in the latter case after 28 days exposure an overall 
survival level of 496 was still recorded. Organisms recovered 
from the almond oil plus phenol after this time included, 
Gram-positive cocci (mainly S epidermidis), Bacillus species, 
other Gram-positive bacilli and coccobacilli, Actinomycetes, 
fungi (Penicillium and unidentified species) and yeasts (Saccharomyces). 
The number of morphological types estimated to be present 
initially were; 33 (including 9 fungi) after 28 days exposure 
this had fallen to 27 (including 8 fungi) in almond oil and 
23 (including 2 fungi) in almond oil plus phenol. 
3.5.6 
3.5.6.1. 
3.5.6.2 
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By comparison a laboratory cultured inoculum of S aureus 
PRIV diluted in 0.196 peptone water, failed to survive 2h 
in either almond oil or almond oil plus 5% phenol. 
A second longer term study is reported in Figure 6 again 
survival of dry airborn micro-organisms was observed. After 
35 days exposure, overall survival levels of 16% in almond 
oil and 9% in almond oil plus phenol were recorde~, after 
71 days these values had fallen to approximately 8% and 
3% respectively. 
Studies using sterile neomycin (0.5%) eye ointment 
Sterility test positive controls 
The antibacterial effects of neomycin in ointment preparations 
when tested using technique 'D' or the BP procedure are 
recorded in Table 35. In positive control tests using neomycin 
sensitive test bacteria, only technique '0' gave positive results. 
The tryptone soya broth media inoculated with ointment 
according to the BP procedure was found to contain 13 iu 
ml-l of neomycin sulphate, as determined by an 'agar diffusion' 
microbiological assay. 
Examination of retained neomycin activity on membrane 
filters using a bioautographic technique 
Plate 11 illustrates a bioautograph prepared with a non-hydrophobic 
...................... ----------------------------------
Table 35 Recovery of positive control bacteria using both technique 'D' and the BP (1973) procedure, to sterility 
test an eye ointment containing neomycin . 
In each r eplicate test one bottle of tryptone soya broth (TSB) and one bottle of thioglycollatemedium (TM) were inoculated with 
either, one portion of abisected membrane used to filter half the extract from a 20g sample of ointment or lg of ointment 
pretreated according to the BP method. 
The challenge bacteria were inoculated, into the final rinse when us1ng technique 'D' and directly into the broth media when 
using the BP procedure . 
Technique 'D' BP (1973) procedure 
Control 
bacteria organisms/test No replicate 
t es ts 
Bottles positive No replicate 
tests 
Bottles posi t ive 
s aureus PRIV 40 - 50 4 
B subtilis Cl07 2 - 4 3 
B subtilis . C107 19 1 
Ps aeruginosa NCTC 150 3 6750 
1 
.TSB 
4 
3 
1 
3 
TM 
4 
3 
1 
3 
TSB 
12 0 
3 0 
3 0 
9 7 
The eye ointment consisted of, white soft paraffin, liquid paraffin, corticosteroid, and neomycin sulphate 0 . 5% w/w. 
Strain of, S aureua and B subti1is used were neomycin sensitive, Ps aeruginosa was neomycin resistant . 
TM 
7 
0 
0 
9 
Plate 11 Bioautograph prepared with S aureus PRIV, one portion 
of a bisected membrane was incubated in contact with 
the plate at 31° for 48h. The complete membrane had been 
used to filter an aqueous extract prepared from a neomycin 
eye ointment. 
Zones of inhibition are visible around the circumference 
of the membrane, in the area covered by the sealing gasket. 
A small zone of inhibition is also visible further towards the 
centre of the membrane. 
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edged membrane which had been used to filter neomycin 
ointment according to technique '0'. Zones of inhibition are 
clearly visible in an arc around the circumference of the 
bisected membrane. In contrast, in all similar checks on 
hydrophobic edged membranes no areas of inhibition were 
visible. 
Effect of various compounds on the antimicrobial activity 
of neomycin sulphate solution 
As shown in Table 36, L-cysteine hydrochloride, dodeca-tungsto-silicic 
acid and dodeca-tungsto-phosphoric acid caused the most 
marked reduc tions in activity (approximately 7 .5iu to 0.5iu 
of neomycin sulphate). However L-cysteine hydrochloride 
and dodeca-tungsto-silicic acid demonstrated antimicrobial 
activity themselves, this was revealed as a narrow ring of 
inhib ition around the circumference of the agar well. Dodeca-
tungsto-silicic acid and dodeca-tungsto-phosphoric acid also 
produced a narrow zone of reduced growth around each well. 
Table 36 
Test Compound 
No compound added 
Effect of various compounds, at a concentration of 
1% w/v, on the antibacterial activity of neomycin 
sulphate, determined using an agar diffusion 
microbiological assay with S aureus PRIV as the seed 
organism 
Zone of inhibition (mm) 
Neomycin solution 
19.l 
Triton/peptone 
solution 
0 
Dodeca-tungsto-silicic acid . 13.4* 13 . 2* 
Dodeca-tungsto-phosphoric 
acid 
Sodium carboxymethylcellulose 
L- cysteine hydrochloride 
13.3* 
17.7 
12.3* 
0* 
0 
Activity visible 
b~t not measurable 
The neomycin sulphate solution used was the 0.1% Triton X lOO/peptone 
extract obtained by testing neomycin ointment (0.5% w/w neomycin sulphate) 
according to technique 'D'. 
The Triton/peptone solution used was the extract obtained by testing ointment, 
which did not contain neomycin, according to technique 'D'. 
*Around the edge of 
which growth is not 
rest of the plate. 
these zones a further narrow zone or halo visible in 
inhibited but reduced in density compared with the 
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3.6 Alternative procedure developed for the microbiological examination 
of creams 
In the comparison of the 'standard' procedure and the '50g 
test' developed in this study, the '50g test' proved more sensitive 
consistently detecting levels of 1-10 viable cells of Ps aeruginosa 
per 1 Og of cream. The standard procedure required counts 
in excess of 10 g-1 for positive results (Table 37). 
Table 37 
Test 
procedure 
. 
'Standard' 
'50g I 
Weight 
tested 
lg 
lOg 
'standard'procedure 
'50g' procedure 
Comparison of two procedures for detection of 
Ps aeruginosa as a contaminant of steroid creams 
Number of samples positive for Ps aeruginosa 
Number of samples tested 
-1 Strain and inoculum level of Ps aeruginosa g 
228 
0.1 
228 
1.0 
6750 
1.0 
6750 
1. 0 - 10 
6750 
10 - 100 
l 
5 
4 
5 
1 
2 
2 
2 
0 
3 
3 
3 
14 
25 
lOg of cream dispersed in 90mls of i strength 
Ringers solution (37°C), lOml aliquots enriched 
in 90mls tryptone soya broth. 
50g of cream dispersed in 450mls of t~yptone 
soya broth (37°C) and lOOml aliquots enriched 
in 400ml of tryptone soya broth. 
25 
25 
All enrichments plated on Pseudosel agar. 
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3.7 Effect of specific processing stages on the level and type 
of microbial contamination in tablets 
The effect of compression on the microbial content of granules 
'a' and 'b' was examined in detail. 
As Table 38 shows, a consistent reduction in total viable 
count occurred during compression in all the 'a' type granules, 
the mean reduction being 71%. A similar value, 72%, was 
obtained using the 'b' type granules. 
The mean reduction in fungal count during compression, 
using granule 'b', was estimated to be 7 5% (Table 39). Fungi 
isolated after compression included species of Penicillium, 
Aspergillus, Alternaria, Cladosporium and Mucor. 
The compression process did not select entirley for sporulating 
bacteria. Vegetative bacteria could also be detected in 
the tablets, including Staphylococci, Streptococci, non-sporing 
Gram-positive bacilli and Gram-negative bacilli. The reduction 
in Bacillus count estimated from granule 'b' was 64% (Table 
39). 
There was evidence of a considerable decrease in the number 
of lactose-fermenting enterobacteria. As Table 40 indicates, 
Table 38 Effect of tablet compression on the total 
viable count of the granules used . 
Type of 
granule 
Replicate 
Ba t ch no . of 
samples granule 
examined 
Mean total viable count g-1 
Granu l e Tablet % reduction 
I a I 1 4 2,230 670 70 
I 
a 
I 2 4 1,930 660 66 
I a I 3 4 2,170 470 78 
'b ' 1 9 2 , 760 760 72 
'b' 2 5 2,420 680 72 
'b' 3 5 1 '920 520 73 
Granule 'a' is based on a mixture of dry yeast powder, ma1ze starch and 
tri-basic calcium phosphate . 
Granule 'b' is based on a mixture of lac t ose, gum acacia, gelatin, maize 
starch and magnesium stearate. 
Total viable counts estimated from pour pla t es prepared from tryptone 
soya agar. 
Table 39 
Fungi: 
Effect of tablet compression on fungi, Bacillus 
and lactose fermenting enterobacteria in granule 'b' 
Bacillus: 
Lactose fermenting 
enterobacteria: Batch 
no. of 
granule 
'b' 
Replicate % reduction 
samples in mean 
viable count 
Replicate % reduction 
samples ~n mean 
viable count 
Replicate 
samples 
% reduction 
~n mean 
viable count 
1 4 78 3 61 6 98 
2 6 73 3 66 7 99 
Counts estimated from pour plates prepared with the following media: 
Sabouraud, tryptone soya and MacConkey, to detect respectively, 
Fungi,Bacillus _ and lactose fermenting enterobacteria. For Bacillus, samples 
also heat shocked at 80°C for 1 min before plating. 
Table 40 
Batch number 
of granule 'b' 
1 
2 
3 
Effect of tablet compression on lactose fermenting 
enter obacteria in granule 'b' 
Replicate 
samples 
13 
8 
6 
Samples positive for lactose 
fermenting enterobacteria: 
Granule Tablet 
13 3 
8 1 
6 1 
Batch 1: lg samples . Batches 2 and 3 : 100mg samples. Lactose fermenting 
enterobacteria detected by primary enrichment of samples in nutrient broth 
(BP) and by secondary enrichment i~ MacConkey broth (BP) . Samples showing 
acid or acid and gas subcultured onto MacConkey agar. Lactose fermenting 
iso l a tes examined via enterot~bes. 
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among 27 replicate enrichments of both granule and tablet, 
all 27 granule samples were positive for these organisms while 
only five positive results were obtained from the tablet. 
All these enterobacteria were found to be Enterobacter or 
Citrobacter species. This result was confirmed by quantitative 
estimation of lactose-fermenting enterobacteria using MacConkey 
agar pour plates (Table 39): a maximum reduction in viable 
count of 99% was obtained during compression of granule 
'b'. 
Total viable counts from 88 commercial batches of one type 
of tablet are given in Table 41. The tablet was similar in 
composition to tablet 'a' and had the active ingredient incorporated. 
For all the batches examined, the decrease in viable count 
during the manufacturing process fell within the range 66-
98%. 
The temperature of 'a' type tablets in the bulk collection 
container was approximately 35°C, but the temperature attained 
immediately after compression will be above this, probably 
within the range 40-50°C. Heat is lost immediately after 
compression to the large mass of metal in the tablet machine 
and to the air as the tablet is discharged from the machine. 
Table 41 Effect of a tablet manufacturing process on the 
total viable count of the raw materials used. 
No. batches Total viable count of tablets (g- 1) 
Granule produced 
batch from Theoretical from Actual Percentage 
granule counts of raw mean value reduction due 
materials used to processing 
1 6 8826 641 93 
2 4 8815 517 94 
3 2 4460 490 89 
4 1 1260 150 88 
5 7 1141 306 73 
6 5 1339 290 78 
7 3 1329 300 76 
8 7 1236 213 83 
9 5 749 206 73 
10 6 429 148 66 
11 3 568 120 79 
12 5 1002 114 89 
13 2 1350 195 86 
14 4 4022 100 98 
15 2 2491 265 89 
16 2 1423 320 76 
17 1 1407 380 73 
18 5 1401 332 76 
19 8 1404 354 75 
20 7 8813 948 89 
21 3 8998 580 94 
All data obtained from commercial batches of the same type of tablet, 
which was compressed from a simple dry blend of dry yeast powder, maize 
starch and tri-basic calcium phosphate plus active ingredient. 
Total viable counts e s timated from pour plates prepared with tryptone 
soya agar. 
A sealed polythene bag was opened and revealed spoiled tablets 
(non-coated) shown in Plates 12 and 13, the spoilage organism was 
a species of Penicillium. A number of infection foci are clearly 
visible in Plate 1.3. 
Plate 12 
Plate 13 
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In the solvent granulation process examined, the three batches 
of dried granule produced showed decreases in total viable 
count of 66%, 71% and 60%, when compared to the counts 
of the raw materials used. All surviving organisms were 
identified as species of Bacillus. 
Although not investigated in this study, the author observed 
the bulk container of tablets (uncoated) depicted in Plates 
12 and 13. The large number of spoiled tablets visible, were 
contaminated with a species of Penicillium. The batch in 
question was produced in a development project and was 
not commercial material • 
• 
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3.8 Studies of Pseudomonas contamination of creams 
3.8.1 Microbiological monitoring of a cream manufacture area 
Table 42 gives the results obtained from a 'swab' monitoring 
study of the manufacture and filling areas, used to prepare 
the 7 contaminated batches of steroid cream 'b' (section 3.1.3). 
Pseudomonas aeruginosa and other Pseudomonas species 
were regularly isolated from locations and equipment remaining 
wet and damp. Pseudomonas aeruginosa was usually isolated 
in relatively small numbers compared with other Pseudomonas 
species, rarely making up more than 10% of the isolates. 
The manufacturing equipment, filling room and filling machines 
were free of Pseudomonas contamination except for, sinks 
and mops and a single instance of a transfer pump found 
heavily contaminated on its outer surface, the inner contact 
parts of the pump were free of contamination. 
Pseudomonas aeruginosa was never isolated from distilled 
or tap water supplied to the area. Weekly examination of 
these supplies revealed only a low count of other Pseudomonas 
species (l-5mC1) in the distilled water. 
The initiation of a twice weekly disinfection programme 
with a 1.0% sodium hypochlorite solution prevented further 
Table 42 'Swab' monitoring of a cream manufacture and 
filling area prior to commencement of a regular 
disinfection program 
Location 
Equipment cleaning room 
under gridded floor 
non-gridded part of floor 
fixed pipework 
tiled wall (at 1' height) 
tiled wall (at 8' height) 
sink 
waste product bin 
Manufacture area 
sink drains 
spatula knives 
manufacture vessel, inner 
bulk cream holding vessel 
floor •( 5 locations) 
oil from stirrer gears 
floor mop 
Filling area 
surface 
outer and inner surface 
I 
filling machine, filling heads 
filling machine, crimping heads 
filling machine, motor gears 
product transfer pump outer surface 
product transfer pump inner surface 
Ps. 
aeruginosa 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
Other 
species 
of 
Pseudomonas 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
Monitoring carried out on 4 occasions during a two week period, a positive 
result indicates that at least once during that time the organisms 
specified were de t ected. 
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isolation of Ps aeruginosa from all locations in the manufacture 
area except for occasional positives from sink drains. A 
similar effect was observed on the other Pseudmonas species, 
the majority of locations remaining free of these organisms, 
only occasionally were low numbers isolated Oess than 10 
colonies/swab plate). 
No production batches were found contaminated with Ps 
aeruginosa after this disinfection procedure had been instigated. 
3.8.2 Survival of Pseudomonas aeruginosa in various creams 
Growth and survival studies using Ps aeruginosa 228 inoculated 
into creams of different varieties and pH are reported in 
Tables 43, 44 and 45 and Figures 7 and 8. Proliferation was 
observed in creams with pH values of 7.2-7 .6. No growth 
or survival after 96h contact was observed in creams of 
pH values 4.3-6.2. Death of Ps aeruginosa 228 was rapid 
in creams containing neomycin (pH 7 .1) or propylene glycol 
(pH 5.3), in the latter case in the minutes required to blend 
. the inoculum into a sample of the cream. 
An initial decrease in the viable count of Ps aeruginosa was 
noted in most instances before proliferation. This decrease 
could be severe enough to produce zero plate counts from 
_j 
Table 43 
Test 
sample 
1 
2 
3 
4 
5 
6 
0 
+ 
+ 
+ 
+ 
+ 
+ 
Survival of Ps aeruginosa 228 ~n 'standard' 
cream buffered at pH 7.6 
Time after inoculation (h) 
24 60 240 576 
+ + 
+ + + 
+ + 
+ + 
+ + + + 
+ + + + 
Test samples 1, 3 and 5 were held ~n collapsable tubes, 2, 4 and 6 
were held in glass beakers. 
888 
+ 
Test samples inoculated with SOOmg of cream (of similar formulation) 
contaminated with Ps aeruginosa 228, the viable count at 'O' time was 
approximately 1.2 x 103g - 1 
Fig 7 (opposite) Growth curves of Ps aeruginosa 228 in 'standard' 
cream buffered at different pH values. 
Table 44 Survival of Ps aeruginosa 228 ~n 'standard ' cream buffered at 
at different pH values 
pH of test 
sample 
Time after inoculation (h) 
0 48 96 264 960 1350 
* 4.5 + 
4.6 + + 
5.1 + 
5.2 + + 
s.s + + + 
5.8 + + + 
* 6. 2 + + + 
6.2 + + + 
* 7.4 + + + + + + 
* 7 . 6 + + + + + 
Test samples were inoculated with SOOmg of cream (of similar formulation) 
contaminated with Ps aeruginosa 228, the resultant viable count at 'O' 
time was approximately 3 x I03g- 1• 
*Quantitative estimati on of Ps aeruginosa 228 represented by growth 
curves in Fig7 opposite. 
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commercial creams 
Table 45 Survival of Ps aeruginosa 228 1n selected commercial creams 
Cream Time after inoculation (h) 
Type pH 0 48 164 340 768 
Steroid 'a' 5.0 + 
Steroid 'a' 4.9 + 
Steroid 'a' 5.1 + 
Steroid 'a' 5 . 1 + 
Steroid I a I 7.2 
adjusted + + 
Steroid I a I 7.3 
adjusted + + + + 
Steroid 'a' + 
neomycin 7.1 + 
Steroid 'a' + 7.1 
neomycin + 
Steroid 'b'* 7.6 + + + + 
Steroid 'b' 7.6 + + + + 
St eroid 'b' 4.8 
adjusted + 
St er oid 'b'* 
adjusted 4.3 + 
Steroid I C I + 5 . 2 propylene glyco l 
Steroid 'c' + 5.3 propylene glycol 
Steroid 'a', 'b' and 'c' represent different types of corticosteroid . 
'adjusted' : pH of cream adjusted by addition o f sodium hydroxide or 
phosphoric acid. 
1272 
+ 
+ 
+ 
*Quantitative estimation of Ps aeruginosa 228 represented in growth curves 
in Fig 8 opposite . 
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viable count determinations and negative results from enrichment 
tests. Figures 7 and 8 illustrate a selection of the type of 
curves obtained. 
Studies demonstrated Ps aeruginosa 228 would proliferate 
in nutrient broth at pH 5.0 and above but not at pH 4.5. 
Attempts to demonstrate proliferation of isolates from inoculum 
sources other than contaminated cream proved unsuccessful. 
Pseud monas aeruginosa strains 228, 7 5, 245 and NCTC 67 50 . 
cultured in a cream Ringers mixture all failed to proliferate 
in commercial steroid creams having either pH values of 
7.6 or 5.0. The initial count in the inoculated cream was 
approximately 2 x 103 g-1, survival was monitored over 530h, 
the maximum survival time was 100h, demonstrated by Ps 
aeruginosa 245 in steroid cream pH 7.6. 
Examination of the antibacterial activity of a number of 
creams 
In an attempt, to identify antibacterial activity in a range 
of creams, an agar diffusion microbiological assay procedure 
was followed. Initial studies placing spots of cream on a 
surface seeded agar plate produced small poorly defined zones 
of inhibition. The q.lternative technique used to obtain the 
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the results given in Table 46 was more successful namely, 
placing cream in wells cut into agar which was seeded throughout 
its depth. 
Only creams containing neomycin and propylene glycol demonstrated 
activity against the range of seed organisms used, chlorocresol 
solution (0.1 %) demonstrated only slight activity. 
Table 46 
Type of Cream 
Steroid pH 7.6 & 5.0, & 
Steroid + clioquinol pH 
5.0 
Steroid containing 
propylene glycol 
pH 5.0 
Steroid + neomycin 
pH 7 •. 0 
Chlorocresol 
solution 0 . 1.% 
Comparison of the antimicrobial activity of 
select ed steroid creams against a range of 
pseudomonads, using an agar diffus ion plate 
assay 
Test organism Zone s~ze (mm) 
A None detec t ed 
B None detected 
c, 1,3,4,5,6,7, None detected 
A 15 
B 17 
c, 1,3,4,5,6,7, 18 
A 18 
B 16a 
c 1 small zone 
3 35 
4 15 b 5 small zone 
6 15 
7 None detected 
c, 1,3,4,5,6,7, small zones 
A, Ps aeruginosa 228, isolated f+om a contaminated cream. 
B, mixed culture containing Ps aeruginosa and 4 other Pseudomonas 
species, plates were inoculated directly with a sample of stored 
water collected from a sink drain. 
C, Pseudomonas isolates 1,3,4,5,6,7, environmental isolates. 
a A further surrounding outer zone visible, 33mm, containing 
2 resistant species . 
b Zone contains resistant colonies. 
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3.9 Survival of micro-organisms in propylene glycol held in sealed 
ampoules and heated to 115°C and 121 °C in an autoclave 
Bacillus subtilis var globigii and Bacillus 201 failed to survive 
115°C for 30 minutes. 
Micro-organisms obtained from dry soil, namely species of 
Bacillus, Actinomycete and fungi survived 30 minutes at 
115°C (Plate 14), only Bacillus and Actinomycetes were 
isolated after 60 and 90 minutes exposure (Plate 15). Actinomycetes 
but not fungi survived 30 minutes at 121 °C, Bacillus were 
not detected in the unheated sample, so were not included 
in the assessment. Full details are reported in Table 47. 
The procedure developed in this study for contaminating 
propylene glycol with dry spores from laboratory spore suspensions, 
provided no practical difficulties and propylene glycol solutions 
6 -1 
with up to 6x10 spores ml were prepared. 
.................... ----------------------------------
Table 47 Survival of micro-organisms tn sealed ampoules of propylene glycol heated to 115°C or 121°C tn an autoclave 
*Mean viable count /SOml propylene glycol after heat treatment 
Challenge Initial viable Time at ll5°C (min) Time at 121°C (min) 
organism count/50ml 
propylene glycol 30 60 90 30 
4.2 X 104 12.3 (3 X 10-
2) 1. 75 (4 X 10-3) 0.5 (1 X 10- 3) 
Soil Bacillus 7.4 102 0 0 0 X 
3.8 X 105 113 (3x 10-3) 7 (2 X 10- 4 ) 3.75 ( 1 X 10-4 ) 
Soi l Actinomycetes 9.8 X 104 8 (8 X 10-3) 0.5 (5 X 10-4) 0 (7 X 10-4 ) 2 . 2 X 106 15.8 
4.2 X 105 0. 33 (7 X 10-5) 0 0 
Soil Fungi 1.5x 104 0 0 0 
1.1 X 105 0 
B subtilis var globigii 3.5 X 105 0 0 0 
Bacillus 201 6 . 3 X 10 6 0 0 0 
*Count s estimated.from at least 3 replicate heat treated samples, figures given tn brackets represent survival as a percentage. 
·~---~---
Micro-organisms recovered, on 0.45)-l 'Solvinert' filters, from 50m1 
quantities of propylene glycol which had been heated at ll5°C in an 
autoclave. 
Plate 14 Propylene glycol heated for 30 minutes, a single mould 
as well as Actinomycetes and species of BaciJlus 
recovered. ' 
Plate 15 Propylene glycol heated for lh, only Actinomycetes 
and Bacillus recovered. 

--------------
.. 
4 DISCUSSION 
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11.1 Type and level of microbial contamination in raw materials, intermediates 
and final products 
Over a three year period a total of 1362 individual samples 
S<:\~1., ef' 
were examined comprising of 600J[aw materials, 91 tablets, 
311 tablet intermediates and 627 creams. Such an extended 
and extensive study was required to provide the reliable 
data needed to answer the four points below (sections 11.1.1 
-11.1.11). Little data is available on raw materials used by 
British pharmaceutical companies or on the commercial 
tablets or creams produced. The few studies carried out 
have been centred on hospital pharmacies (Public Health 
Laboratory Service 1971, Westwood 1971, Baird et all976). 
The data that is availa~le on raw materials and final preparations 
has been generated in other European countries or the USA, 
but studies on creams have been particularly limited. 
11.1.1 Assessment of the risk the microbial contaminants detected 
in raw materials and final preparations may present to the 
patient 
Salmonella and S aureus were not recovered from any of 
the samples tested. However, the following pathogenic organisms 
were isolated, pseudomonads including Ps aeruginosa, E coli, 
Klebsiella and Proteus. 
------- --~~ --
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Pseudomonads (particularly Ps aeruginosa) and species of 
Klebsiella have been identified regularly as the cause of 
infections aquired from, non-sterile pharmaceutical preparations, 
hospital equipment and disinfectants (see Tables I C to 3). 
Escherichia coli is a member of the normal bowel flora but 
certain serotypes cause diarrhoea! disease in infants. Proteus 
is an opportunistic pathogen, attacking areas of the body 
such as the urinary tract (Pe!czar and Reid 1965). 
Pseudomonas aeruginosa was recovered from 7 batches of 
one type of cream and E coli from I batch of filled soft 
gelatin capsules. These two organisms as well as the other 
pathogens specified namely, other pseudomonads, Klebsiella 
and Proteus were detected in a number of different raw 
materials such as, empty gelatin capsules, gelatin, shellac 
orange, gum acacia and dry yeast powder. All these materials 
were destined for tablet or capsule preparations. 
It is doubtful whether any of these pathogenic species isolated 
would represent a serious threat to the patient via the oral 
route. Escherichia coli may be the only exception but in 
most of the samples examined counts did not exceed 1 g -1• 
Pseudomonads, Klebsiella and Proteus present a more 
serious threat as contaminants of topical preparations, so 
the most serious finding was the isolation of Ps aeruginosa 
from creams. Pseudomonas aeruginosa as a contaminant 
of eye drops, creams, hospital equipment and disinfectants 
has caused many infections (Tables 1C and 3), being particularly 
1 
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infective to debilitated patients. It presents additional problems 
as it is resistant to many antibacterial agents (Russel! 19711) 
and may even proliferate in topical preparations. In this study 
it was clearly demonstrated that proliferation may take place in 
creams, with a contaminated batch reaching a count of 20,000 g-1 
after 112 days with no visible effect to the product. 
It was obviously important to determine the cause and cure for such 
a contamination problem, the investigation carried out is discussed 
in section 11.8. 
In the introduction to this thesis other opportunistic pathogens were 
described which are particularly infective to a debilitated patient. 
These included S marcescens and certain species of yeast and fungi 
(Tables IIA, IlB and I!C), both have been the cause of infections aquired 
from non-sterile pharmaceutical preparations or hospital equipment 
(Table 1 C and 3). Reports by workers such as Suarez Fernandez et 
al (1976) and Suarez Fernandez and Genis (1979) also outline the dangers 
presented by mycotoxin producing fungi as contaminants of pharmaceutical 
preparations. 
Even though many enterobacterial isolates were identified, no species 
of Serratia was detected. 
Selective media were not used routinely for the enumeration of moulds 
but the low fungal count recorded on total viable count plates, suggest 
there is no persistent fungal contamination problem with any of the 
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raw materials or products studied. Similarly yeasts, although identified 
as regular contaminants of sugar, no count in excess of 200 g-1 was 
recorded. 
4.1.2 Relevance of regulatory and 'in house' controls 
Microbial limits on non-sterile pharmaceutical preparations and their 
raw materials have been introduced mainly over the last 10 years. 
The USP XIX and BP 1973 include recommendations for absence of 
Salmonella, E coli, Pseudomonas and S aureus and obligatory limits 
are quoted for a few raw materials such as gelatin and gum tragacanth, 
these are detailed in the respective monographs. 
This study has shown that the majority of samples examined comply 
with the recommendations of the BP 1973 for absence of Salmonella, 
• 
E coli and Pseudomonas, the actual figures for the samples tested 
being, 92% of raw materials, 96% tablets and capsules and 99% of 
creams. 
The fact that pathogenic species were isolated from raw materials 
and final products and that such organisms have been found by other 
workers (see Tables 1 C and 3) to be the cause of infections acquired 
from non-sterile pharmaceutical preparations, is firm evidence of 
the need for regulatory controls. 
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On the basis of the results of this study, it is recommended that the 
next edition of the BP includes specific microbial limits for gum acacia 
and shellac orange, which specify at least absence of E coli and that 
consideration also be given to imposing similar controls on dry yeast 
powder. 
Increasing the number of monographs which contain specific microbial 
limits, poses few problems in comparison with extending such limits 
to include additional named species or viable counts. Even if agreement 
were reached on the pathogenic species to include and the count limits 
to impose, considerable practical problems could be faced especially 
when comparing results between different laboratories. Alternatively, 
'in house' limits can be imposed by the manufacturer, to provide extra 
information and assurance about product quality. 
Extending or increasing the complexity of microbiological analysis, 
in a busy quality control laboratory, can only be considered if the additional 
work provides information which is significant to product quality. 
This point seems to have been overlooked by other workers (eg Kruger 
and Zimmermann 1975 and Henning and Costin 1972) who have suggested 
a range of procedures for examination of raw materials but fail to 
provide adequate justification for doing so. 
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In this study the need to continue routine testing of samples for presence 
of enterobacteria, faecal streptococci and total viable count was considered. 
The presence of such organisms or detection of a high total viable count 
will not necessarily alter the efficacy of the product or harm the patient, 
so the justification for this additional work was examined. 
It can be reasonably argued, that the presence of enterobacteria, faecal 
streptococci or pseudomonads in a sample is strong evidence of contact 
with faecal material, decaying matter or stagnant water. Similarly, 
a high viable count may be indicative of poor manufacturing or storage 
conditions. 
However, to further justify this additional testing the significance 
of these three parameters on the detection of E coli, enterobacteria 
. --
and pseudomonads was investigated, by examining the combined data 
obtained from 8 raw materials of natural origin. The significant statistics 
to emerge were that of batches with total viable counts in excess 
103 g -I, 3296 were contaminated with E coli, 9096 with enterobacteria 
and 1396 with pseudomonads, for batches containing less than 100 g -I 
the figures fell to 1.496, 3896 and 2.896 respectively. Similarly there 
was an association between the presence of either pseudomonads or 
enterobacteria and detection of E coli. 
---------------
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Attempts to demonstrate a relationship between the presence of indicator 
organisms and pathogenic species have been reported in association 
with foods. Drion and Mossel (1972) observed in dried foods that the 
ratio of Enterobacteriaceae to Salmonella was 1000:1, Tomkin and 
Keupeuer 1973 observed that the rate of Salmonella isolation rose 
from 12% to 70% as viable count increased from 104 to 107• Miskinim 
et al (1976) studying various foods correlated presence of Salmonella, 
Clostridium perfringens and S aureus with viable count and coliform 
content but concluded, that presence of indicator organisms alone 
was not a sufficiently accurate basis for passing or rejecting a batch. 
As it has been demonstrated in this study, that raw materials having 
a high total viable count or containing enterobacteria, may also be 
contaminated with certain pathogenic species. Inclusion of these two 
checks in routine analysis would seem worthwhile. They may form 
the basis of 'in house' standards which if exceeded necessitate further 
more extensive studies before releasing the batch in question. 
Only 4% of samples contaminated with faecal streptococci were also 
contaminated with E coli. This suggests that the faecal streptococci 
isolated did not necessarily originate from faecal material. 
Bergey's Manual (8th edition) suggests that faecal streptococci 
such as S faecalis and S faecium may have an epiphytic relationship 
with plants. This association with plant material could explain 
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the regular contamination of cocoa powder with faecal streptococci 
but not the consistent contamination of yeast powder. It 
would appear that, faecal streptococci used as indicators 
of faecal pollution of water, can not necessarily fulfil this function 
in raw materials used in the pharmaceutical manufacture. 
4.1.3 Assessment of the data obtained against results reported by other workers 
As already indicated little data has been presented in this country 
and what is available has been related to hospital pharmacies. 
' 
In this study of raw materials Ps aeruginosa was detected in shellac 
orange and empty gelatin capsules, E coli was detected in these materials 
and also in gum acacia, gelatin powder and cocoa. Other workers such 
as Kruger (1973) and B~hlmann et al (1972) similarly isolated these 
two organisms from only a limited number of samples of a narrow 
range of materials which included, gelatin, talc and pancreatin. 
Shellac orange was the only material found regularly contaminated 
with E coli (53% of samples) or Ps aeruginosa (18% of samples). The 
mean total viable count of 15,100 g-1 for samples of shellac orange 
tested was well in excess of all other materials. These results are 
in sharp contrast to those of Kruger (1973) and Buhlmann et al (1972), 
who failed to detect Pseudomonas or enterobacteria in shellac orange 
and recorded viable counts of less than 1000 g -l, with mean results 
-------------------------------------------------------------------------------- -
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of !53 and less than 100 g -I respectively. Shellac orange as tested 
in this study was subsequently dissolved in an alcoholic solution and 
used for tablet coating. This treatment as expected killed all vegetative 
forms removing any risk presented by the material, providing cross 
contamination with other raw materials or final products is prevented. 
Batches of cocoa examined in this study exhibited a wide range of viable 
counts, enterobacteria and faecal streptococci were isolated and one 
batch yielded E coli. Gabis et a! (1970) examining cocoa as a food 
additive only isolated Bacillus and Micrococcus species but reported 
counts ranging from !00-2700g-l, while Craven et a! (1975) identified 
cocoa for chocolate as a source of S eastbourne. Buhlmann et a! {1972) 
reported counts in excess of 104 g-1 and isolated enterobacteria. 
Kallings et a! (1966) examining starches frequently isolated coliforms 
from batches of potato starch and recorded total viable counts up 
to 104 g -I. In similar studies on maize starch they failed to detect 
coliforms and lower viable counts were recorded. Kruger (1973) found 
maize starch free of enterobacteria. 
Similarly in this study, potato starch was found to have a much higher 
total viable count than maize starch and more batches of potato starch 
were contaminated with enterobacteria. 
---------------
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Dry yeast powder and empty gelatin capsules have not been included 
in other studies on raw materials. In this study batches of dry yeast 
powder had consistently high viable counts, all were contaminated 
with enterobacteria and most with faecal streptococci. In contrast, 
empty gelatin capsules showed a variable degree of contamination, 
83% of batches had total viable counts of less than lOg -I and were 
free of contamination with enterobacteria, however, E coli and Ps 
aeruginosa were isolated from certain batches and counts of over 3xl04 g -I 
recorded. Moore (personal communication) found batches of capsules 
could be contaminated with thermophilic bacteria, but in this study 
high counts were due to presence of enterobacteria. It is possible 
to purchase capsules treated with ethylene oxide, this would seem 
a wise precaution. 
The results obtained for lactose are in agreement with those of Kruger 
(1973) and Harrewijn et a! (1972) ie low viable count with a low, but 
detectable count of enterobacteria. In contrast, Shiller (1968) reported 
counts of 3000 g -I and Pedersen and Ulrich (1968) detected E coli. 
Samples of talc were all found to have a low viable count, less than 
JOg-! and were free of pseudomonads and enterobacteria. In contrast, 
higher counts ranging from over J03g-J to over J011g-1, were reported 
by Kruger (1973), Buhlmann et a! (1972) and Gallien (1972), Pedersen 
and Ulrich (1968) also detected E coli. The difference in results may 
--------------------
205 
be due to the grade of material examined; in this study all batches 
of talc were described as 'sterilised'. 
With the exception of E coli and Salmonella, little data has been presented 
by other workers concerning the types of Enterobacteriaceae present 
in raw materials, even though the family contains opportunistic pathogens 
such as Serratia, Klebsiella and Proteus. However, Harrewijn et al 
(1972) studying lactose found Klebsiella and Enterobacter species as 
the most common isolates. From the data presented by Kruger (1972) 
on a range of raw materials Citrobacter appears to be the most common 
isolate. In this study Citrobacter and Enterobacter species were isolated 
most regularly with occasional isolation of Klebsiella and Proteus. 
Except for one batch of soft gelatin capsules from which E coli was 
isolated, the oral preparations examined in this study were free of 
contamination with the pathogenic species specified in the BP (1973) 
and USP XIX. Mean total viable counts of each type of tablet/capsule 
were less than 500g -1 with the majority of individual samples being 
less than 100g-1• Fisher, Fuglsang-Smidt and Ulrich (1968); Fuglsang-Smidt 
and Ulrich (1968) and Gallien (1972) obtained similar results, no pathogenic 
species were isolated and the total bacterial count of most samples 
was less than 1 00/tablet. 
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Other workers have only presented limited data on creams but Baird 
and Shooter (1976) and the Public Health Laboratory Service (1971) 
found creams manufactured in hospital pharmacies to be regularly 
contaminated with Ps aeruginosa. Ulrich et a! (1971) and the Public 
Health Laboratory Service (1971) each examined less than 30 samples 
of unspecified commercially produced creams. Pseudomonas species 
and S aureli~ were not detected and total viable counts of less than S {...._ 
10 g-1 were reported for most samples, but Ulrich did identify 
creams with counts in excess of 10,000 g -1• 
In this study 99% of cream samples recorded total viable counts of 
less than 10 g-1, and except for 7 samples which yielded Ps aeruginosa 
and one which yielded another pseudomonad, no pathogenic species 
were detected. 
4.1.4 Future quality control programme for microbiological analysis of raw 
materials, tablets/capsules and creams, based on results obtained in 
this study 
In most pharmaceutical companies it would be impractical to test 
all the raw materials used and all the non-sterile products manufactured. 
On the basis of this study it would also seem to be unnecessary as most 
of the samples examined were free of contamination with pathogenic 
species and enterobacteria and had total viable counts of less than 
100 g-l 
207 
There was a marked difference in results obtained from raw materials 
of animal and vegetable origin as compared with inorganic and synthetic 
materials. No pathogenic species, pseudomonads or enterobacteria 
were detected in this latter group, the mean viable count for the whole 
group being 36g-1• In contrast, from the materials of natural origin, 
E coli and other enterobacteria, Ps aeruginosa and other pseudomonads 
were isolated, the mean viable count of this group was 1340g -l. Data 
presented by other workers shows a similar picture (Kruger 1973, Buhlmann 
et al 1972), the difference being even more marked for certain active 
ingredients of natural origin such as digitalis (Shiller 1968) and thyroid 
powder (Kallings et al 1965 and 1966). 
The origin of a raw material obviously provides a guide to the possible 
level and type of microbial contamination, materials of natural origin 
presenting the greatest risk of contamination with pathogenic species. 
On the basis of the results obtained from raw materials studied it is 
suggested each type of material be placed into one of three groups 
which determine test frequency, namely those requiring; no monitoring, 
intermittent monitoring (eg every 5 batches) or every batch monitored. 
Materials should be assigned to each group on consideration of the 
results from previous microbiological studies. The raw materials tested 
in this study have been placed accordingly into such groups (see Table 
48 in the Conclusion to this thesis). 
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Adopting such a ·scheme will save considerable time and expense and 
effort is concentrated on materials presenting a genuine risk. 
Final preparations can similarly be placed into groups on the basis 
of previous microbiological results but consideration should also be 
given to the manufacturing process and raw materials used. 
Of the tablet preparations examined only soft gelatin capsules would 
need every batch examining. Microbiological examination of tablet 
packaging containers would seem unnecessary as the samples tested 
were free of contamination with pathogens and had low viable counts. 
In contrast certain aqueous tablet intermediates were found to be 
heavily contaminated and so require continual or frequent monitoring. 
For test purposes, creams can also be placed into groups but they do 
present the additional problem that micro-organisms may proliferate 
in certain preparations. It would seem a wise precaution to avoid 
placing any creams in a group requiring no microbiological monitoring. 
Creams containing antimicrobials (other than preservative) namely, 
clioquinol, neomycin and propylene glycol all had total viable counts 
of less than 10 ml-l and species of Bacillus were virtually the only isolates. 
Such preparations would only require intermittent monitoring. From 
the other creams studied, Gram positive cocci and Bacillus were the 
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most frequent isolates with occasional recovery of yeasts and species 
of Penicillium, but from the 390 batches studied only 2 had total viable 
counts in excess of 1 OOg -l. These creams would similarly only seem 
to require intermittent monitoring but the situation is made more 
complex by the fact that Ps aeruginosa was detected in 7 batches. 
A decision to reduce the test frequency of a particular cream below 
a level of 100% may also need to take account of, product formulation, 
significance of microbial contaminants from the water and other raw 
materials used, and as demonstrated in this study, the significance 
of contaminants from the manufacturing environment. The specific 
problems associated with testing creams are discussed more fully in 
sections 4.6 and 4.8. 
------
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lf..2 Comparison of enrichment and plating systems for detection of E coli, 
other enterobacteria, faecal streptococci and pseudomonads from 
raw materials 
Various authorities and workers have suggested procedures and techniques 
for testing raw materials, eg BP (1973), USP XIX, Pharmaceutica acta 
Helvetiae (1975), Henning et a! (1972), Henning and Costin (1972), 
Wa!lhauBer (1972), Kruger and Zimmerman (1975) and Buhlmann 0968), 
but little information is available or given on their effectiveness. 
It was outside the scope of this study to compare all the numerous 
alternatives so media and procedures specified in the BP (1973) and 
USP XIX were chosen as the basis for the studies while including selected 
alternative media. 
It must be emphasised, that all studies on media and techniques (except 
for Salmonella recoveries) were carried out using organisms which 
had not been cultured in the laboratory but were natural contaminants 
of the raw materials, and therefore, likely to be damaged and in various 
states of hydration. Only organisms in this condition provide a suitable 
bases for assessing efficiency of recovery media, as the techniques 
are aimed at detecting such contaminants. This point also seems to 
have been ignored by other workers. 
211 
The study was in two parts, 'in use' evaluation of alternative media 
during the routine study of raw materials, and secondly, inoculation 
of a range of media with raw materials known to be contaminated 
with the required test organism. 
In both studies nutrient broth proved at least as effective as all other 
media tested, for detection of E coli, other enterobacteria, faecal 
streptococci, Ps aeruginosa and other Pseudomonas species. 
Other significant points were that for detection of E .coli, nutrient 
broth suggested by the BP (1973) was more effective than lactose broth 
suggested in USP XIX or EE broth suggested by various European workers 
(Kruger and Zimmerman 197.5, Henning et al1972), Further EE broth 
suppressed the growth of faecal streptococci. 
The BP (1973) procedure for detection of E coli proved the 
most effective but plating on MacConkey agar instead of 
inoculating MacConkey broth, the secondary enrichment specified, 
proved only slightly less efficient and had the advantage of 
demonstrating the presence of other enterobacteria and faecal 
streptococci. 
For recovery of enterobacteria, all of the four enrichment media were 
equally effective, but differences were found with the two plating 
media used. Violet red bile dextrose agar, suggested by Buhlmann 
(1968), proved no substitute for MacConkey agar, the superior recovery 
efficiency, more clearly differentiated colonial morphology and more 
discrete colonial size make MacConkey agar the media of choice. 
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In both parts of this two part study, one of the most striking observations 
was the failure of 0.0396 cetrimide broth to detect Pseudomonas species 
in particular Ps aeruginosa. This supports findings of Hart et al (1978) 
who demonstrated, 0.0396 cetrimide broth was ineffective in recovering 
a range of named laboratory strains of Ps aeruginosa and other Pseudomonas 
species. The results from the study in this thesis, as they were obtained 
using· the natural Pseudomonas contaminants of raw materials, strongly 
suggest the next edition of the BP should not recommend 0.0396 cetrimide 
broth for detection of pseudomonads. Jn this study nutrient broth proved 
the most efficient alternative. Using 0.0396 cetrimide broth and following 
the BP positive control procedure, there was no problem recovering 
a laboratory cultured inoculum of Ps aeruginosa NCTC 67 50, the specified 
test strain. Besides this demonstrating the inadequacy of laboratory . 
cultures as a realistic indicator of recovery efficiency, it must be 
a point of some concern, that Pseudomonas contamination of a raw 
material could be missed, because a recommended control system is 
insensitive to the deficiencies of the specified recovery media. 
It is important pathogenic species be readily recognised on the appropriate 
selective or differential media, so Pseudosel agar was chosen in preference 
to 0.0396 cetrimide agar for detection of Pseudomonas species from 
enrichment media, even though in the comparative study cetrimide 
agar proved marginally more efficient. Diffusable pigments produced 
by I's aeruginosa stand out more clearly on Pseudosel ensuring this 
pathogenic species is recognised on a plate which may contain other 
Pseudomonas species. Hart et al 0978) working with laboratory strains 
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of Pseudomonas similarly favoured 'Pseudosel', for this same reason. 
Salmonella was not isolated from the raw materials studied, so natural 
contaminants were not available to assess critically alternative media 
for detection of this organism. Using named laboratory cultures, all 
media tested proved equally effective in detecting low numbers of 
the test species in the presence of other enterobacteria, but a more 
realistic inoculum is needed to confirm these observations. A significant 
point from these studies was that use of secondary enrichment media 
such as selenite broth as specified in the BP (1973), may hinder isolation 
of Salmonella due to overgrowth with Ps aeruginosa or lactose fermenting 
enterobacteria., The incubation time used of 48h as specified in the 
BP (1973) may contribute to the problem, the USP XIX recommends 
only 12-18hr. Gundstrup (1974) observed competitive growth of Ps 
aeruginosa in tetrathionate broth and recommends use of a special 
selective media BMF agar, containing brilliant green and mannitol 
as the fermentable carbohydrate, to differentiate between Pseudomonas 
and Salmonella species. 
Positive control studies using S aureus PRIV were successful using nurtient 
broth as an enrichment medium and Baird Parker agar for isolation. 
No naturally contaminated raw materials were available for a more 
meaningful assessment of this and alternative procedures, so further 
studies are still required. 
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The fact that differences in efficiency could be distinguished 
between different recommended medias, indicates this sort 
of comparative study is worthwhile, especially when severe 
deficiencies can be highlighted. 
On the basis of the results from these stu~ies into the comparative 
efficiency of enrichment and plating media a scheme for examination of 
raw materials is proposed, this is detailed in the conclusion to this thesis 
(Figure 9). 
Enterotubes were used in this and other parts of the study to examine 
enterobacteria to genus or species level, they proved easy to use and 
could be interpreted reliably. This rapid system has been recommended 
by many workers such as Menshikov and Yanisker (1977), Wust and 
. 
Kayser (1974), Painter and Isenberg (1973), Tomfohrde et a! (1973) 
and Finlayson and Gibbs (1974). 
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4.3 Development and validation of an enzymic technigue for microbial 
examination of pharmaceutical grade gelatin 
The liability of gelatin to contamination with pathogenic micro-organisms 
has been recognised by the USP XIX (1975) and by the BP (1973). The 
former requires the absence of E coli and Salmonella from a sample 
of lOg of gelatin and imposes a total count limitation of 1000 organisms 
g -l. The BP specifies that E coli be absent from a lg sample and Salmonella 
from lOg. 
Methods for the examination of gelatin usually involve enrichment 
in broth, with or without initial solubilization, at 45° (Leininger, Shelton 
and Lewis 1971; USP XVIII; BP 1973). However, membrane filtration 
has two advantages if used for the testing of gelatin. 
Firstly, after filtration, the membrane can be placed in broth and enriched 
without producing a viscous solution. Rose (1972) states that viscosity 
complicates the recovery of Salmonella from gelatin. Observations 
in this study also indicate that increase in viscosity tends to reduce 
microbial growth. 
Secondly, the membrane can be placed directly on an agar plate or 
nutritive pad. Depending upon the medium used, this procedure can 
give either a total microbial count or the count of a specific organism 
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such as Salmonella or E coli. 
Aqueous solutions of gelatin up to concentrations of 10% prepared 
by warming at 45°, proved difficult to filter through 0.45p pore size 
membranes. Hence the alternative procedure using enzymic solubilization 
of gelatin was developed. 
For each of the 33 samples studied enzymic solubilization increased 
the quantity of gelatin that could be filtered through a 0.45p membrane, 
, the mean increase being 233%. This permitted the filtration of I Og 
of gelatin {the test quantity specified in the BP and USP) through at 
most two membranes, using non-enzymic solubilization up to 20 membranes 
could be required. Laboratory fermented proteases may be used but 
a commercial proteases proved more effective. 
Studies demonstrated the commercial enzyme and laboratory fermented 
protease had no antimicrobial effect on S abony NCTC 6017, E coli 
NCTC 9002, Ps aeruginosa NCTC 6750 and S aureus PRIV and that 
these organisms {less than 50 viable cells) inoculated into an enzyme 
gelatin mixture, could be detected by filtration of the solution and 
culture of the membrane in nutrient broth or on selective agar. Quantitative 
estimation of the recovery of E coli and S abony from the enzyme 
gelatin mixture demonstrated there to be no significant difference 
between counts obtained and control counts from 0.1% peptone water 
217 
similarly inoculated. 
Even though work with laboratory cultured organisms demonstrated 
the enzymic filtration procedure to be effective, the validation studies 
were continued but now on recovery of the natural contaminants of 
gelatin. A wide range of species were recovered from gelatin samples 
examined but studies were centred on recovery of E coli from samples 
containing a low count of this organism (less than 1 g-1 ). 
Escherichia coli occuring as a natural contaminant of gelatin was recovered 
using the enzymic procedure with the same efficiency as the BP (1973) 
procedure and more efficiently than the USP XVIII procedure (First 
Supplement). Poor growth observed in USP enrichments after 24h 
compared with either the lactose broth containing membranes or the 
BP enrichment technique, may be due to the lower incubation temperature 
recommended in the USP of 30-35°, (rather than 37°) which will give 
a gelatin solution of lower viscosity, in this study 31 °C was used. 
On the evidence of this study, if the USP procedure is followed a low 
count of E coli could be missed, especially if 24h rather than 48h incubation 
of the enrichments is chosen. 
218 
Placing membranes on MacConkey agar, E coli was detected at least 
as effectively as from equivalent membranes placed in nutrient broth 
or lactose broth, the enrichment media suggested by the BP and USP 
respectively. Also, a quantitative estimation of E coli was obtained 
a 'suspect' and 'confirmed' positive results for E coli were recorded 
24h sooner. Therefore, direct plating of the membrane has certain 
advantages over enrichment culture which may be of value for routine 
microbiological quality control of gelatin or for more detailed evaluation 
of batches suspected of being contaminated with E coli. 
The increased total viable counts recorded for gelatin samples using 
enzymic solubilization and membrane filtration, as opposed to aqueous 
solubilization and pour plates, further demonstrates the enzymic procedure 
has no antimicrobial effect on the natural contaminants of gelatin 
and that total viable counts can be estimated from enzymically prepared 
solutions of gelatin. 
The enzymic procedure developed offers membrane filtration as a 
practical alternative method for the examination of high grade gelatin 
suitable for inclusion in pharmaceutical preparations. The enzyme 
having its effect by breaking down the high molecular weight molecules 
of which gelatin is composed, molecules such as these can blind even 
a 0.45p membrane (personal communication Millipore UK). 
--------- - -
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4.4 Application of membrane filtration techniques to microbiological examination 
of selected insoluble powders and viscous solutions 
Millipore (1969) suggested a membrane filtration procedure for the 
examination of insoluble powders, this was used as a basis for the studies 
with maize starch and dry yeast powder. The technique depends on 
suspending the powder in aqueous vehicle, allowing to settle then filtering 
the supernatant. However, little success was achieved, traces of powder 
present on membranes incubated on agar media encouraged the growth 
of spreading colonies, this combined with low recovery efficiencies 
suggest there is no advantage in adopting a filtration procedure to 
examine powders, especially if the powder demonstrates no antimicrobial 
activity. The low recovery efficiencies are probably due to the failure 
of the suspending medium, 0.1% peptone water, to remove all micro-
organisms adhering to thE; powder. Incorporation of a non-ionic surfactant 
such as Tergitol 15-S-9 in the suspending medium may improve recovery. 
Attempts to remove powder from the suspending medium using an 
8J.I membrane as a pre-filter caused too great a reduction in viable 
count to be of any practical value. Even though most micro-organisms 
should pass through an 8J.I pore, the fact that micro-organisms are 
usually attached to particulate matter and also that the efficiency 
of the filter will increase with build up of powder, probably explains 
the reduced count. 
--- -----------
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As discussed previously, the membrane filtration of gelatin was improved 
using enzymic solubilization. Other raw materials could also benefit 
from enzymic solubilization. Gum acacia formed a viscous solution 
when enriched in liquid media but in solution only small quantities 
would filter through a 0.45p membrane, a polysaccharidase may increase 
this. Cellulases are already recommended to improve filtration of 
parenteral preparations containing small quanti ties of cellulose (USP 
XVIII), they may also be effective in mediating filtration of larger 
quantities of cellulose. 
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4.5 Development and validation of techniques for the detection of micro-organisms 
in ointments and comparison of these with existing techniques 
In this study 4 membrane filtration procedures were developed (designated 
techniques 'A'- 'D') for enumeration or detection of microbial contaminants 
in ointment preparations. These procedures combined the use of the 
ointment solvent, isopropyl myristate with a dispersion technique and 
were aimed at overcoming disadvantages encountered with existing 
" 
techniques (a summary of these techniques is given in Table 7). The 
four proposed techniques are similar the differences being confined 
to changes in, the relative proportions of ointment tested, ointment 
solvent, dispersant or to inclusion of a surfactant in the dispersant. 
The study falls into a number of sections related to validation of the 
4 procedures developed or to comparisons with alternative techniques. 
4.5.1 The use of dry airborn micro-organisms as a challenge inoculum for 
studies with ointments and oils 
Inocula of dry airborn micro-organisms were used to evaluate the efficiency 
of procedures for microbiological examination of ointments and for 
survival studies in ointments and oils. These organisms were not in 
an aqueous phase and were considered to be representative of organisms 
which may contaminate ointment preparations during manufacture 
and filling. 
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The technique developed in this study for collection of airborn micro-organisms 
in an oily vehicle, provided an inoculum which gave statistically consistent 
data. By collecting organisms in an appropriate oil, it was a simple 
operation to blend the oil (appropriately diluted in further oil) into 
an ointment base. 
This technique enables a worker to collect micro-organisms from the 
atmosphere of a particular pharmaceutical processing area, the inocula 
collected can then be used in studies requiring a realistic challenge 
to the product. The technique also gave consistent data when used 
to contaminate an aqueous vehicle, a practical application for this 
was not followed up though. 
A range of airborn micro-organisms, including viruses, Chlamydia, 
Rickettsia, bacteria, Actinomycetes and fungi, could be present in 
such an inocula. Special methods are necessary for isolation and quantitation 
of certain groups so for the purposes of this study the term airborn 
micro-organisms was taken to include, bacteria, Actinomycetes and 
fungi only. 
To obtain a meaningful evaluation of a microbiological quality control 
procedure, the challenge inoculum used must be representative of 
the organisms likely to contaminate the product during manufacture 
or filling and must also survive in the product in the period before 
--------~~-
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recovery is attempted. 
Little attention has been paid in other studies to the type or condition 
of the challenge inoculum used. This may affect the value and significance 
of the recovery efficiency figures quoted. In the studies by other workers 
listed in Table 7, the recovery efficiencies from ointments had been 
determined using laboratory cultures blended into the ointment in 
an aqueous vehicle. The only exception being Tsuji and Robertson 
(1970) who included dried spores of a laboratory culture of B subtilis 
in their evaluation of a mixed solvent system for ointments. 
Laboratory cultured organisms are convenient to use but are not representative 
of the condition of natural ointment contaminants. These organisms 
are unlikely to be associated with water due to the anhydrous nature 
of this dosage form. Ointments are manufactured at temperatures 
which may exceed 100°C and under conditions which should exclude 
contact with water, However, the possibility of contamination with 
micro-organisms in water cannot be ignored, as manufacturing equipment, 
vessels and pipework may be washed with detergent solutions and water. 
If not effectively dried viable organisms may remain and even proliferate. 
When assessing the efficiency of disinfectants and preservative systems, 
the limitations presented by the use of laboratory cultured micro-organisms 
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are well known and discussed in a review by Russell (1974). Growth conditions 
and number of previous subcultures, may both influence an organisms sensitivity 
to antimicrobial agents such as penicillin (Hugo and Stretton 1966) 
and parabens (Furr and Russell 1972). 
Similarly, laboratory cultures are of limited value when assessing the 
efficiency of techniques for detection of micro-organisms in ointments. 
Procedures designed to incorporate,' then remove an inoculum from 
an ointment must also stress the organism, eg though contact with, 
non-aqueous environments or solvents such as isopropyl myristate, 
hexane or xylene. The resultant effect on the inoculum may be dependant on 
previous cultural history. Dry airborn microbial contaminants of ointments 
may be associated with particular mater. This can afford protection 
to the cells but due to their desiccated state vegetative cells may 
be damaged already. If contaminants present in ointment are in an 
aqueous phase, they may have been damaged through heat, or contact 
with active ingredients. If proliferation does occur, this is likely to 
be in an undefined solution devoid of nutrients, which bears no resemblance 
to laboratory culture media. 
In addition to the objections discussed already, concerning the use 
of laboratory cultured organism for evaluating the efficiency of ointment 
test procedures, there are further problems associated specifically 
with the use of aqueous inocula. 
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The addition of water to an ointment alters its true anhydrous condition. 
Tsuji and Robertson (1970) suggest even if the inoculum is well blended 
into an ointment, cells will still be surrounded by a thin film of water 
which may favour recovery. The type of aqueous vehicle used for 
the inoculum may also influence recovery. Walsh and Allwood (1973) 
working with E coli suggest that 'the immediate environment of the 
cells in the ointment may influence viability'. Studies by Allwood 
and Hambleton (1973) demonstrated the antimicrobial effect of dispersing 
an aqueous inoculum in an ointment base. After 30 minutes exposure 
to either light liquid paraffin or a mixture of white soft paraffin 
and light liquid paraffin at 1!2°C, only 15% of the E coli inoculum 
could be recovered. 
Our studies with light liquid paraffin (I!0°C) inoculated with an aqueous 
inoculum of S aureus PRJV gave a similar picture as only 17% of the 
inoculum could be recovered. 
In contrast to aqueous inocula, this study demonstrated, inocula of 
dry airborn micro-organisms suffered no rapid decrease in viable count 
when inoculated into ointment bases. The bases studied included light 
liquid paraffin (1!0°C), liquid paraffin and BP (1973) eye ointment base. 
Even after ?Oh contact with these two latter materials, decrease in 
count was only in the range of 5-10%. This is a significant point and 
demonstrates that when such an inoculum is added to these ointment 
bases no decrease. in count will occur before recovery is attempted. 
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Hence, there is a stable base line from which recovery efficiency may 
be calculated. In contrast, the results from this study and from other 
workers quoted, suggests that for aqueous inocula total viable count 
may decrease immediately after inoculation. 
The extended survival of dry airborn micro--organisms in ointment 
base and liquid paraffin is also a demonstration of the potential, such 
contaminants have to survive in oily pharmaceutical preparations, 
well in the shelf life of a product. 
4.5.2 Recovery efficiencies of techniques for detection of micro-organisms 
in ointments 
The recovery efficiencies of techniques 'A', 'B', 'C' and 'D', developed 
in this study, were evaluated using dry airborn micro-organisms which 
had been blended into BP (1973) eye ointment base. 
Technique 'D' proved the most efficient with a mean recovery efficiency 
of 21% being recorded, testing 20g samples of ~intment. No problems 
were encountered filtering half the extract from 20g quantities of ointment 
through a single membrane. After rinsing the membrane was always 
visibly free of oily patches and deposits. Therefore, using just two 
membranes 20g of material was tested. 
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As technique 'D' proved the most efficient subsequent studies on the 
other three techniques developed were limited. 
A range of recovery efficiencies are quoted by different workers (Table 7) 
using alternative vehicles and procedures, some are above and some 
below the figure obtained for technique 'D', but in every case the weight 
of sample tested was less by a factor of between 20 and 1000. 
The difficulty of transferring micro-organisms from the ointment isopropyl 
myristate mixture to the aqueous phase is thought to be the reason 
the recovery efficiencies of techniques 'A', 'B', and 'C' were themselves 
different and also lower than 'D'. Using technique 'C', which was similar 
to 'D' except the surfactant Triton X 100 was omitted from the extraction 
stage, dispersion .of the ointment isopropyl myristate mixture was 
noticeably reduced and the resultant recovery efficiency was only 
496. Transfer of micro-organisms will be reduced if oil water contact 
is reduced. Similarly, the efficiency of technique 'B' was higher than 
'C', the techniques were exactly the same except that in the former 
6g of ointment was tested and in the latter 20g. The smaller quantity 
of ointment will disperse more readily .presenting a larger relative 
surface area to the aqueous phase in which transfer of micro-organisms 
can occur. 
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Although improved compared with the other three techniques, the 
reason the efficiency of technique 'D' was no higher than 21% was 
again thought to be due to the difficulty of transferring micro-organisms 
from the ointment isopropyl myristate mixture to the aqueous phase. 
Tergitoll5-S-9 was used as an alternative to Triton X 100 and gave 
improved dispersion, but the more stable emulsion formed failed 
to clear sufficiently to allow filtration of the aqueous phase. Similarly, 
alternative ointment solvents such as light liquid paraffin, almond 
oil, ethyl oleate, arachis oil and coconut oil, all proved satisfactory 
solvents for BP eye ointment base. However, using these solvents 
the quantity of ointment that could be filtered, following technique 'D', 
was reduced compared with isopropyl myristate, due to the formation of more 
stable emulsions. So a balance of adequate dispersion with ability 
to filter is required. To improve on the figure of 21% obtained, 
there are many other combinations of ointment solvents and surfactants 
which could be evaluated. 
The sensitivities of both technique 'D' and the BP (1973) suggested 
procedure, when used for sterility testing of BP (1973) eye ointment 
base, were sufficient to give positive results when 20g of ointment . 
was tested, containing 1-2 dry airborn organisms g-1• In both methods, 
more than one of the test bottles always demonstrated growth indicating, 
even lower contamination levels could be detected. Theoretically, technique 
'D' with a demonstrated efficiency of 21% should give positive results 
from a 20g test sample containing only 0.25 organisms g -I. 
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For comparative purposes also included in this sensitivity study were 
technique 'A', using a 6g sample, and a simple direct inoculation procedure 
(unlike BP test there was no pre-treatment of the samples with dispersants) 
using 6g and 20g samples. The sensitivities of these techniques was 
lower, by a factor of over 10, compared with technique 'D' or the BP 
procedure. The actual minimum contamination level required to ensure 
a positive sterility test was not accurately determined but from the 
results obtained, it would be expected to fall within the range 20-100 
organisms g-1, for both technique 'A' and the 6g and 20g direct addition 
procedures. 
The results of these sensitivity studies are in agreement with our findings 
from the recovery efficiency tests. Technique 'D' was demonstrated 
to be more efficient than 'A' and correspondingly technique 'D' was 
shown also to be the more sensitive. 
Of all these 11 procedures, which were examined for sensitivity, the 
simple direct addition was the most rapid but a 20g test sample; required 
20 bottles of media, if a limit of lg of ointment per test bottle was 
followed. Similarly, 20 bottles were required for the BP procedure 
plus a further 20 for subcultures prepared after 7 days incubation. 
Only 11 bottles of media were required for the 4 half membranes obtained 
using technique 'D'. Hence, if technique 'D' is adopted, media costs, 
preparation time, the size of sterilization loads and incubator space 
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are less by a factor of 10, compared with the BP test. 
No problems with adventitious test contaminants were encountered 
with the negative control tests performed in conjunction with any 
of these senstivity tests. However, the aseptic handling of large numbers 
of media bottles as in the BP or other direct inoculation procedures, 
must increase chances of isolating such contaminants. This point is 
especially important in a busy industrial quality control laboratory 
handling many production samples per day, isolation of adventitious 
test contaminants at best will delay a production batch at worst cause 
incorrect rejection of sterile material. 
Neomycin is an antibiotic regularly incorporated into eye ointment 
preparations. A claimed advantage of membrane filtration procedures 
as opposed to direct addition, is that organisms isolated on the membrane 
are separated from and rinsed free of, such inhibitory materials (Mi!lipore 
1969 and Russell 1979 and EP 1978). This claim was fully supported 
in positive control studies, using technique 'D' and the BP procedure 
to test an ointment containing neomycin. Only technique 'D' consistently 
detected low numbers (less than 50) of neomycin sensitive organisms, 
thus demonstrating no inhibitory concentrations of ·neomycin remained 
on the membrane. In contrast, the tryptone soya broth inoculated 
according to the BP procedure contained 13 iu mC1 of neomycin sulphate. 
This means the application of the BP (1973) test is limited, being unsuitable 
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for ointments containing neomycin or other antimicrobials, unless 
activity can be diluted out or an inactivator is available. 
Except for the positive control studies, all the validation work performed 
on technique 'D' involved the use of dry airborn micro-organisms. 
The reason for this choice has already been discussed, but it was also 
stated, that the possibility of an ointment being contaminated with 
organisms present in an aqueous phase could not be ignored. So technique 
'D' was also evaluated with aqueous inocula. 
The efficiencies obtained using aqueous inocula were lower than the 
21% obtained for dry airborn mirco-organisms, ranging from 12-20% 
for laboratory cultured organisms and Pseudomonas species (cultured 
in the water in which they were originally isolated). Even though thi~ 
latter, more realistic inoculum was included, it is doubtful wether 
these efficiency figures or those obtained by other workers using aqueous 
inocula can be considered meaningful, bearing in mind the problems 
already detailed concerning the use of aqueous inocula. The recoveries 
in this study only serve to demonstrate, that technique '0' will recover 
aqueous contaminants, including pseudomonads, from ointments and 
that such contaminants may be expected to give positive results from 
a 20g sample, when present at a level of 10 organisms g-l or even 
less. To confirm this figure and to obtain accurate efficiency figures 
more studies are required. These would need to demonstrate the aqueous 
4.5.3 
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inoculum was well dispersed in the ointment and that the challenge 
organisms survived in the ointment (or decreased by a known amount) 
during the period between inoculation and recovery. 
Evaluation of membrane filtration techniques proposed by other workers 
for the microbial examination of ointments 
An important consideration during the development of the filtration 
techniques, proposed in this study for the microbial examination of 
ointments, was that a significant quantity of material could be tested. 
There were two reasons for this. 
Firstly, due to their viscous nature, ointments are liable to be unevenly 
contaminated throughout a manufactured batch or filled unit. Testing 
a small sample of ointment may render a sterility test or microbiological 
study of even less significance, than a test on a similar sized sample 
taken from a different dosage form. 
Secondly, an inherent problem with procedures for examination of ointments 
has been their low recovery efficiencies. Table 7 lists 23 efficiency 
values for various solvents or dispersants as reported by other workers, 
I 0 values of I 0% or less are recorded and most others are well below 
100%. 
----~--~ 
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Using technique '0' developed in this study 20g of ointment could be 
tested by filtering through at most 2 membranes. 
As shown in Table 7, the quantities filtered by other workers using 
alternative procedures were much lower, the maximum through a single 
0.45f! membrane being 0.5g of ophthalmic ointment as reported by 
Tsuji et al (1970) and Tsuji and Robertson (1970), using isopropyl myristate 
and a mixed solvent system respectively. Also using isopropyl myristate, 
Hart and Ratansi (1975) filtered 0.2g of an oily cream while Allwood 
and Hambleton (1973) only filtered 0.025g of white soft paraffin. 
These procedures, proposed by other workers, were also examined 
in this study; to determine the quantity of material each procedure 
would filter through a single 0.45Jl membrane, while leaving a membrane 
that could be rinsed free of oily deposits. The results were disappointing, 
0.15g was the maximum quantity which could be filtered with any 
sort of consistency (even if hydrogenated lanolin was omitted from 
the BP eye ointment base used). This was achieved using the mixed 
solvent suggested by Tsuji and Rober,tson (1970) namely, isopropyl 
myristate, carbon disulphide and xylene. Using only isopropyl myristate 
and following the USP XIX procedure, less than O.lg could be filtered, 
this was only increased marginally by using pressure rather than vacuum, 
for filtration and rinsing. Further with all these procedures problems 
were encountered rinsing membranes free of oily deposits and instances 
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of membranes blocking after filtration of very small quantities (less 
than IOOg) were common. 
None of these procedures proposed by other workers was considered 
suitable for routine quality control testing of ointment preparations 
for either, sterility or to determine the level and type of microbial 
contamination. There are two practical reasons for this. 
Firstly, the quantity of ointment that could be tested was too small. 
Tp satisfy the USP XIX sterility test requirement to test at least 3g 
of ointment, on the basis of this study and following the USP suggested 
test procedure, 30 membrane filters would be required per test. Obviously 
such multiple testing is expensive, time consuming and increases drastically, 
the possibility of isolating adventitious test contaminants. 
Secondly, procedures used for the routine quality control of ointment 
preparations must be reproducable, in terms of the practicalities of 
the test. This means the membrane must not block before the required 
quantity is filtered and it must also be free of oily patches and deposits. 
If an operator encounters problems during a test, this may result in 
isolation of adventitious test contaminants or cause the operator to 
introduce a modification to the standard procedure, both of which 
can invalidate the test. 
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Technique 'D' developed in this study overcomes both of these two 
objections. Ointment samples of 20g could be tested using just two 
membranes and there were no problems encountered with premature 
blockage of the membrane or oily residues remaining on the rinsed 
membrane. 
4.5.4 Survival of micro-organisms in various oils 
These studies were carried out with 3 aims in view, to obtain information 
about survival of dry airborn micro-organisms in isopropyl myristate, 
to provide further validation information concerning technique 'D', 
and to provide more information about the challenge system developed 
in this study, ie dry airborn micro-organisms. 
The USP XIX and EP (1978) suggest the use of isopropyl myrlstate 
as an ointment solvent and it was used in this and other published studies 
already cited. The antimicrobial activity of isopropyl has been 
examined by a number of workers. Tsuji et a! (1970) obtained D 
values (see Appendix) of 11.0, 4.5 and 1.9 for dry heat sterilised 
material and values of 188, 329 and 19 for filter sterilised 
material, for aqueous inocula of S aureus, E coli and Ps 
-- -
aeruginosa respectively. Robertson (197 4) suggested the 
increased toxicity was caused by release of free fatty acids 
during heating, which causes a decrease in pH of water extracts. 
Filter sterilised isopropyl myristate was used in this and the 
other studies cited. Allwood and Hambleton (1973) report D 
values of 110 and 45 for E coli, in isopropyl myristate (at 42°C) 
-----------------~-- -----
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which had been obtained from different suppliers. Hart and 
Ratansi (1975) working with Ps aeruginosa were the only workers 
to report no toxicity. This contrasts with results of Tsuji 
et a! (1970) who obtained D values ranging from 19-61j. for 
different strains of Ps aeruginosa. 
In this study the three batches of isopropyl myristate (at 
lj.0°C) examined had a marked antimicrobial effect on an 
aqueous inoculum of S aureus, D values of 6 (Fluka material), 
16 and lj.6 (2 batches from Givauden) were recorded. In marked 
contrast, the total viable count of dry airborn micro-organisms 
showed no decrease after 90 minutes contact. The count 
of vegetative species only was similarly little affected. -
Survival studies were performed at lj.0°C rather than ambient 
temperature, as the temperature of the isopropyl myristate 
ointment mixture may be at this level prior to extraction, 
when tested according to technique 'D'. 
It is apparent from this study, isopropyl myristate exerts 
variable antimicrobial activity against aqueous inocula of 
S aureus, which may be dependant on the source of the material. 
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Other studies performed with different species suggest the same 
and further demonstrate how activity can vary between 
different species and even different strains (Tsuji et a! 1970). 
Workers using isopropyl myristate as an ointment solvent 
must appreciate it is toxic to micro-organisms in an aqueous 
vehicle. Contact time should be kept to a minimum, especially 
if contamination with aqueous inocula is suspected. From 
our studies, it appears other ointment solvents may be no 
better. Survival of an aqueous inocula of S auerus in light 
liquid paraffin was little better than in isopropyl myristate 
Allwood and Hambleton (1973) similarly found survival of 
E coli in light liquid paraffin was poor. 
Relating the results obtained from these studies with isopropyl 
myristate to technique 'D'. 
When using this technique, the t to 2t minutes contact micro-
organisms may have with isopropyl myristate (before extraction 
into the dispersant) will have no significant antimicrobial 
effect on dry airborn micro-organisms. Hence, will not decrease 
the recovery efficiency of such organisms. However, if an 
aqueous inocula is used some reduction in recovery efficiency 
must occur, but this need only be limited in such a short contact 
time, provided the D value of the isopropyl myristate is not 
too low. On the basis of the D values calculated in this study 
for S aureus, the reduction in viable count, assuming 2t minutes 
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contact time, would be within the range I 0% - 60%. The 
60% reflects the very low D value obtained with isopropyl 
myristate from F!uka, this material was not used in any other 
part of this study. If contamination of an ointment with organisms 
in an aqueous phase is suspected, isopropyl myristate with 
a D value of above 40 should be used as this represents just a 
13% reduction in 2i minutes contact. 
If direct filtration of ointment solubilised in isopropyl myristate 
is attempted, as suggested in the USP XIX or by Tsuji et al 
(1970), contact time will be greater than 2t minutes. In this 
study when using such procedures, as already discussed, membranes 
could block before filtration was completed, but even if filtration 
proceeds smoothly Robertson (197 4) suggests contact time 
will be 3-5 minutes. For such procedures the 'D' value of 
the isopropyl myristate used is even more critical. 
Dry airborn micro-organisms have been used regularly in 
this study, to evaluate procedures developed for recovery 
of micro-organisms from ointment preparations. The stability 
of such dry inocula in ointment preparations or other non-
aqueous materials contrasted with the rapid death of aqueous 
inocula. To provide a further demonstration of the use of 
dry 'natural' inocula when studying pharmaceutical preparations, 
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the survival of dry airborn micro-organisms in almond oil 
containing phenol was examined. 
Almond oil containing 5% phenol is a parenteral preparation 
which is sterilised by membrane filtration and then aseptically 
filled into ampoules. 'Terminal' sterilisation through an autoclave 
cycle is not possible, due to the anhydrous nature of the product. 
Other ampoule products if they contain thermolabile materials 
also rely on aseptic handling to ensure sterility but due to 
their aqueous nature usual!y have the additional protection 
of bacteriocide. The general assumption with phenol in almond 
oil is that it falls into the same category due to the presence 
of such a high level of phenol. Our studies with an aqueous 
inoculum of S aureus did not contradict this assumption . 
• 
However, studies with dry airborn inocula gave a completely 
different picture with slow reduction in viable count recorded, 
not too different from the similarly inoculated almond oil 
control. 
If this study had been limited to a challenge with aqueous 
inocula of laboratory cultures, an erroneous conclusion could 
have been drawn about the antimicrobial properties of the 
preparation. An inocula of dry airborn micro-organisms is 
representative of the organisms which could contaminate 
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the product during aseptic manufacture. The use of such an 
inoculum in this short study serves to emphasise, again, the 
different patterns of survival exhibitied by dry and aqueous inocula. 
It was significant that a wide range of organisms, eg Staphylococci, 
yeasts, moulds, could survive in almond oil containing phenol. 
Aqueous parenteral preparations containing a preservative 
are required to reduce the count of a bacterial inoculum to 
zero (lml sample) after 24h (BP 1980, Advance Notice). 
Sykes (1965) defines the three factors of importance for effective 
disinfecting action by chemical means: (i) adsorption of the 
compound by the cell wall; (ii) penetration into the cell protoplasm, 
(iii) reaction of the compound with one or more of the cell 
constituents. A possible explanation for the absence of antimicrobial 
activity demonstrated by phenol in almond oil, is that phenol is not 
released to the cell wall without the mediating effect of 
and aqueous phase hence phenol is not available for the second 
two steps. Further, many of the challenge micro-organisms 
will be protected by encasing organic matter such as skin. 
This can also seriously reduce the effectiveness of bacteriocides, 
providing a mechanical barrier or a local competative reaction 
with the formation of a non-bacteriocidal complex (Russell 1974). 
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The fact that survival of dry airborn micro-organisms was 
better in almond oil rather than almond oil containing phenol 
may be due to traces of moisture present in the inoculum 
or in the oil which enables phenol to exert some activity. 
4.5.5 Other studies related to the recovery of micro-organisms 
from ointment preparations 
This part of the study covered the examination of the antimicrobial 
activity of non-ionic surfactants and investigation of problems 
associated with sterility testing or microbiological examination 
of ointments containing neomycin. 
It was considered important at the start of studies involving 
ointment preparations to ensure that non-ionic surfactants, 
which are suggested in the EP (1978), USP XIX and by other 
workers without comment, have no antimicrobial effect when 
used to rinse membranes. It was outside the scope of this 
study to evaluate all the alternatives so only, Tergitol 15-
S-9 (a po1yethylene glycol ether of a linear secondary alcohol) 
and tween 80- (polyoxyethylene sorbitan fatty acid ester) 
were examined. The results obtained demonstrated that the 
non-ionic surfactants examined have little or no antimicrobial 
activity when use as rinse media, at concentrations of 0.1 %, 
in 0.1% peptone water. 
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As already discussed, membrane filtration offers advantages 
over direct addition test procedures. However, certain qualifications 
are necessary concerning use of membrane filtration for testing 
preparations containing antimicrobials, these apply especially 
to ointments. 
After filtration of an antibiotic preparation, a non-hydrophobic 
edged filter may retain antimicrobial activity around its perimeter. 
This was demonstrated after filtration of neomycin ointment 
using Technique D, the zone cf inhibition on the bioautograph 
was the arc trapped by the sealing gasket of the filtration 
apparatus. A hydrophobic edged membrane demonstrated 
no such retained activity. It would seem a wise precaution 
to use hydrophobic edged membranes when ~esting preparations 
containing antimicrobials, especially antibiotics which tend 
to be active at low concentration. 
Oily material remaining on a membrane may retain antimicrobial 
activity. This was thought to be the reason for the small 
zone of inhibition visible on the centre of the bioautograph 
referred to above, even though no material had been visible 
on the membrane after filtration. It is essential to discard 
filters which contain any visible oily material, the sample 
must be retested, if necessary using a more effective procedure. 
------------------ --------------
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The USP XIX recommends that suitable inactivating agents 
be added to culture media to neutralise preservatives or other 
antimicrobial agents present in test samples. The EP (1978) 
recommends that similar agents be used even if samples are 
tested by membrane filtration. A range of inactivators is 
specified by Russell (1973) which include Lubrol W:!: lecithin 
for quaternary ammonium compounds and p aminobenzoic 
acid for sulphonamides. 
Penicillins and cephalosporins can be inactivated using B 
lactamase enzymes. Penicillinase can be fermented in the 
laboratory from a suitable resistant strain or purchased from 
commercial suppliers. These enzymes can be used to inactivate 
~ lactam antibiotics prior to testing or even added direct 
. . 
to enrichment broths. 
Unfortunately there have been no such studies on enzymes 
for inactivating neomycin or other aminoglycoside antibiotics. 
There are three groups of enzymes, phosphotransferases, 
adenyltransferases and acetyltransferases which can attack 
the 2-deoxystreptamine and 3-aminohexose groups present 
on the aminoglycoside group of antibiotics. Crude enzyme 
preparations can be prepared by sonic disintegration of resistant 
cells, Russell (1979) suggests that these enzymes could be 
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added to recovery media. However, as yet no information 
is available on their application to the study of pharmaceutical 
preparations. 
Our study on inactivators was limited to more readily available 
non-enzymic materials. Dodeca-tungsto-phosphoric acid 
and dodeca-tungsto-silicic acid and L--cysteine hydrochloride 
all reduced the activity of a neomycin sulphate solution by 
over 90% but the latter two demonstrated a degree of inherent 
antimicrobial activity. Sodium carboxymethyl cellulose 
similarly reduced activity but only by about 50%. 
Neomycin is a polybasic compound not inactivated by most . 
excipents and reagents used in the pharinaceu~ical industry. However, 
it will react with certain anionic materials forming insoluble 
complexes. The inactivating materials used in this study 
were anionic so this reaction may be the cause of the reduction 
in activity observed. 
In the positive control studies performed on the .BP (1973) 
sterility· test procedure which was used to test a neomycin ointment 
preparation, the test organism, S aureus PRIV, which is neomycin 
sensitive and capable of growth in tryptone soya and thioglycollate 
broths, was only detected in the thioglycollate medium. This 
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may be due to the presence of L-cystine, an anionic compound, 
and constituent of fluid thioglycollate medium only. Schoenard and 
Stafseth (1953) demonstrated that 80-100 times more neomycin 
was required to have the same killing effect on S pullorum 
when using a defined synthetic medium rather than nutrient 
broth or 1% tryptone-water. Their defined media contained 
• 
L-cystine as well as other amino acids and vitamins added 
to a glucose-asparagine-mineral base. 
No further studies were carried out, but the results obtained 
suggest certain materials may be effective inactivators of 
neomycin and that they may be suitable for use in microbiological 
studies. Neomycin unlike penicillin is active against non-
multiplying bacteria (Schoenard and Stafseth 1953), so an 
inactivator is particularly important when examining sterile 
or non-sterile preparations containing this antibiotic. If no 
inactivator is used contaminating micro-organisms may be 
killed even before filtration is completed. 
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~.6 Alternative procedure developed for the microbiological examination 
of creams 
The problems associated with microbiological examination 
of pharmaceutical creams are poorly documented, the microbial 
limit tests given in the BP (1973) and USP XIX fail to give 
adequate procedures and few contributions have been made 
by other authors. 
The 'standard' technique, for examination of creams used 
in this study, like techniques used by other workers (Tenenbaum 
1970), was limited in terms of the quantity of creams tested. 
From a lOg emulsified sample of cream, the equivalent of 
l g was tested. This quantity may not be sufficient to detect 
the low levels of Ps aeruginosa which have been demonstrated, 
. 
may survive in the product (see Section ~.8). 
The alternative technique developed, '50g test', provided no 
practical difficulties even though from a 50g emulsified sample 
the equivalent of lOg of cream was tested. The technique 
was sufficiently sensitive to detect Ps aeruginosa present 
in creams at a level of between l-10 organisms per lOg while 
the 'standard' technique required between l 0-l 00 per lOg. 
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On consideration of the dangers Ps aeruginosa may present 
to the patient (see Tables 1 C and 3), and the fact that this 
study has demonstrated, that the viable count of Ps aerugnosa 
in a cream may decrease to non-detectable levels before 
eventually proliferating, some days or weeks later. Even 
though this alternative technique requires increased culture 
media, its use is surely justified for routine microbial tests 
on creams, or at least for testing creams considered particularly 
susceptible to microbial contamination. 
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4.7 Effects of specific processing stages on the level and type 
of microbial contamination in tablets 
The total viable counts recorded for most tablet preparations 
studied were lower than might have been anticipated knowing 
the counts of the constituent raw materials. Griseofulvin 
tablets contain a significant proportion of potato starch, 
on the basis of this material alone a final viable count in 
excess of 300g -1 would be anticipated, the actual figure 
was less than 1 Og -1• The veterinary steroid tablet studied 
was composed largely of dry yeast powder and a tablet count 
in excess of 2000g -l would be expected, the actual figure 
was 418g-1• Other tablets studied contained raw materials 
such as gum acacia, maize starch and cocoa, but the viable 
count of the tablets did not reflect the counts of the constituent 
materials. 
A decreased viable count may be anticipated for certain tablet 
preparations, alcoholic and acetone granulation processes 
or inclusion of granulating solutions which contain a preservative 
will obviously have an antibacterial effect. Schiller et al 
(1968) demonstrated the importance of such treatments in 
reducing the viable count, especially of heavily contaminated 
active ingredients. 
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It has been shown in this study that solvent granulation of 
raw materals with drying at 50°C reduces viable count by 
60-70%, the surviving organisms being largely Bacillus species. 
Such processes are routinely used in tablet manufacture for 
the preparation of granule ingredients and drying damp granules. 
Solvent granulation is used in the manufacture of effervescent 
tablets or to granulate water sensitive ingredients. Granules 
may be dried in an oven but modern practice is to use 'Fluid 
Bed Dryers' which dry the granule rapidly at 50-70°C, usually 
within 15-30 minutes. 
The antibacterial processes in tablet manufacture already 
discussed were suspected not to be the only means by which 
the microbial count could be reduced during processing. The 
veterinary steroid tablet studied had a reduced count but 
was manufactured by simply blending the ingredients prior 
to compression (ie direct compression). This prompted studies 
into the compression stage of the tablet manufacturing process. 
The total viable count of the granule was found to decrease 
during compression, reductions of between 66-78% being 
recorded for granules 'a' and 'b'. This decrease can be significant 
if control limits eg of 100 or 1000 micro-organisms g-1 are 
placed on tablets by the manufacturer, customer or 
-------------------------------------------------------------------------------- --
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regulatory authorities. A raw material which fails such standards 
initially can be used to manufacture a product which may 
then comply. The two types of granule selected for this study 
had total viable counts ranging from I ,900 to 2,800 organisms 
g -l, where as tablets manufactured from these showed counts 
ranging from 470-760g -l. The tablets though, not the granules, 
would satisfy a limit of 1000 organisms g-1• 
The effect of compression on specific groups of micro-organisms 
was also examined using granule 'b'. 
It was significant that fungi were demonstrated to be killed by 
the compression process. Tablets are protected from microbial 
spoilage by their low water content, most tablets being formulated 
to have a free water content of less than 2%. However, protection 
is not guaranteed against osmophilic micro-organisms. The 
author observed tablets visibly contaminated with a species 
of Penicillium (Plates 12 and 13). Beveridge 0980) states 
that small quantities of water condensed on the tablet surface 
may be sufficient to allow fungal growth, metabolic activity 
then provides added moisture allowing further growth. It 
must also be remembered fungi present the additional problem 
that certain species produce dangerous mycotoxins (Suarez 
Fernandez et all977). 
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The fact that the number of enterobacteria were reduced 
during compression is also important, decreases of 98 and 
99% being recorded for lactose fermenting enterobacteria. 
Although no pathogenic species were isolated from the tablets 
this group of bacteria include intestinal pathogens such as 
E coli and Salmonella which must be excluded from pharmaceutical 
preparations (BP 1973, USP XIX). 
Bacillus spores demonstrated the most resistance to the killing 
effect of compression with only a 64% reduction in count. 
The routine analysis of the veterinary steroid tablet (similar 
in composition to granule 'a') further demonstrated the antimicrobial 
effect of compression. The total viable count of the raw 
materials and tablets were determined and the fall in the 
count of the tablets calculated. This decrease was within the 
range 66 to 93%, which is wider than the 66-78% recorded 
for the granules 'a' and 'b'. The higher rates of kill were thought 
to reflect the presence in some raw materials, of a greater 
proportion of organisms showing a high susceptibility to the 
killing effect of compression. As has been shown in this study 
the susceptibility of different microbial groups to this killing 
effect varies. 
253 
Providing the active ingredients and excipients are suited 
an increasingly wide range of tablets are manufactured following 
a direct compression process. This process is usually quicker 
and simpler than the traditional aqueous and solvent granulating 
process. The significant point is that in the direct compression 
manufacturing process, the compression stage is the only 
stage in the process exerting an anti-microbial effect. 
The organisms that are present in the raw material, and survive 
the granulation stage may be killed at the compression stage 
by a combination of two events. First, the compression force 
of up to 5 tons, generates heat: the temperature of tablets 
immediately after compression was estimated as being 40-
500C. Secondly, the process will give rise to shearing forces 
as crystals tear across each other, this will cause mechanical 
damage to cells. 
These studies emphasise the importance of checking raw 
materials as well as final products for the presence of specific 
pathogens. Although the compression process will reduce 
the number of such organisms it cannot be relied to kill them. 
In fact, the possibility is that the chance of detecting these 
organisms in samples of the final product is considerably 
reduced. This underlines the need to monitor raw materials 
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to ensure that the final product is free of potential pathogens. 
Processes have been discussed which decrease the level of 
microbial contamination present in the final tablet but there 
are also stages which may increase the nurriber of contaminants. 
Contact with process operators, the atmosphere and equipment 
during the manufacturing process will obviously increase 
levels of contamination. However, in a modern hygenic manufacturing 
plant the contribution made to the final microbial count should 
be small in relation to that from the raw materials. During 
manufacture the greatest risk of significant increases in microbial 
contamination occurs during stages which utilize aqueous 
solutions. This is usually during aqueous granulation. Growth 
may occur in the granulating solution or in the damp granule. 
Kallings et a! (1966) suggest granulation stages may provide 
excellent conditions for bacterial growth. 
In this study granulating solutions were identified, with high 
total viable counts and containing enterobacteria such as 
Klebsiella and Proteus. In contrast solutions containing a 
preservative such as sodium benzoate were largely free of 
contamination. Granulating solutions were usually stored 
for a number of days as sufficient solution was manufactured 
----------------------------·-----------
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for several tablet batches. This time is obviously sufficient 
to allow the count to increase, therefore, it is important 
solutions are freshly prepared and only solutions containing 
a preservative be considered for storage. 
There are many references to Gram negative species, such 
as Klebsiella and Pseudomonas, multiplying in the presence 
of recognised antimicrobials (eg Kelsey and Maurer 1966, 
Burdon and Whitby 1967, and Baird et al1976). Granulating 
solutions may contain materials such as gum acacia which 
have been demonstrated to be regularly contaminated with 
Gram negative species, therefore, it would seem a wise precaution 
to freshly prepare even preserved solutions. 
Also in the studies on tablet intermediates it was interesting 
to note that the 'tablet granules' examined had viable counts 
in the range of less than 10 g -l to 2~0 g - 1, even though the 
granulating solution used contained 106 g-1• On this basis 
the count of the granule should have been over lOOOg-1• 
The reduction in count was thought to be due to the presence 
ot an active ingredient with antimicrobial properties (dequalinium 
chloride) and also to the granule drying process. It was significant 
though that Klebsiella a contaminant of the granulating solution 
could still be recovered from 1 Og samples of the dry granule. 
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This provides further warning of the advantageous rather than absolute 
nature of certain antimicrobial processes inherent in tablet 
manufacture. 
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4.8 Studies on Pseudomonas contamination of creams 
As discussed in Section 4.1 seven filled batches of one type 
of cream, were found to be contaminated with Ps aeurginosa. 
Studies in this part of the thesis were related to determination 
of, the source, the cure and the significance of this serious 
contamination problem. 
4.8.1 Sources of Ps aeruginosa 
Investigation of the manufacturing and filling facility revealed 
modern well kept areas which were always clean and tidy. 
All water supplies were found to be free of Ps aeruginosa, 
before, during and after the contaminated batches were prepared. 
In contrast, Baird et al (1976) working in hospital pharmacies, 
identified distilled and tank water as sources of Ps aeruginosa 
found as contaminants of creams. 
·However, in this study Ps aeruginosa and other pseudomonads 
were frequently isolated, from moist sites in the purpose built 
equipment wash room, from sink drains and from floor cleaning 
equipment. Twice weekly disinfection of the wash room with 
hypochlorite solution virtually irradicated these organisms, 
except for occasional isolates recovered from sink drains and 
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sink water traps. Improved control of the cleaning equipment 
(eg storing mops dry) drastically reduced isolations from this 
source. I 
After instigation of the disinfection treatment no further 
batches of cream were found contaminated with Ps aeruginosa. 
Although disinfectants can inhibit growth of Ps aeruginosa 
and other pseudomonads, correct design of the manufacturing 
facility is the only real solution for effective control. Even 
if initially successful, use of disinfectants can provide a dangerous 
false sense of security. Pseudomonads are well known for 
their ability to proliferate in the presence of many disinfectants 
(Baird et a11976, Burdon and Whitby 1967), so choice of the 
correct disinfectant is important. Disinfection procedures 
may easily be neglected or inadequately controlled, once 
an initial contamination problem has been solved. Subsequent 
incorrect dilution, handling or application may all result in 
ineffective disinfection. North (1980) suggests, when a process 
operator decides a surface requires disinfection, as many 
as 23 correct decisions are needed, before disinfection can 
be guaranteed. 
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The wash area for the cream manufacturing equipment was 
demonstrated as an ideal situation for pseudomonad growth. • 
This is not surprising as the area was enclosed and used for 
steam cleaning and high pressure washing, causing many surfaces 
to remain continually moist. 
A correctly designed area should have, good ventilation, 
which ensures surfaces dry out at the end of each day, and 
no cracks, crevices, fixed pipework or porus surfaces which 
act as traps for water and dirt. Inclusion of a waste trap 
heater in all sinks should also control this source of Ps aeruginosa 
(Ay liffe et a! 1974). 
Finally to ensure there are no locations within a topicals 
. 
manufacture area in which Ps aeruginosa is proliferating, 
a regular monitoring programme should be adopted, similar 
to that followed in this study. High counts of other Pseudmonas 
species should also serve as a warning that other pathogenic 
pseudomonads such asPs cepacia could contaminate the preparations 
manufactured. 
4.8.2 Survival of Ps aeruginosa in various creams 
To ensure that future contamination ·problems were avoided, 
even though Ps aeruginosa was not isolated from creams after 
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the disinfection programme commenced, it was considered 
essential to demonstrate why only one steroid cream ('b') 
was susceptible to contamination. 
Except for preparations containing propylene glycol, the other 
creams studied differed mainly in the active ingredients present. 
Steroid cream 'a' differed from 'b' only in type of corticosteroid 
incorporated and pH, the respective values being 5.0 and 7 .3. As 
Ps aeruginosa had not been isolated from 'a' even though more 
batches had been examined, studies were centred on the effect 
pH may have on susceptability to contamination with Ps aeruginosa. 
The challenge inoculum used was not a laboratory culture 
but a cream contaminated with Ps aeruginosa (228). Growth 
of the inoculum, in commercial creams or the laboratory 
prepared 'standard' cream, was recorded only in creams of 
pH 7.2-7.6, this included steroid cream 'a' in which the pH 
had been increased from 5.0 to 7.3. No growth was detected 
in creams of pH 4.3-6.2, this included steroid cream 'b' in 
which the pH had been decreased from 7.3 to 1;.8. The length 
of time the challenge inoculum survived also decreased with 
decrease in pH. 
The result obtained was anticipated as growth of Ps aerugionsa 
will be inhibited as the pH decrease below 7. In studies using 
--·· -------------------
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nutrient broth, strain 228 proliferated at pH 5 but not at 
pH 4.5. The activity of chlorocresol (the preservative used 
in all the creams studied) also increased with decrease in 
pH, due to increased disassociation of the molecule, at acid 
pH (Russelll974). 
On the basis of these studies, steroid cream 'b' was manufactured 
to pH 5.0-5.3 rather than 7 .3. No subsequent contamination 
problems were encountered, but at this time the major source 
of Ps aeruginosa had been remov'ed, so risk of contamination 
was reduced. 
It is essential creams are manufactured to standards which 
minimise microbial contamination, especially w_ith pathogenic 
or spoilage organisms, and also that creams are formulated 
to minimise the probability of such organisms surviving or 
proliferating. The studies so far have identified and attempted 
to rectify deficiencies in both these areas. 
Significant points relating to quality control also emerged 
from the challenge studies on creams so this aspect was considered. 
It is usual for challenge inocula to decrease in viable count 
when introduced into a test environment, even if proliferation 
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subsequently occurs. During this phase, resistant cells are 
selected and adapt to the new environment. In this study 
the decrease in viable count of Ps aeruginosa after inoculation 
into cream, was particularly severe; after 48h decreasing 
by over 90%, and in certain cases below the detection level 
of the enrichment and viable count recovery procedures used. 
Pseudomonas aeruginosa then either remained undetected 
or proliferated to levels as high as 105 g -l. If production 
batches of creams contaminated with Ps aeruginosa follow 
similar growth curves with similar time scales, there is a 
possibility contaminated batches could be missed. The growth 
curves were variable with the depressed count extending 
from 7 to 56 days before proliferation subsequently occurred. 
Growth patter~s may.be more variable with other strains 
and different creams, so the Jag time could be even further 
extended. It is significant to note that a decrease in viable count 
was also observed in batches of the commercial cream found 
to be contaminated with Ps aeruginosa. From 7 contaminated 
batches, 5 of the subsequent repeat tests were negative or 
showed a reduced count. ' 
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These results pose a problem for the Quality Controller who 
must therefore decide the optimum time for sampling a cream, 
to detect contaminants entering during manufacture or filling. 
A point which does not seem to have been considered in other 
studies or reviews on the testing of non-sterile pharmaceutical 
preparations. 
If samples are taken when the count is depressed, the number 
of organisms present may be below the sensitivity of the 
detection procedure used. A contaminated batch could be 
passed as satisfactory and days later be heavily contaminated. 
On the basis of the results from the survival studies, samples 
should be taken and examined as soon as possible after manufacture 
or filling. However, some reservations must be p~aced against 
the possibility of obtaining a representative sample from 
bulk quantities of cream. This is demonstrated by the 6 out 
7 negative results obtained from bulk samples of commercial cream, 
all shown to be positive for Ps aeruginosa after filling. This 
difference may be due to local pockets of infection which 
are dispersed during filling, spreading the contaminants and 
increasing chances of detection. 
In addition to ensuring sampling is timed correctly, there 
are five other significant points to emerge from these survival 
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studies related to the quality control testing of creams. 
Firstly, it is important samples taken for microbial analysis 
are examined immediately. 
Secondly, repeat tests to confirm a positive result are likely 
to be negative. However, this is no justification for assuming 
the organism has died out or that the first test was invalid. 
Tests on material suspected of or sensitive to contamination 
with pseudomonads should be performed in duplicate initially. 
Thirdly, to ensure proliferation has not occurred, additional 
tests should be performed on creams 2 months after filling. 
However, if incorporated into a batch release specification, 
commercial restraints are likely to prevent routine implementation 
of such a control. 
Fourthly, this study emphasises the significance of recovering 
a single colony forming unit of Ps aeruginosa, from a batch 
of cream. Even if repeat tests are negative only a prolonged 
and extensive study may prove the material satisfactory. 
It is not sufficient to culture the isolate and challenge the 
cream, as a negative result is inconclusive and does not prove 
the organism will die out. In this study Ps aeruginosa strain 
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228 would only infect. creams if the inoculum used was another 
sample of cream contaminated with the proliferating organism. 
Fifthly, good aseptic technique is particularly important when 
testing creams. If Ps aeruginosa is isolated as an incidental 
test contaminant, eg from a water bath, a prolonged investigation 
would be required to prove the cream satisfactory and rejection 
of the complete batch is risked. 
The problems involved in effective testing of creams for 
Ps aeruginosa contamination emphasise that absence of this 
or any other organism is not proved by microbiological testing. 
As with other pharmaceutical preparations, quality must 
be built in by 'Good Manufacturing Practices' and correct 
formulation. However, these requirements do seem particularly 
pertinent to creams. 
In this study on the survival of Ps aeruginosa in various creams, 
the BP procedure for determining the 'Efficacy of Antimicrobial 
Preservatives in Pharmaceutical Preparations' (Advance notice 
of Appendix for BP 1980) or comparable procedures in the 
USP XIX, were not followed. Notable differences being, 
the level of challenge used, ie 103 organisms g-1 rather than 106 
as specified in the BP, and the method of culturing the test 
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organisms, ie in cream or in a cream Ringers mixture rather 
than nutrient media as specified in the BP. However, observations 
were made which were relevant to these stated methods. 
The BP suggests challenge tests with Ps aeruginosa NCTC 
6750 and both the BP and USP suggest challenges be performed 
with environmental isolates which could contaminate the 
product during manufacture. In this study Ps aeruginosa 
NCTC 67 50 and two environmental isolates of Ps aeruginosa, 
cultured in a cream Ringers mixture, failed to infect a cream 
shown to support the growth of Ps aeruginosa 2281 previously 
cultured in cream alone. Similarly, Ps aeruginosa 228 when 
cultured in a cream Ringers mixture was not infective. 
The BP and USP suggest topical preparations are monitored 
for survivors up to a minimum 28 days after inoculation. 
In this study periods of over 40 days elapsed before proliferation 
was observed, it would seem worthwhile to extend the 28 
day period to a minimum of 56 days. 
The aim of this study was not to evaluate the test procedures 
given in the BP and USP. However, the results obtained serve 
to emphasise the significance of the source of the challenge 
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inocula and its method of culture on the ability of a test 
organism to proliferate. Although recognising the need to 
use standard organisms and procedures, surely such compendia 
should place greater emphasis on the need to chose a challenge 
inoculum which may have a chance of proliferating. As 
shown in this study, an ideal source is a contaminated preparation 
of similar formulation to the material under test. The results 
also indicate how easy it is to obtain a false picture about 
the preserved state of cream by choice of either the wrong 
challenge organism or incorrect cultural conditions for that 
inocula. 
4.8.3 Examination of the antibacterial activity of a number of 
creams 
The study on survival of Ps aeruginosa in creams emphasised 
the problems facing a Quality Controller in demonstrating 
·a batch of cream to be free of harmful or spoilage organisms. 
An attempt was made to reduce these problems at least 
in part. A sensitive procedure, developed in this study, for 
detection of micro-organisms in creams has already been 
discussed (section 4.6). Such a technique is obviously of 
value in detecting low levels of pseudomonad contamination. 
It has been suggested already in this thesis (Section 4.1.4 ), 
that raw materials and final preparations be placed in groups 
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which determine whether continual, intermittent or no microbiological 
monitoring is required. To help assign different types of 
creams to an appropriate group. Knowledge of the materials 
inherent antibacterial activity is of value. 
The results from the challenge studies and the microbiological 
analysis of production samples, demonstrated that creams 
formulated with propylene glycol had increased resistance 
to microbial contamination, compared with other creams 
tested. Only species of Bacillus were isolated from production 
samples and the Ps aeruginosa 228 challenge inocula was 
rapidly killed. So apart from pharmacological reasons, there 
is obvious benefit in formulating creams with propylene 
glycol, which is known to possess antimicrobial properties 
(Robertson et a! 1948). This suggests microbial examination 
of such creams for quaity control purposes need only be 
intermittent. 
Creams were examined directly by microbiological assay 
(agar diffusion), to determine if such a technique was suitable 
as a rapid method for identifying preparations exhibiting 
definite antimicrobial activity. The seed organisms chosen 
were species of Pseudomonas (including Ps aeruginosa), environmental 
isolates and mixed cultures from stored water samples. 
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Creams containing propylene glycol or neomycin produced 
obvious zone of inhibition, but not all test organisms were 
inhibited by neomycin and in certain cases resistant colonies 
were visible within the zones of inhibition. The other creams 
tested showed no activity. This does not necessarily mean 
these creams are more susceptible to microbial contamination, 
not all antimicrobials will diffuse into agar. However, the 
technique does indicate which creams may be least susceptible 
to microbial contamination. Having this information, the 
limited resources of a Quality Control laboratory can be 
biased to testing creams which may be at greater risk. This 
may be important when first instigating a Quality Control 
programme to monitor either pharmaceutical or cosmetic 
creams. 
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4.9 Survival of micro-organisms in propylene glycol held in sealed 
ampoules and heated to 115°C and 121 °C in an autoclave 
To minimise the risk of microbial spoilage and contamination 
of topical pharmaceutical preparations, the Nordic Pharmacopoeia 
requires these preparations to be manufactured and filled 
aseptically, ie using procedures normally reserved for parental 
preparations. To supply markets adhering to this compendia 
the manufacturer must supply creams to this standard. 
The sterilisation, by heat, of propylene glycol one constituent 
of certain sterile creams was examined. It was hoped that 
sterilisation of propylene glycol, the base for a steroid cream, 
would be the first stage of an aseptic manufacturing process 
and that it could be achieved at 115°C. This temperature 
was chosen as the BPC 1973 states, 'Propylene glycol is 
sterilised by heating in sealed ampoules in an autoclave'. 
In our studies using propylene glycol held in sealed ampoules, 
laboratory cultures of B subtilis var globigii and Bacillus 
201 (laboratory isolate), dried onto the powder 'Hyflo', were 
most susceptible to kill, no survivors being detected after 
30 minutes exposure. However, species of soil Bacillus (not 
laboratory cultured) demonstrated much greater resistance, 
survivors being detected after 90 minutes exposure. 
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Bacillus species from the soil showed increased resistance 
as compared to soil fungi. Bacillus and Actinomycetes showed 
a similar degree of resistance but strict comparisons were 
difficult as initial challenge levels were different, as would 
be expected when using a natural system. 
The validity of the statement as it stands in the BPC 1973 
seems in doubt. Bacillus and Actinomycetes from soil were 
detected after 90 minutes exposure at 115°C and Actinomycetes 
were detected even after 30 minutes at 121 °C. The BPC 
should provide details of the sterilisation time and temperature, 
results from this study suggests, a temperature of 134 °C 
could be required to obtain a realistic sterilisation time with 
an adequate safety margin. Alternative methods of sterilisation 
such as filtration or dry heat at 150°C are probably more 
satisfactory options. 
A soil challenge is an exacting test of a sterilisation process 
but is more realistic than the artifical challenge of laboratory 
prepared cultures. It would be expected that a large proportion 
of the natural contaminants of propylene glycol will be associated 
t 
with particulf matter, so to be realistic similar organisms 
should be used in the challenge. 
--------------
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In the cream manufacturing process it was hoped to sterilise 
50Kg lots of propylene glycol. If the propylene glycol is only 
contaminated with 2 organisms g -l the resultant count will 
be 105 per 50 Kg. This study has shown that with a total challenge 
in excess of I05organism, sterilisation at 115°C for 1 j-hours 
cannot be guaranteed especially if the count was made up 
predominantly of Bacillus and Actinomycete species. 
In this case it was decided to use a filtration procedure for 
, sterilisation of propylene glycol. 
As a consequence of these studies, a technique was developed 
for preparing 'a dry' inoculum of a laboratory spore suspension 
in propylene glycol. The technique proved simple to carry 
. 
out and provided high inoculum levels. The procedure should 
be suitable for contaminating any liquid which requires to 
be challenged with an inoculum free of water, and if required 
the inoculum can also be dryed onto particulate matter. 
I 
5 CONCLUSIONS 
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Unless manufactured aseptically pharmaceutical preparations will contain 
microbial contaminants. The types or levels of contamination which 
may present a risk to the patient have been the source of considerable 
discussion. However, it has been recognised by many regulatory authorities 
that limits are necessary, particularly for the absence of named pathogens. · 
This study has looked at levels and types of microbial contamination 
in certain non-sterile pharmaceutical preparations and at the contributions 
made to this level by the raw materials used and by certain manufacturing 
processes. 
In order to determine levels and types of contamination accurately, suitable 
. methadology is required. This study has attempted to evaluate techniques 
available and where· neces7ary develop alternatives. When evaluating 
existing techniques or validating the new techniques developed, emphasis 
was given to using the 'natural', non-laboratory cultured contaminants 
of the respective raw material or final preparation. 
The whole study has been viewed mainly from the standpoint of quality 
control and quality assurance of commercial pharmaceutical production, 
but the findings should be relevant to hospital pharmacies and also 
to aspects of cosmetic and food manufacture. 
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The majority of final preparations examined had low total viable counts 
and were free of any pathogenic species, however, the occasional identification 
of a preparation containing organisms which may be considered hazardous, 
demonstrates that such testing is worthwhile and should be continued. 
Flaum (1978) states 'Perhaps the most essential single factor that can 
guarantee the quality of a drug product is high quality raw materials\ 
Due emphasis was given in this study to the microbiological examination 
of raw materials. On the basis of the results obtained a testing programme 
is proposed for the range of materials examined (Table 118). This divides 
raw materials into 3 categories which determine the frequency with 
which incoming batches are examined. The resources of the laboratory 
can then be concentrated on materials presenting the greatest risk. 
It was proposed, three raw materials be considered for specific microbial 
limits in a future edition of the BP. It is interesting to note that for 
one of these, gum acacia, the BP 1980 (introduced subsequent to the 
completion of these studies) now includes a limit for E coli contamination. 
Comparisions of alternative enrichment and plating medias for the examination 
of raw materials identified differences in efficiency; on the basis of 
these studies a procedure for the examination of raw materials is proposed 
(Figure 9). Jt was demonstrated in this study that total viable count 
Table 48 
a 
b 
c 
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Test Scheme for Raw Materials 
Do not require monitoring 
Arachis oil 
Betamethasone powder 
Calcium phosphate tribasic 
China clay 
Citric acid 
Glucose 
Glyceryl monostearate 
Liquid paraffin 
Magnesium stearate 
Inorganic chemicals 
Propylene glycol 
Surface active agents 
Talc (sterilised) 
Vitamin Bl2 
Require intermittent monitoring (eg every 5 batches) 
Cellulose 
Lactose 
Sugar 
Colourings 
Require every batch monitoring 
*Aluminium hydroxide magnesium carbonate gel 
Cocoa powder 
Gelatin capsules 
Gelatin powder 
Gum acacia 
Maize starch 
Potato starch 
Shellac orange 
Dried yeast powder 
*BP (1973) requirement. 
There was insufficient data to assign bone meal or flavourings to an appropriate 
group. 
Fig 9 
Enterotube 
Enterobact-
eriaceae 
Suggested procedure for microbiological 
examination of raw materials 
/ITest Sample 
Nutrient broth 37° /24h 
MacConkey 
broth 44°/24h 
Indole production 
44°/24h 
~ 
faecal 
streptococci 
DCA, Brilliant Balrd 
Green and Bismuth Parker 
SulPhite agars 
37 /24h 
agar 37° /24h 
Salmonella S aureus 
Nutrient broth 31° /24h 
Pseudosel 
'agar 31° /48h 
Pseudomonas species/ 
Ps aeruginosa 
*12-18h may give better results if overgrowth with Pseudomonas is a problem. 
#A lOg sample suspended or dissolved in a suitable vehJ:cle should also be examined for total viable count, 
----------------------------------------
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or detection of enterobacteria can be useful pointers to E coli or pseudomonad 
contamination, so these tests were included in the scheme. Although 
similar conclusions were not drawn about the value of faecal streptococci 
as indicators, they are accepted as being indicative of faecal pollution, 
so the test was included. 
Worthy of particular note is the failure of 0.03% cetrimide broth to detect 
Ps aeruginosa as a contaminant of raw materials, this is the recommended 
medium in the BP 1973 and has been retained in the BP 1980. Nutrient 
broth proved the most efficient alternative and should be specified in 
the next edition. In fact, nutrient broth was found to be as effective 
or more effective than all others examined for detection of E coli, Salmonella, 
other enterobacteria, faecal streptococci and pseudomonads. In the 
proposed test procedure, two nutrient broth enrichments are required 
each at different temperatures, further studies could demonstrate a 
single incubation temperature and hence just one enrichment was sufficient. 
Due to dissatisfaction with certain existing procedures, a number of 
alternatives were developed for the examination of specific raw materials 
or final products. 
The membrane filtration procedure developed for the examination of 
gelatin samples involved the use of enzymic solubilisation, this had no 
antimicrobial effect and overcame disadvantages found with direct enrichment 
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techniques or non-enzymic filtration. 
For microbiological examination or sterility testing of ointment preparations 
membrane filtration offers advantages over direct enrichment techniques 
as micro-organisms retained on the membrane can be separated from 
oily material. The filtration procedure developed in this study, designated 
technique 'D', had advantages over existing filtration techniques both 
in terms of the greatly increased quantity of material that could be tested 
and the consistency and reproducibility of the technique. The technique 
was shown to be suitable for sterility testing, as contamination levels 
of 1-2 organisms g -l were detected when testing a 20g sample. Advantages 
were also demonstrated over the BP (1973) sterility test procedure for 
eye ointments. Subsequently technique 'D' has been used for the routine 
sterility testing of a range of ointment preparations, including veterinary 
intermammary injections, otherwise tested by direct inoculation (British 
Veterinary Pharmacopoeia 1977). 
The technique developed for preparation and use of dry airborn micro-
organisms and used in validation studies of technique 'D', provided an 
inoculum suitable for quantitative determinations and which was typical 
of contaminants that may be found in a pharmaceutical preparations. 
Such an inoculum should be useful 'in other studies requiring a 'realistic' 
challenge system. 
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The manufacturing process for non-sterile pharmaceutical preparations 
may result in an increase in levels of microbial contamination, as demonstrated 
in studies on creams or aqueous tablet intermediates. In contrast, tablet 
compression was shown as causing a significant reduction in microbial 
contamination. The extent of kill varied for different microbial groups. 
It was significant that enterobacteria, the contaminants presenting most 
risk in an oral preparation were most susceptable. 
Studies on Ps aeruginosa contamination of creams demonstrated how 
the manufacturing environment and product formulation can lead to 
a serious contamination problem. Fortunately, in this case, the problem 
was detected and the situation rectified. However, the growth/survival 
studies carried out as part of this study, using a non-laboratory cultured 
I 
Ps aeruginosa contaminant from a cream, demonstrated how such contamination 
could be missed. The time at which samples are taken is critical, and 
the subsequent interpretation must be performed by a person appreciative 
of the significance of recovering even a single colony forming unit. 
A sensitive procedure was developed for detection of contaminants in 
cream, this is obviously of value when, as demonstrated, even low levels 
of contamination (less than Jg -I) may eventually proliferate. Also, a procedure 
is suggested for rapid screening of creams to identify those which could be 
sensitive to microbial spoilage. In the absence of previous microbiological 
data this information could be of value. 
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Certain regulatory authorities require all topical preparations to be manufactured 
aseptically.· Studies on sterilisation of propylene glycol, a base for a 
sterile cream, lead to the observations which cast doubts on the validity 
of the BPC (1973) (and now The Pharmaceutical Codex 1979) statement 
that propylene glycol could be sterilised by heating in sealed ampoules 
in an autoclave. Membrane filtration is a more practical alternative. 
The technique developed in this investigation for contamination of non 
aqueous liquids with dry laboratory spores may be of value in other similar 
studies. 
In this thesis, inevitably, only a limited number of aspects relating to 
the microbiology of pharmaceutical preparations could be studied. Besides 
identifying problems attempts have been made to provide solutions. 
Hopefully, this information will prove of value to others researching 
the subject or those directly involved with microbiological quality control 
of pharmaceutical manufacturing processes. 
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APPENDIX 
1 Statistical calculations 
1.1 Students t-distribution, paired variates (Alder and Roessler 1964) 
t = D- md 
s-d 
satisfies a Student's t-distribution with n-1 degrees of freedom, 
where 
s-d 
n 
= mean of variable D 
= number of variates 
D = difference between each pair of variates 
D = · mean of the population of D values (sample mean) 
sd = estimate of the standard deviation of the population 
of differences 
sd = best estimate of the standard deviation of the mean 
of samples of n variates 
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1.2 Confidence limits (Alder and Roessler 1964) 
2 
ands-=s xrn 
Therefore m = X +ts-
- X 
m = mean of variable X 
x = population mean 
n = number of variates 
s = estimate of the standard deviation of the population 
s- = best estimate of the standard deviation of the mean X 
of samples of n variates 
t = t value for n-1 degrees of freedom corresponding 
to the probability value required, for the two tail 
areas, obtained from tables. 
D values 
This is the time in minutes required to kill 90% of micro-organisms. 
It was calculated using the following formula: 
D = U 
Jog a -log b 
3 
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U = time in minutes to decrease the number of micro-organisms 
from a to b (Ub - Ua) 
a = number of micro--organisms at time Ua 
b = number of micro-organisms at time Ub 
Media 
Medium A; 
Peptone 6.0g 
Lab Lemco powder 4.0g 
Yeast extract 3.0g 
Beef extract 1.5g 
Dextrose l.Og 
Distilled water To 1 litre pH 6.6 
Medium B; 
Same as Medium A except that Lab Lemco powder has been 
omitted. 
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Effect of tablet compression on the microbial content of granule 
ingredients 
K. A. C. Chesworth, A. Sin clair, A, J. Stretton* and W. P. Hayes* 
Glaxo Laboratories Limited, Barnard Castle, CountY Dllrham, Great Britain, and •Department 
of Chemistry, University of Technology, Loughborough, Leicestershire, Great Britain. 
Abstract 
The compression stage in the manufacture of pharmaceutical tablets was found to reduce the 
total viable microbial count of the tablet granules by about 70%. There was also a significant 
reduction in the level of lactose fermenting enterobacteria. 
Introduction 
A report by the Royal Swedish Medical Board concluded that an outbreak of salmonel-
losis in Sweden was due to thyroid· tablets contaminated with Salmonella (Kallings et al., 
1965, 1966). The source of the organism was traced to imported thyroid powder. This 
report created considerable interest in the types and levels of microbial contamination 
likely to be present in other tablets. 
Fischer, Fuglsang-Smidt and Ulrich (1968), and Fuglsang-Smidt and Ulrich (1968), 
examined 696 batches comprising 237 different types of tablets. They found only 53 
batches had total viable counts of over 100 bacteria/tablet, and failed to isolate either 
Escherichia coli or Salmonella from even the most contaminated batches. Only nine 
of their batches had total viable counts in the range of 104 to 10" organisms per tablet. 
Similar results have since been obtained by Gallien (1972), and earlier by Kallings et 
aL (1966), although Kallings did isolate Escherichia coli from a batch of calcium lac-
tate tablets. 
Sykes (1971) reviewed the control of microbial contamination in oral and topical 
pharmaceutical products, with special reference to raw materials. He drew attention 
to the high levels of contamination present in some natural active ingredients and other 
materials used in tablets, e.g. starches, talc and water. 
Studies on raw material commonly used in tablets were made by Pedersen and 
Ulrich (1968), Buhlman et al. (1972), and Kruger (1973). The materials included lac-
tose and magnesiumstearate, which usually had low total viable counts, whereas 
materials such as gelatin and gum acacia were found to be variably contaminated, with 
counts ranging from 10 to 104 organisms/g. 
Except for the work of Schiller et al. (1968), previous studies have been limited to 
the microbiological quality of the raw materials or the final tablets. Schiller reported 
how the microbiological state of active ingredients of animal and plant origin could 
improve during the chemical treatments required to prepare them for incorporation 
into a tablet. 
In this present study, the compression stage in .tablet manufacture was investigated 
to determine its effect, if any, on the microbial content of the tablet fmally produced. 
Materials and methods 
Tablet granules 
Two different types of granule were used in the experimental work. The composition 
41 Microbios Letters 1977 4 41-45 
of granule a was 84% dried yeast powder (inactive), !I% maize starch and 5% tribasic 
calcium phosphate. Granule b contained 60% lactose, 22% gum acacia, 1% gelatin 16% 
maize starch and 1% magnesium stearate. Active ingredients were omitted in each in· 
stance. 
Granule a was simply a dry blend of the specified ingredients; granule b was pre-
pared by a 'wet' granulation process. The different granules were compressed on 
differing types of machine: granule a on rotary punch equipment (Manesty D, pro-
ducing 400 tablets/min) and granule b on a single punch machine (Manesty F). Repli-
cate samples were taken from each batch of granules before compression, and from 
each batch of tablets immediately after compression. 
The natural microbial con tarninan ts of the raw materials incorporated in granule 
a and b were used to assess the antimicrobial effect of compression, no laboratory 
cultures were added. The addition of dried or aqueous inocula to sterilized ingredients 
was thought unrepresentative of the condition of contaminants present in actual pro· 
duction granules. 
Microbiological examination 
Counting methods: samples (I 0 g) were suspended in 0.1% peptone water (90 m!) 
and placed on a rotor arm shaker (250 rpm) for 20 min so that the tablet or granule 
was fully dispersed. Two replicate samples of the granules and of corresponding tablets 
were accommodated on the shaker on each occasion. Four 1 m! samples were taken 
from each suspension and their viable counts were determined by using the pour plate 
technique. 
Tryptone soya agar USP (Oxoid) was used to estimate the total viable counts and 
the Bacillus counts. For the latter, samples were first 'heat shocke.d' at 80°C for 1 min 
(Harrewijn et al., 1972) before plating out. Sabouraud agar (LAB M) was used for 
estimating fungal counts, and MacConkey agar number 2 (Oxoid) for lactose ferment-
ing enterobacteria (Cowan and Steel, 1974). 
Total viable count plates were incubated at 31°C for 48 h to determine the bac-
terial count, then at 25°C for a further 72 h to determine the fungal count. Sabouraud 
agar pour plates were incubated at 25°C for 96 h, MacConkey agar pour plates at 37°C 
for 48 hand Bad/Ius count plates at 31 °C for 48 h. 
A further assessment was also made of the survival oflactose fermenting enterobac-
teria. Replicate 1 g or lOO mg samples were examined, using a modification of the BP 
1973 test for Escherichia coli. The samples were enriched in 100 ml of nutrient broth 
and subcultured into MacConkey' purple broth (Oxoid). After this secondary enrich-
ment, all samples showing acid, or acid and gas, were subcultured on to MacConkey 
agar number 2 (Oxoid). Following incubation at 37°C for 24 h, all suspect colonies 
were examined using enterotubes (Roche Diagnostics). 
Results 
As Table I shows, a consistent reduction in total viable count occurred during com-
pression in all the a type granules, the mean reduction being 71%. A similar value, 
72%, was obtained using the b type granules. 
The mean reduction in fungal count during compression, using granule b, was esti~ 
mated to be 75% (Table 2). Fungi commonly isolated before and after compression 
were species of Penicillium, Aspergillus, Alternaria, Cladosporium and Mucor. 
42 Microbios Letters K. A. C. Chesworth et al. 
• 
r, 
------------------------------------------------------------------------------------ -
• 
Table 3 Effect of tablet compression on lactose fermenting enterobacteria in 
granule b 
Batch number 
of granule b 
2 
3 
Replicate 
samples 
13 
8 
6 
Samples positive for lactose fermenting 
enterobacteria: 
Granule Tablet 
13 
8 
6 
3 
Batch 1: 1 g samples. Batches 2 and 3: 100 mg samples, Lactose fermenting enterobacteria 
detected by primarY enrichment of samples in nutrient broth (BP I and by secondary enrichment 
in MacCont<ey broth (BP). Samples showing acid or acld and gas subcultured on to MacConkey 
agar. Lactose-fermenting isolates examined via enterotubes. 
Discussion 
The total viable count of the granule drops during compression. This drop can be 
quite. significant when control limits of either lOO or 1,000 micro-organisms/g are 
placed on some tablets by the manufacturer, purchaser or regulatory authorities. A 
raw material that may fail initial microbiological standards can be.used to manufac-
ture a product that will then comply with the specified limits. :rhe granules selected 
for this study had total viable counts ranging from I ,900 to 2,800 organisms/g. where-
as tablets manufactured from these showed counts ranging from 470 to 760/g. The 
tablets though, not the granules, would satisfy a limit of 1,000 organisms/g. 
The total viable count of the tablets is higher than should normally be expected. 
The majority of different tablets examined by Kallings et al. (1966), Fischer et al. 
(1968), Fuglsang-Smidt and Ulrich (1968), and Gallien (1972), had counts ofless 
than 100 organisms/g or tablet. For our study, however, the raw materials were spec-
ificaliy selected for their high total viable count in order that the resulting count of 
the granule would be high enough to provide quantitative data on the effect of com-
pression. 
A significant point to emerge is that fungi can be killed by the compression pro-
cess. The importance of this is that given the correct conditions of humidity, some 
species cause spoilage problems in tablets. 
The fact that the numbers of enterobacteria were reduced during compression is 
also important. Although no pathogenic species was isolated from the tablets, this 
group of bacteria includes intestinal pathogens such as Escherichia coli and Salmonella 
which must be excluded from pharmaceutical products (United States Pharmacopoeia, 
XIX; British Pharmacopoeia, 1973; Stott et al., 1975). 
A routine analysis of total viable counts from a range of different tablets further 
demonstrated the effect of compression. Over 80 batches were examined of one par-
ticular tablet having a composition similar to that of granule a. The total viable counts 
both of the tablets and their raw materials were checked. The manufacturing process 
was very simple, involving no anti-microbial treatments of the raw materials but just 
simple blending followed by compression. The fall in total viable count for the tablets 
came within the range 67-93% (unpublished observations), which is a wider range 
44 Microbios Letters K. A. C. Chesworth eta/. 
r---------------------------------------- - -
l 
" 
Table 1 Effect of tablet compression on total viable microbial count of 
granules used 
Replicate Mean total viable 
Type of Batch number samples count per g %reduction 
granule of granule examined Granule Tablet in tvc 
a 4 2,230 670 70 
a 2 4 1,930 660 66 
a 3 4 2,170 470 78 
b 9 2,760 760 72 
b 2 5 2,420 680 72 
b 3 5 1,920 520 73 
Granule a is based on a mi>:ture of dry yeast powder, maize starch and tri-basic calcium phosphate. 
Granule b is based on a mixtun~ of lactose, gum acacia, gelatin, maize starch and magnesium 
stearate. 
Total viable counts estimated from pour plates prepared from tryptone soya agar. 
The compression process did not select entirely for sporulating bacteria. Vegeta-
tive bacteria could also be detected in tbe tablets, including Staphylococci, Streptococci, 
non-sparing Gram-positive rods and Gram-negative rods. The reduction in Bacillus 
count estimated from granule b was 64% (Table 2). 
There was evidence of a considerable decrease in tbe number oflactose-fermenting 
enterobacteria. As Table 3 indicates, among 27 replicate enrichments of both granule 
and tablet, all 27 granule samples were positive for these organisms while only five 
positive results were obtained from the tablet. All these enterobacteria were found 
to be Enterobacter or Citrobacter species. This result was oonfrrmed by quantitative 
estimation of lactose-fermenting enterobacteria using MacConkey agar pour plates 
(Table 2): a maximum reduction in viable count of99%was obtained during com-
pression of granule b. 
Table 2 Effect of tablet compression on fungi, Bacillus and lactose fermenting 
enterobacteria in the granule 
Lactose fermenting 
Fungi Bad/1(.1$: enterobacteria: 
%reduction %reduction % reduction in 
Batch no. Replicate in mean Replicate in mean Replicate mean viable 
of granule b samples viable count samples viable count samples count 
4 78 3 61 6 98 
2 6 73 3 66 7 99 
Counts estimated from pour plates prepared with the following media: Sabouraud, trVpton soya 
and MacConkey number 2, to detect respectively, Fungi, Bacillus and lactose fermenting entero-
bacteria. For Bacillus, samples also heat shocked at 80° C for 1 min before plating. 
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than the 66-7 8% recorded in Table 1. The higher rates of kill were thought to reflect 
the presence, in some raw materials, of a greater proportion of organisms showing a 
high susceptibility to the killing effect of compression. 
A reduction in total viable count can be anticipated for certain types of tablet where 
raw materials are subject to particular treatment during the manufacturing process. 
The processing may involve drying the material at SO'C for several hours, which kills 
the majority of organisms, other than those present in the form of spores. Similar 
reductions can be caused by treatments with solvents or antibacterial solutions such 
as industrial methylated spirit and benzalkonium chloride. Schiller et al. (1968) 
emphasize the importance of such treatments for reducing the total viable count, 
especially of heavily contaminated active ingredients. 
The organisms that are present in the raw material, and survive the granulation 
stage may be killed at the compression stage by a combination of two events. First, 
the compression force, of up to 5 tons, generates heat: the final temperature of tablets 
after compression is 40-SO'C. Secondly, the process gives rise to shearing forces that 
can cause mechanical damage to the cells. 
The importance of checking raw materials, as well as final products, for the pre-
sence of specific pathogens must be emphasized. Although the compression process 
will reduce the number of such organisms, it cannot be relied upon to kill them. In-
deed, the possibility is that the chance of detecting these organisms in samples of the 
final product is considerably reduced, which underlines the need for monitoring raw 
materials to ensure that the final product shall be free from potential pathogens. 
References 
British Pharmacopoeia. 1973. London. HMSO. A121-A123. 
BUHLMANN X. 1968. Method for microbiological testing of non--sterile pharmaceuticals. App/, 
Microbiol. 16 1919-23. 
COW AN P. and Steel J. 1974. Manual for Identification of Medical Bacteria. Second edition. 
Cambridge University Press. p. 104. 
FISCHER A., Fuglsang-Smldt B. and Ulrich K. 1968. IV. Tablets. Dansk Tidss. Farm. 42 125-31. 
FUGLSANG-SMIDT B. and Ulrich K. 1968. V. Tablets. Dansk Tidss. Farm. 42 257-63. 
GALLIEN R. 1972. Mikrobielle Kontamination van Fertigprodukten und Rohstoffen Problematik, 
Ergebnisse Schlubfolgerun93n. Pharm. lnd. 34 929-32. 
HARREWIJN G. A., Mossel D. A. A. ana ae Groote J. 1972. Assessment of the bacteriological 
safety of lactose. Neth. Milk Dairy J. 26 141-8. 
KALLINGS L. 0., Ernerfeldt F. and Silverstolpe L. 1965. The 19641nquiry by the Royal Svvedish 
Medical Board into microbial contamination of medical preparations; final report. 
KALUNGS L 0., Ernerfeldt F., Ringertz 0. and Silverstolpe L. 1966. Microbiological conta-
mination of medical preparations. Acta Pharm. Suecica 3 219. 
KRUGER D. 1973. A contribution to the subject of microbial contamination of active ingredients 
and adjuvants. Drugs made in Germany 16 111-25. 
PEDERSEN E. A. and Ulrich K. 1988. Microbial content in non-sterile pharmaceuticals. Dansk 
Tid~s. Farm. 42 71-83. 
SCHILLER 1., Kuntscher H., Wolff A. and Ne kola M. 1968. Microbial content of non-sterile 
therapeutic agents containing natural or seminatural active ingredients. Appl. Microbial. 16 1924-8. 
STOTT J. A., Hodgson J. e. and Chaney J, C. 1975. Incidence of Salmonellae in animal feed and 
the effect of pelleting on content of Enterobacteriaceae. J. A pp/. Bact. 39 41-56. 
SYKES G. 1971. The control of microbial contamination in pharmaceutical products for oral 
and topical use. J. Mond. Pharm. 14 8-21. 
United States PharmacopOeia XIX. 1975. Easton, Pennsylvania. Mack Printing Company, p. 588-92. 
Accepted 18 August 1977 
45 Effect of compression on microbial content of tablets 
• 
.. 
I 
News to Authors 
We can process your manuscripts for CYTOBIOS and MICROBIOS rapidly providing 
the typescript and illustrations have been carefully and accurately prepared in the 
correct style. 
Papers for MICROB lOS LETTERS will be published very swiftly indeed, and in 
many instances take only about eight to ten weeks from acceptance to publication . 
In general, manuscripts for MICROBIOS LETTERS should not exceed 5,000 words in 
length and include only one or two Tables and/or Figures. Those papers which are too 
long for MICROBIOS LETTERS on submission will be considered for either MICROBIOS 
or CYTOB lOS. 
By following the style of our biomedical journals you can obtain the advantages of 
some of the most rapid publication rates for research papers available anywhere. 
Read the leaflets prepared for authors, entitled Information for contributors and 
Photographic illustrations, and send manuscripts for the biomedical journals 
MICROBIOS, CYTOBIOS and MICROBIOS LETTERS to The Executive Editor, 
The Faculty Press, 88 Regent Street, Cambridge, England. 
·• 
* 
* 
* 
* 
* 
MICROBIOS, CYTOBIOS and MICROBIOS LETTERS are all prestige biomedical 
research journals. 
Each author receives a free copy of the journal issue in which the paper 
is published. 
Fifty free reprints in attractive covers. 
World~wide distribution, so authors invariably receive many requests for reprints. 
Three volumes of each title are published annually. Each volume consists of three 
to four issues. 
Subscription rates and leaflets for authors are available from 
The Faculty Press, 88 Regent Street, Cambridge, England 
THE FACULTY PRESS 88 Regent Street Cambridge England 
• 
• 
,• 
-, 
' ' 
·T' 
···~ 
60 COMMUNICATIONS, J. Pharm. Pharmac., 1977, 29, 60 
An enzymic technique for the microbiological examination of 
pharmaceutical gelatin 
K.A. C. CHESWORTHt, A. SINCLAIR, R. J. STRETTON*, W, P. HA YEs*, Glaxo Laboratories Ltd., Analytical Department, 
Barnard Castle, Co. Durham and *Chemistry Department, University of Technology, Loughborough, Leics., U.K. 
The liability of gelatin to contamination with pathogenic 
micro~organisms has been recognized by the United 
States Pharmacopeia XIX (1975) and by the British 
Pharmacopoeia (1973). The former requires the absence 
of Esc~erichia coli and Salmonella from a sample of 
10 g of gelatin and imposes a total count limitation of 
1000 organisms g-1• The British Pharmacopoeia specifies 
that E. coli be absent from a 1 g sample and Salmonella 
from 10 g. 
Methods for the examination of gelatin usually 
involve enrichment in broth, with or without initiaJ 
solubilization, at 45° (Leininger, Shelton & Lewis 1971; 
U.S.P. 1970; B.P., 1973), Membrane filtration is an 
alternative to the direct enrichment method and is 
recommended by Biihlmann (1968) and by Miiler & 
Korczynski (1972) as a suitable technique for the 
testing of soluble material. Membrane filtration has 
two advantages if used for the testing of gelatin: 
1. After filtration, the membrane can be placed in 
broth and enriched without producing a viscous solution. 
Rose (1972) states that viscosity complicates the 
recovery of Salmonella from gelatin. Our own observa-
tions indicate that increase in viscosity tends to reduce 
microbial growth. 
2. The membrane can be placed directly on an agar 
plate or nutritive pad. Depending upon the medium 
used, this procedure can give either a total microbial 
count or the count of a specific organism such as 
Salmonella or E. coli. 
Aqueous solutions of gelatin up to concentrations of 
10 % prepared by warming at 45°, proved difficult to 
filter through 0·45 p.m pore size membranes. Hence an 
alternative procedure using enzymic solubilization of 
gelatin was examined and the weights of gelatin filterable 
by each of the two methods described were compared. 
In each of the procedures described gelatin powder 
(10 g) was added to 0·1 % peptone water (100 ml) to 
give a concentration of 10 % w/v. 
Method 1, Non-enzymic procedure. The peptone-gelatin 
suspension was held at 8-10° for 1 h then at 45° for 30 
min, or longer if the gelatin failed to dissolve. The 
resultant viscous solution was diluted 1 f times in 
peptone water (0·1 %) (45°) containing Tween 80 
(0·1 %) and :filtered through a membrane (Sartorius 
0·45 .urn, 47 mm diameter). 
Method 2, Enzymic digestion. A sterile solution of a 
protease {'Proteinase', Nutritional Biochemicals Cor-
poration, Ohio) was added to the peptone-gelatin 
suspension, and incubated at 37o for between 25 and 45 
min, depending upon the rate at which the gelatin sample 
t Correspondence. 
dissolved. The solution obtained was diluted 1 t times 
with peptone-Tween solution (37°) and filtered as in 
Method I. 
Protease 1Q-20 mg g-1 of gelatin, adequately solu-
bilized most gelatin samples. However, some samples 
required up to 50 mg g-1 of gelatin. Thus, 5 mg m1-1 is 
the niaximum protease concentration used in the 
stated method. 
Gelatin suitable for use in pharmaceutical pre-
parations was obtained from five suppliers, the 33 
samples obtained included 18 different makes or grades. 
Each sample was solubilized using the two procedures 
described, and the quantities of gelatin from each that 
could be :filtered through a single membrane were 
compared. When solubilized by the enzymic procedure, · 
gelatin filtered was greater by weight for all samples than 
gelatin not enzymatically treated. Although in many 
cases the 10 g sample of gelatin could not be filtered 
through one membrane :filter it could all be sampled 
using two :filters. This represents an improvement over 
the non-enzymic procedure where less than 25 % of the 
gelatin samples could be sampled using two filters. 
To ensure the enzymatic procedure had no adverse 
affect on the recovery of bacteria, control tests were 
carried out using Escherichia coli (NCTC 9002), 
Salmonella abony (NCTC 6017), Pseudomonas aeruginosa 
(NCTC 6750) and Staphylococcus aureus (Glaxo 
Laboratories Strain PRIV). 
The organism was added to a 5 mg ml-1 solution of 
the protease in peptone water (0·1 %). The solution was 
then held at 37° and viable counts made at 15 min 
intervals for 60 min. 
The survival curves indicated that none of the four 
types of bacteria had changed significantly in numbers 
during this time. 
To demonstrate that these four organisms could be 
recovered by the enzymfc technique 50 bacteria of each 
type were inoculated into a protease gelatin mixture 
(5 mg mi-1 of enzyme) and the solubilization and 
filtration procedures were carried out. The membrane 
:filters obtained were either enriched in accordance with 
the B.P. 1973 method or placed directly on selective 
agar media: for S. abony-bismuth sulphite; for Ps. 
aeruginosa-Pseudosel (Biihlman, 1968); forS. aureus-
Baird Parker and for E. coli-MacConkey (Oxoid 
No. 2). The organisms were detected by both the B.P. 
1973 method and the direct selective agar technique. 
This last test was repeated to obtain a quantitative 
estimation of the recovery of S. abony and E. coli. The 
counts on the selective media were compared with 
control counts obtained by inoculating peptone water 
(0·1 %). 
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Table 1. Replicate 10 g samples of gelatin tested for E. coli contamination using 1-B.P. 1973 test, direct enrichment 
of gelatin; If- enrichment of membrane filter in accordance with B.P. 1973: JII-Incubati'on of membrane filter on 
MacConkeyagar no. 2, IV-U.S.P. test, direct enrichmentofgelatin;V-enrichment of membrane filter in accordance 
with U.S.P. ,· VI-Incubation of membrane filter on MacConkey agar no. 2. 
Number of Samples *Time (h) to obtain Mean viable 
replicate positive 'suspect' 'confirmed' E. coli count 
~ . Recovery samples for E. coli after positive positive per lOg of procedure 24h gelatin 
I 9 6 48 72 
( .... 11 9 5 48 72 
Ill 10 6 24 48 3 
IV 15 I 48-72 72-96 
V 15 6 48 72 
VI 15 9 24 48 2 
• Suspect positive B. coli-Considered as colony with E. coli characteristics on MacConkey agar no. 2, or, in case 
of B.P. test, acid and gas production from MacConkey broth (37°) and indole production (37°), 
Confirmed positive E. coli-Isolates producing acid and gas from MacConkey broth (44°) and producing indole 
(44°) or isolates confirmed biochemically. 
The t-test for differences between the pairs of 
results (10 replicates) showed no significant difference 
between the control and the test results at the 5 % level, 
indicating that the enzymatic treatment did not affect 
the viability of the organisms. 
Samples of gelatin (10 g) were tested for E. coli 
contamination using the B.P. 1973 procedure. Equiva~ 
lent samples of gelatin were solubilized enzymatically 
and filtered, the membranes were then either enriched 
according to the B.P. procedure or incubated on 
MacConkey Agar No. 2. Before placing the membranes 
on MacConkey agar, they were incubated on a pad 
soaked in 'Resuscitation Membrane Broth' (Oxoid) for 
2hat37°. 
A similar set of comparative recoveries were carried 
out based on the U.S.P. XVIII procedure. The U.S.P. 
enrichments were examined after 24 h and little visible 
growth occurred when compared with either the lactose 
broth containing membranes or the B.P. enrichment 
technique. This may be due to the lower incubation 
temperature recommended in the U.S.P. of 30-35°, 
rather than 37°, which will give a gelatin solution of 
lower viscosity. 
The results summarised in Table 1, show that E. coli 
occurring as a natural contaminant of gelatin can be 
recovered using the enzymatic procedure with the same 
efficiency as the B.P. procedure, and possibly more 
efficiently than the U.S.P. procedure. If the membranes 
are placed directly onto MacConkey agar No. 2 a 
quantitative estimation of E. coli is obtained and suspect 
and confirmed positive results for E. coli can be obtained 
24 h sooner than by enrichment techniques. 
The enzymic procedure offers membrane filtration as 
a practical alternative method for the examination of 
high grade gelatin suitable for inclusion in pharmaceu-
tical preparations. 
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